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Abstract 
Innate immunity is the first line of defense against microbes and it is 
indispensable in preventing infections as well as in the development and 
regulation of the adaptive immune system. Innate immunity is based on the 
ability of genome-encoded proteins to recognize and bind microbial surface 
structures, which is followed by the activation of the innate immune response via 
various cell signaling pathways.  
Tumor necrosis factor receptor (TNFR) signaling and cytokine release are 
strictly regulated and essential for a normal immune response. However, in 
certain diseases, like infections and autoimmune diseases, cytokines are 
produced in excess, which prolongs the inflammation and causes tissue damage. 
Clinical medicine is trying to prevent cytokine overproduction by suppressing 
TNFR signaling. However, this is challenging, since despite the extensive 
research carried out in this field in recent years, the mechanisms and regulation 
of TNFR signaling are not thoroughly understood. 
The pathways of innate immunity signaling are evolutionarily conserved 
from insects to humans. Unlike mammals, insects have no adaptive immunity, 
and hence they are completely dependent on their innate immune response. For 
these reasons the fruit fly (Drosophila melanogaster) is a suitable model 
organism for studying innate immunity. In Drosophila, the immune response to 
Gram-negative bacteria is mediated mainly via the Imd (immune deficiency) 
signaling pathway, whose intracellular parts resemble the mammalian TNFR 
signaling pathway. The aim of this research project was to identify and 
molecularly characterize the components of the Imd pathway and regulatory 
proteins using a large-scale RNA interference (RNAi) screen. The function and 
importance of three of the identified regulators, namely Tak1-associated binding 
protein 2 (Tab2), Inhibitor of apoptosis 2 (Iap2), and Poor Imd response upon 
knock-in (Pirk), were then further assessed. Using Drosophila S2 cells we 
showed that Tab2 is essential for both the early and sustained immune responses, 
while Iap2 mainly regulates the sustained immune response. In addition, we 
discovered that when Iap2 was removed from fruit flies by in vivo RNAi the flies 
became susceptible to Gram-negative bacterial infections.  
Pirk was a previously unknown protein that we demonstrated could suppress 
the Imd pathway activity both in S2 cells and in flies. The inhibitory action of 
Pirk was shown to be efficient enough to sensitize the flies to Gram-negative 
bacterial infections. We found that Pirk interacts with the receptor of the Imd 
pathway, PGRP-LC (Peptidoglycan recognition protein LC), and the down-
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stream component IMD. However, the elucidation of the exact mechanism of 
Pirk action requires further studies. 
The present study demonstrates that Imd signaling is strictly regulated and 
more complex than was previously thought. Drosophila as a model organism 
provides tools to efficiently study innate immunity. In addition, the results 
gained from this research in flies can provide new perspectives and may help 
understand also the mechanisms of signaling in the mammalian innate immune 
system. 
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Tiivistelmä 
Synnynnäinen immuniteetti on elimistön ensimmäinen puolustusjärjestelmä 
taudinaiheuttajia vastaan. Se on välttämätön niin infektioiden ehkäisyssä kuin 
hankitun immuunivasteen kehityksessä ja säätelyssä. Synnynnäinen immuniteetti 
perustuu siihen, että perimän koodaamat proteiinit kykenevät tunnistamaan 
erilaisia mikrobien pintarakenteita ja välittämään tästä tiedon soluille 
signalointireittejä pitkin. TNFR (tuumorinekroositekijäreseptori) -signalointi-
reitti ja sen käynnistämä sytokiinieritys ovat tarkkaan säädeltyjä ja 
välttämättömiä normaalille immuunivasteelle. Kuitenkin tietyissä sairauksissa, 
kuten infektioissa ja autoimmuunitaudeissa, liian voimakas sytokiinituotanto 
ylläpitää tulehdusta ja aiheuttaa kudostuhoa. Liiallista sytokiinien tuotantoa 
voidaan estää TNFR-signalointia hillitsemällä. Tämä on kuitenkin haastavaa, 
sillä huolimatta alalla viime vuosien aikana tehdystä tutkimuksesta, 
signalointimekanismeja ja niiden säätelyä ei vielä täysin tunneta.  
Synnynnäisen immuniteetin signalointireitit ovat säilyneet evoluutiossa 
hyönteisistä ihmisiin. Hyönteisillä ei nisäkkäistä poiketen ole lainkaan hankittua 
immuniteettia, vaan ne ovat täysin riippuvaisia synnynnäisestä immuniteetistaan. 
Näistä syistä banaanikärpänen (Drosophila melanogaster) sopii hyvin 
mallieläimeksi tutkittaessa synnynnäisen immuniteetin toimintaa. 
Banaanikärpäsellä immuunivaste Gram-negatiivisia bakteereita kohtaan välittyy 
Imd-signalointireitin kautta, joka solunsisäisiltä osiltaan vastaa nisäkkäiden 
TNFR-signalointireittiä. Tässä tutkimusprojektissa pyrimme RNAi (RNA-
häirintä)-seulaa käyttäen tunnistamaan Imd (immune deficiency)-
signalointireittiin kuuluvia ja sen säätelyyn osallistuvia proteiineja. Näistä 
kolmen uuden säätelijän, Tab2:n (Tak1-associated binding protein 2), Iap2:n 
(Inhibitor of apoptosis 2) ja Pirkin (Poor Imd response upon knock-in), toimintaa 
ja merkitystä banaanikärpäsen Imd-signaloinnille selvitettiin tarkemmin. 
Osoitimme solumallia apuna käyttäen, että Tab2 on välttämätön niin välittömälle 
kuin pitkäkestoiselle immuunivasteelle, kun taas Iap2 osallistuu vain 
pitkäkestoisen immuunivasteen säätelyyn. Lisäksi havaitsimme, että 
banaanikärpäset, joilta Iap2 on poistettu in vivo RNAi-menetelmää käyttäen, ovat 
herkkiä Gram-negatiivisten bakteerien aiheuttamille infektioille. 
Pirk on aiemmin tuntematon proteiini, jonka osoitimme hillitsevän Imd 
signalointia sekä solumallissa että elävissä kärpäsissä. Pirkin vaikutus oli niin 
tehokas, että geenin yli-ilmentäminen kärpäsissä riitti herkistämään ne Gram-
negatiivisten bakteerien aiheuttamille infektioille. Havaitsimme, että Pirk 
vuorovaikuttaa Imd-signalointireitin reseptorin, PGRP-LC:n (Peptidoglykaania 
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tunnistava proteiini LC), ja IMD:n kanssa. Sen toiminnan tarkkaa mekanismia ei 
kuitenkaan vielä tunneta. 
Tehty tutkimus osoittaa, että Imd signalointi on tarkkaan säädeltyä ja 
aiempaa luultua monimutkaisempaa. Banaanikärpänen mallieläimenä tarjoaa 
mahdollisuuden tutkia tehokkaasti synnynnäisen immuniteetin säätelyä. 
Tutkimuksesta saadut tulokset tuovat uusia näkökulmia myös nisäkkäiden 
immuunisignaloinnin toiminnan selvittämiseen. 
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1. Introduction 
The number of microorganisms in the human gut alone is approximately ten 
times the number of cells within the entire human body. Most of the microbes 
that accompany us throughout our lives are harmless commensals, or live in 
mutualistic relationship with us. But some species are harmful, and these we 
refer to as pathogens. To combat pathogens, organisms have developed efficient 
host defense systems that involve recognition of the microbe, a signaling 
machinery to activate the immune response, and a battery of arms to kill the 
infectious agent. Yet the immune system needs continuous balancing and 
regulation, because both over-responsiveness and non-responsiveness to 
microbes may lead to detrimental outcomes. In addition, maintaining immunity 
is costly. Therefore, the host must adjust and target its resources correctly to 
avoid unnecessary loss of precious energy that otherwise could be used to 
promote growth or reproduction. 
From the microbe’s perspective the host is a rather hostile environment, 
although rich in nutrients. To be able to survive, the microbe must find its own 
niche within the host and escape the host’s immune system. Microbes achieve 
this by either avoiding detection or by suppressing the host’s innate immune 
system. This requires evolution and adaptation from the microbe, but is usually 
followed by co-evolution of the host: microbial adaptation creates selective 
pressure for the host to re-establish and improve the immune system once again. 
Hence, host-pathogen interactions are dynamic, and often involve multiple 
aspects of immune defence strategies. Investigating these interactions requires a 
global view on the organism’s responses. Due to the ethical problems related to 
carrying out the experiments in mammals, various non-mammalian model 
organisms are commonly used. Studies have revealed similarities in host defense 
mechanisms between species as well as in the strategies microbes use to avoid 
and survive these lines of defense.  
This study used the well-characterized and genetically tractable model 
organism Drosophila melanogaster to study innate immune signaling and signal 
regulation from the host’s perspective. The main focus was on the Drosophila 
Imd pathway. The Imd pathway is evolutionarily conserved and resembles the 
mammalian TNFR signaling pathway, which is implicated in inflammatory 
responses in mammals. By examining the Imd signaling in the Drosophila 
system, we hope to reveal new perspectives of host defense strategies also in 
mammals. 
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2. Review of the literature 
2.1 Innate immunity 
The human body provides a number of environmental niches for microbes to 
colonize in. The skin, respiratory tract, urogenital tract, and especially the 
intestine are crowded with various microorganisms that we are, under normal 
condition, happily unaware of. However, the same microbes contribute to the 
decay of our body after we have died. To prevent this from happening 
prematurely we need an efficient immune system to restrict the proliferation of 
commensal microbes, destroy the pathogenic ones, and deny their access to the 
parts of the body that need to be preserved sterile; in other words, to keep us 
alive. The epithelia and mucosa form a physical barrier between us and the 
environment. Proteolytic enzymes, low pH, reactive oxygen species (ROS) and 
the production of antimicrobial peptides (AMPs) limit microbial growth in our 
body. However, for more sophisticated defense mechanisms, the immune system 
needs to recognize putative pathogens by distinguishing self from non-self, and 
elicit an adjusted response against the detected target. In mammals, this involves 
both the innate and adaptive components of the immune system. This thesis 
focuses on innate immunity. 
The innate immune response has ancient origins and is present in all 
eukaryotes from unicellular organisms to plants, invertebrates and vertebrates. It 
is based on the ability of genome-encoded proteins to recognize and bind 
microbial structures. These pattern recognition receptors (PRRs) were first 
described by Charles Janeway Jr. in 1989, when he presented his famous 
hypothesis in the Cold Spring Harbor Symposium on Immune Recognition 
(Janeway 1989). According to this theory, microbial structures are recognized by 
the PRRs of the antigen-precenting cells (APCs), which in turn signal the 
presence of non-self and stimulate lymphocyte activation. After 20 years of 
research and the identification of various PRRs and signaling molecules that 
transfer the message from APCs to the cells of adaptive immunity, we can now 
admire how accurate this hypothesis was (Medzhitov 2009). 
PRRs are unique in their ability to bind a broad range of molecules that have 
a common structural motif referred to as pathogen associated molecular patterns 
(PAMPs) (Janeway 1989) or microbe associated molecular patterns (MAMPS). 
The detected molecules usually fulfil the following criteria: they are constantly 
present in certain types of microbes but not in host cells allowing the 
discrimination between self and non-self, and they play essential roles in 
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microbe physiology, which limits the possibility of the microbes to escape 
detection through the adaptive evolution of these molecules. MAMPs are 
therefore often structural components of the cell wall, such as peptidoglycan 
(PGN), lipopolysaccharide (LPS), lipoteichoic acid, and lipoproteins from 
bacteria, and β-glucan of the fungal cell wall. Viral particles are synthesized 
within the host cells and therefore can not be distinguished as non-self similarly 
to bacterial or fungal components. Viruses are therefore recognized on the basis 
of differences between host and viral DNA or RNA as well as the subcellular 
localization of these nucleic acids. A variety of PRRs have been identified so far, 
the Toll-like receptors (TLRs), C-type lectins and proteins of the NOD 
(nucleotide-binding oligomerization domain) family probably being the best 
characterized ones (Medzhitov 2007). 
TLRs bind a large array of MAMPs and induce inflammatory and 
antimicrobial responses. They also activate macrophages, which in turn produce 
pro-inflammatory cytokines including tumour necrosis factor (TNF) and 
interleukins IL-1β and IL-6. These molecules trigger specific cell signaling 
pathways to activate the local and systemic inflammatory responses. The 
responses launch local coagulation cascades to prevent microbial dissemination 
via the blood circulation system and increase the permeability of blood vessels 
thus facilitating the recruitment of leukocytes and serum proteins to the site of 
infection. Furthermore, the acute phase proteins produced in hepatocytes activate 
complement and opsonize pathogens to be phagocytosed by neutrophils and 
macrophages. Dectin 1 is a transmembrane receptor present on dendritic cells 
and macrophages, and it belongs to the group of C-type lectins. Dectin 1 binds β-
glucan and has therefore an important function in antifungal defense, being 
involved in the phagocytosis of fungal cells and the production of reactive 
oxygen species (ROS) and cytokines. NODs are responsible for PGN recognition 
in vertebrates, and initiate signaling pathways that regulate the production of 
pro-inflammatory cytokines and chemokines. In addition, NOD signaling 
recruits neutrophils to the site of infection and contributes to the initiation of 
adaptive immune responses (Hargreaves and Medzhitov 2005, Medzhitov 2007, 
Medzhitov 2009, Iwasaki and Medzhitov 2010). 
Since PRRs themselves can not distinguish a pathogen from a symbiotic or 
commensal microbe, adjusting the innate immune response adequately requires 
delicate balancing via multiple cell signaling pathways. Many of these signaling 
pathways involve the activation of NF-κB transcription factors. The next 
chapters will provide a simplistic view on the regulatory mechanisms associated 
with these complex pathways. 
2.2 NF-κB signaling cascades 
NF-κB is a transcription factor that regulates the expression of multiple target 
genes involved in various cellular processes including the immune system 
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(Ghosh et al. 1998, Li and Verma 2002). In mammals, the NF-κB protein family 
consists of five related transcription factors, p50, p52, p65 or RelA, c-Rel and 
RelB (Moynagh 2005, Perkins 2007). Of these, p50 and p52 are derived from the 
larger precursor proteins p105 and p100, respectively. What is common to all 
these proteins is the N-terminal DNA-binding domain called the Rel homology 
domain (RHD), which mediates dimerization and binding of the proteins to their 
DNA target sequence at the promoter region of the genes whose expression they 
modulate. The transcriptional activity of NF-κB is regulated by the composition 
of the homo- or heterodimer, as well as interactions with inhibitory proteins 
called IκBs. Binding of IκB to NF-κB suppresses the transcription activity by 
preventing the nuclear translocation of NF-κB (Li and Verma 2002, Perkins 
2007). 
NF-κB signaling pathways are classified in two categories: the canonical and 
non-canonical pathways. In both pathways the fundamental steps in signal 
transduction are approximately the same. In the canonical pathway, ligand 
binding to a cell surface receptor leads to the recruitment of adaptor proteins to 
the cytoplasmic domain of the receptor. These adaptor proteins initiate signaling 
steps that activate the IκB kinase (IKK) complex. The IKK complex consists of 
the catalytic kinase subunits IKKα and IKKβ, and a regulatory subunit IKKγ, 
also called NEMO. The IKK complex phosphorylates the NF-κB inhibitor IκB, 
which leads to degradation of IκB and the release of NF-κB, which in turn can 
translocate into the nucleus and initiate the transcription of target genes (Gilmore 
2006, Perkins 2007). IκB is one of these genes, providing a negative feed-back 
loop for the regulation of the pathway’s activity. 
While the canonical pathway activates NF-κB dimers consisting of RelA, 
RelB, c-Rel, and p50, the non-canonical pathway activates p100/RelB 
complexes. Signaling via the p100/RelB complex is implicated in the generation 
of B and T lymphocytes during the development of the lymphatic system, and 
triggered by a relatively small group of cell-differentiating stimuli, such as 
lymphotoxins and B cell activating factor (BAFF). The signal is propagated via 
NF-κB-inducing kinase (NIK) to the IKK complex, which in this case comprises 
of two IKKα subunits and lacks the regulatory subunit IKKγ. The IKKα complex 
then activates p100. p100 is cleaved into its active form p52, which dimerizes 
with RelB and translocates into the nucleus (Hayden and Ghosh 2004, Moynagh 
2005). A simplified model of NF-κB signaling is depicted in Figure 1. 
NF-κB signaling regulates the expression of pro-inflammatory cytokines, 
chemokines and other inflammatory molecules. It has been implicated in various 
autoimmune diseases as well as in cancer. Multiple upstream cell signaling 
pathways activate NF-κB signaling, one of them being the TNFR signaling 
pathway, which will be described next. 
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Figure 1. NF-κB signaling. 
2.2.1 TNFR signaling 
For more than a century it had been known that malignant tumors are often 
reduced in size due to bacterial infections. However, the molecule responsible 
for the tumor suppressing activity, tumor necrosis factor (TNF), was not 
discovered until 1984 (Pennica et al. 1984). Besides inducing apoptosis in certain 
tumor cells, TNF is involved in immune signaling, and necessary for a normal 
immune response. Disturbances in TNF production or signal regulation may 
have severe consequences, and TNFR signaling has been implicated in a large 
variety of human diseases, including sepsis, diabetes, cancer, and autoimmune 
diseases. Due to their importance to human health, TNF and TNFR signaling 
have been intensively studied, and many aspects of the signal regulation have 
already been unveiled. The signaling has turned out to be very complex, not only 
because there are multiple TNF receptors and partially redundant signaling 
pathway components that are activated in a tissue and cell-specific manner, but 
furthermore because TNFR signaling branches into other signaling pathways, 
and the sequential activation of these is not thoroughly understood. The TNFR1 
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signaling cascade described here is therefore a very simplified overview of the 
complex signaling regulatory networks that are triggered in response to TNF. 
TNF is a cytokine that trimerizes and binds its transmembrane receptor 
TNFR on the plasma membrane. The binding releases a protein called SODD 
(silencer of death domain) from the intracellular domain of TNFR, which in turn 
leads to the recruitment of TRADD (TNF receptor associated death domain), 
RIP (receptor interacting protein), TRAF2, and FADD to the signaling complex 
(Hehlgans and Pfeffer 2005). From here, the pathway branches into three 
cascades: apoptosis signaling, mitogen activated protein kinase kinase kinase 
(MAPKKK) signaling, and NF-κB signaling. Apoptosis signaling is initiated by 
the FADD-mediated recruitment of caspase-8 to the TNFR signaling complex. 
Caspase-8 is thereafter activated, possibly by self-cleavage, which triggers a 
protease cascade leading to apoptosis. Inhibitor of apoptosis proteins c-Iap1 and 
c-Iap2, which also have E3 ubiquitin ligase activity, are recruited by TRAF2, and 
regulate the caspase-mediated apoptosis signaling. TRAF2 also signals to 
MAPKKKs, such as MEKK1 or ASK1. These kinases initiate kinase signaling 
cascades, which in turn result in JNK pathway activation. The third arm of 
TNFR signaling leads to the activation of NF-κB, and this requires RIP. The 
signal is propagated to the IKK complex, which consists of two catalytic 
subunits (IKKα, IKKβ) and the regulatory subunit IKKγ. In addition, two 
chaperone proteins Cdc37 and Hsp90 are involved in the regulation of the 
subcellular localization of the IKK complex. The IKK complex phosphorylates 
IκB, which releases NF-κB that sequentially translocates to the nucleus and 
initiates transcription of its target genes, such as inflammatory cytokines (Chen 
and Goeddel 2002). The TNFR1 signaling pathway is illustrated in Figure 2. 
In mammals, research on TNFR signaling is often conducted in continuous 
cell lines or mouse-derived cells ex vivo, since many of the TNFR pathway 
mutants induce lethality. To gain an organismal view on the signaling and to 
avoid the compensatory effects of adaptive immunity, non-mammalian model 
organisms have been used. Innate immune signaling pathways are conserved 
throughout evolution from insects to mammals. Therefore it is not surprising that 
also the mammalian TNFR signaling cascade has its counterpart in Drosophila. 
Despite the receptor itself being different in flies, the intracellular components of 
the Drosophila Imd (immune deficiency) signaling pathway share striking 
similarities with TNFR pathway components. Although research performed in 
flies cannot be directly extrapolated to humans, understanding the signaling in 
Drosophila may still broaden our minds and fuel new ideas for how the signaling 
regulation works in the mammalian system. 
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Figure 2. TNFR1 signaling. 
2.3 Drosophila as a model organism 
The human urge to conquer diseases, promote longevity and improve the quality 
of life drives us continuously to search for new drugs and treatments. 
Maintaining the balance that we call health requires complex cell signaling 
networks and careful regulation that we do not yet thoroughly understand. But 
due to obvious ethical and practical problems we cannot study humans on the 
organismal level to answer questions on how the human body functions in 
response to environmental stresses. There are also limitations to the use of other 
mammalian models. The life span of the mouse or rat, although short compared 
to humans, seems an eternity to a scientist who needs to complete his crossing 
scheme and carry out his experiments on the offspring. Ethical concerns reduce 
the amount of animals one can sacrifice for science, and the requirements of a 
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controlled environment and constant professional care make experiments in 
mammals expensive. The question therefore arises if we can overcome these 
problems by using non-vertebrate models, such as nematodes or flies, for 
studying human diseases. 
Drosophila melanogaster has been used as an experimental model organism 
for more than a hundred years. It is big enough to be easy to handle under the 
microscope but small enough not to require too much laboratory space.  
Drosophila are inexpensive to maintain, fast in reproduction and relatively short-
lived. Before anyone even knew how genetic information was encoded in the 
chromosomes the first studies on linkage groups were performed by Calvin 
Bridges in Drosophila. The large polytene chromosomes in Drosophila larval 
salivary glands served as the first rough map of the fly genome, greatly 
facilitating the scientific work before releasing the first annotated sequence of 
the entire fly genome in 2000 (Adams et al. 2000). The intensive and systematic 
genetic research carried out in Drosophila for so many decades has also yielded 
wonderful tools for scientists. The balancer chromosomes, EMS mutagenesis 
screening, and stock collections of mutant fly lines and deficiencies have long 
been part of the fly scientist’s tool box. More recently, P element techniques 
developed by Rubin and Spradling (Rubin and Spradling 1982, Spradling and 
Rubin 1982), tissue-specific expression of genes or RNAi constructs using the 
UAS-GAL4 expression system by Brand and Perrimon (Brand and Perrimon 
1993), and the genome-wide collection of RNAi fly lines (Dietzl et al. 2007) 
have further broadened the possibilities of studying gene function in Drosophila 
in vivo. Moreover, the availability of the genome sequences of twelve related 
Drosophila species provides a unique opportunity for evolutionary studies (The 
12 Genomes Consortium 2007). And if these factors are not attractive enough, 
Drosophila offers a compact genome with less redundancy compared to humans. 
This means that the effects of gene knock-outs, which in mammals might be 
masked by related proteins sharing the same functions, are more likely to be 
detected in Drosophila. In addition, the fundamental mechanisms of cell biology 
are evolutionarily conserved, and it has been estimated that 77% of the genes 
associated with human diseases have corresponding ones in the fly genome 
(Reiter et al. 2001, Chien et al. 2002). This also applies to the innate immune 
signaling pathways, of which the most famous example is the discovery of the 
Toll-like receptors (Medzhitov et al. 1997) soon after the importance of Toll for 
the fly immune system had first been described (Rosetto et al. 1995, Lemaitre et 
al. 1996).  
Insects do not have adaptive immunity, which makes them totally dependent 
on their innate immune response. Compared to mammalian models, in which the 
adaptive immune response can compensate and hide the phenotype of interest, 
experiments carried out in flies are easier to interpret. Together with the less-
redundant, well annotated genome, the ease of performing genetic screens, and 
the possibility of generating inducible knock-down and overexpression 
constructs have made Drosophila a popular model organism in studying 
conserved cellular mechanisms and signaling pathways. 
2.4 Overview of the Drosophila immune system 
Drosophila lives in a natural environment that consists of decomposing fruits 
and is rich in bacteria and fungi. The fly therefore needs an effective and well-
adjusted immune response to be protected from pathogens, simultaneously 
tolerating the commensal bacteria in the gut. In contrast to mammals, Drosophila 
has no adaptive immunity. However, Drosophila has developed a sophisticated 
innate immune defense (reviewed by Lemaitre and Hoffmann 2007) and is 
highly resistant to microbial infections, which makes it a good model for 
studying innate immunity. 
Drosophila immunity relies on multiple mechanisms that can be roughly 
divided into cellular and humoral responses. Drosophila’s circulating blood 
cells, hemocytes, are capable of phagocytosing bacteria. Bigger objects that are 
too large to be phagocytosed are encapsulated by specialized cells called 
lamellocytes. The activation of proteolytic cascades leads to clotting of 
hemolymph and melanin formation. Finally, the recognition of microbial patterns 
triggers the activation of multiple cell signaling cascades and the synthesis of 
effector molecules, such as the antimicrobial peptides (AMPs), especially in the 
fat body. Figure 3 represents an overview of the Drosophila immune system. 
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Figure 3. Schematic presentation of the Drosophila immune system. 
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2.5 Cellular response 
Unlike mammals, insects do not have a closed blood-circulation system. Instead, 
the body cavity of both larvae and adult flies is filled with free-floating and 
sessile blood cells that are called hemocytes. Drosophila blood cells can be 
divided into three classes based on their appearance and functional properties: 
plasmatocytes, lamellocytes, and crystal cells (for a review, see Williams 2007). 
Due to the relative easiness of studying blood cells in larvae compared to adult 
flies, the following aspects are based on larval hemocytes. Plasmatocytes form 
the largest group by representing more than 90% of the hemocytes in non-
infected animals. Plasmatocytes are responsible for phagocytosing both apoptotic 
cells that need to be removed, as well as invading microbes. Lamellocytes appear 
large and flat, and they can only be found in larvae, although they are rare in 
healthy animals. In contrast, parasitoid wasp infestation readily induces the 
formation of lamellocytes. Lamellocytes primarily function by encapsulating 
foreign objects, such as parasitoid wasp eggs that are too large to be 
phagocytosed. The third group of cells, crystal cells, comprises approximately 
5% of the larval hemocytes. They are nonphagocytic and involved in the 
melanization process. The name crystal cell derives from the prophenoloxidase 
(pro-PO) crystals that the cells carry and release in response to activation. 
Phagocytosis is an evolutionarily conserved defense mechanism originally 
discovered in invertebrates, and recent research has even emphasized the 
similarities between invertebrate and vertebrate phagocytic machineries. 
Phagocytosis is a step-by-step process that involves the recognition and binding 
of the target followed by cytoskeletal reorganization, engulfment, internalization 
and destruction of the target within phagosomes. These mechanisms have been 
intensively studied in Drosophila, since the Drosophila embryonic hemocyte-
derived cell lines are capable of phagocytosis, and are easily manipulated by 
RNAi (Clemens et al. 2000). Based on multiple studies utilizing RNAi screening 
(Rämet et al. 2001, Rämet et al. 2002b, Pearson et al. 2003, Kocks et al. 2005) 
and mass spectrometry (Stuart et al. 2007), hundreds of proteins have been 
implicated in phagocytosis. Stuart et al. (2007) alone reported 617 proteins to be 
associated with phagosome formation, and their interaction network was mapped 
using a systems biology approach. Approximately 70% of these proteins have 
mammalian orthologs (Stuart et al. 2007). How the protein interaction network 
functions remains elusive. 
Several types of receptor proteins have been implicated in triggering 
phagocytosis. The two best-characterized ones are the multiple EGF-repeats 
containing protein called Eater, and Scavenger Receptor CI (SR-CI) (Kocks et al. 
2005, Pearson et al. 1995, Rämet et al. 2001). Other proteins belonging to the 
family of scavenger receptors, Croquemorte and Peste, have also been implicated 
in the phagocytosis of micro-organisms (Philips et al. 2005, Stuart et al. 2005). 
In addition, Croquemorte is required for the removal of apoptotic cells (Franc et 
al. 1996, Franc et al. 1999). PGRP-LC has been associated with phagocytosis 
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(Rämet et al. 2002b), although it is principally thought to mediate microbial 
recognition leading to the activation of the humoral arm of the Drosophila 
immune response. Last but not least, a very peculiar protein with more than 
18,000 putative isoforms, Dscam, has been reported to be required for efficient 
phagocytosis of bacteria (Watson et al. 2005). 
The engulfment and internalization of the target require the synergistic action 
of multiple pathways, especially those involved in cytoskeleton remodeling, 
vesicle trafficking, and other cellular functions, such as energy metabolism 
(Pearson et al. 2003, Stuart et al. 2007). Finally, the target is destroyed inside the 
phagosomes by a cocktail of lysosomal enzymes, reactive oxygen species, nitric 
oxide, and intracellular antimicrobial peptides. The exact mechanisms of this 
killing are not yet thoroughly understood. 
Opsonins are molecules that bind microbial surfaces and thereby promote 
microbial killing and phagocytosis. In Drosophila, thioester-containing proteins 
(TEPs) are a family of six secreted proteins, three of which are known to be 
induced upon infection (Lagueux et al. 2000). They are structurally related to the 
α2-macroglobulins and components of the mammalian complement system 
(Blandin and Levashina 2004). TEPs have been suggested to function as 
opsonins in Drosophila, but this has not yet been verified. Instead, in cultured 
cells of Anopheles gambiae TEP-1 has been associated with the opsonization of 
both Gram-negative and Gram-positive bacteria (Levashina et al. 2001). 
Foreign objects that are too big to be phagocytosed are insulated from the 
host tissues by encapsulation. This defense mechanism has developed to protect 
the host from parasitoid wasps that lay their eggs into Drosophila larvae. The 
process involves the detection and recognition of the wasp egg by plasmatocytes, 
which triggers a still poorly characterized signaling network resulting in the 
proliferation and activation of lamellocytes. Lamellocytes surround the foreign 
body and form a capsule around it. The intruder is eventually killed, although not 
always, inside the capsule probably due to ROS production or toxic 
intermediates of the melanization cascade. The molecular mechanisms involved 
in this process are largely unknown. 
Unlike mammals, insects have an open circulatory system. This means that to 
prevent the loss of body fluids after injury in the fly cuticle, efficient hemolymph 
clotting mechanisms are essential for the insect’s survival. Coagulation of the 
hemolymph also protects the host from micro-organisms that would otherwise 
enter through the wound. Instead of freely spreading into the host system, 
microbes are trapped into the clot. Clotting often involves melanization as well, 
but the latter is not required for the formation of the clot, since the coagulation 
system is effective also in the absence of PO activity (Scherfer et al. 2004). 
Instead, melanization of the site of injury is thought to contribute towards killing 
the microbes through the toxic intermediates released during the process 
(Scherfer et al. 2004, Theopold et al. 2004). Hemolymph clotting in Drosophila 
is relatively poorly understood compared to the other aspects of the immune 
defense. However, some proteins have been associated with coagulation, the 
best-studied ones being Hemolectin (Goto et al. 2001, Goto et al. 2003) and 
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Fondue (Scherfer et al. 2006). Hemolectin is a large hemocyte-specific protein 
that is the major structural component of the fibers forming the clot. In contrast, 
Fondue is not required for the formation of these fibers, but instead needed to 
cross-link them together (Scherfer et al. 2006). In addition, pull-down and 
proteomic analyses have identified other factors associated with clotting, such as 
mucin-like proteins and proteins involved in phenoloxidase cascades (Karlsson 
et al. 2004, Scherfer et al. 2004). 
Melanization is a rapid reaction that occurs at the site of cuticular injury or on 
the surface of an encapsulated parasitoid egg, and can be detected easily due to 
the black-coloured melanin that is synthesized in the process. Melanization is 
thought to be activated primarily by crystal cells that rupture in response to JNK 
signaling (Bidla et al. 2007) and release pro-PO. However, one of the three pro-
PO encoding genes in Drosophila is exclusively expressed in lamellocytes, 
suggesting that it might be involved in melanization during encapsulation (Irving 
et al. 2005). After pro-PO is released it is cleaved by a serine protease, and the 
cleaved PO sequentially activates the cascade leading to the production of 
melanin and toxic intermediates that may contribute to the killing of the 
microbes. The PO cascade must be strictly regulated to prevent excess 
melanization, and this inhibitory action is mediated by Serpin27A, a serine 
protease inhibitor that prevents pro-PO cleavage (De Gregorio et al. 2002). 
Overall, Drosophila has a sophisticated cellular response to pathogens 
consisting of both features that have been conserved in evolution and features 
that are unique to invertebrates. In addition, Drosophila has an efficient humoral 
immune response involving the production of potent antimicrobial peptides 
(AMPs). AMPs and the signaling events leading to the production of AMPs are 
described in the following chapters. 
2.6 Humoral response 
Besides the cellular responses, microbial challenge in Drosophila triggers the 
secretion of effector molecules from the fat body into the hemolymph. The fat 
body is an immune-responsive tissue, which is also involved in other functions, 
such as energy metabolism. It is therefore often referred to as the Drosophila 
equivalent of the mammalian liver. Being large in size, the fat body of a third 
instar larva extends almost throughout the entire larval body. Due to the open 
circulatory system hemolymph can freely surround the fat body, which in turn 
can, at least in theory, recognize the microbial components in the hemolymph 
and initiate AMP production. The role of hemocytes in the microbial recognition 
and initiation of AMP production is not completely understood, yet it is 
reasonable to assume that the circulating hemocytes that float around in the 
hemolymph might be able to recognize microbes and signal to the fat body that 
AMP production is needed. To support this, there is increasing evidence that 
signaling between hemocytes and the fat body is required for the full activation 
 
 
 
 
27
of the humoral immune response (Agaisse et al. 2003, Foley and O’Farrell 2003, 
Dijkers and O’Farrell 2007, Shia et al. 2009). 
In a normal homeostatic state no AMPs are transcribed and therefore they are 
not detected in the hemolymph. However, AMPs are readily synthesized and 
secreted during systemic infection, and the synthesis is paused once the intruding 
microbes have been destroyed. This process requires signaling, and multiple 
pathways are involved in the regulation of humoral responses. The most 
important ones for the production of AMPs are the Imd and Toll pathways. The 
Drosophila Imd pathway bifurcates to the JNK pathway, which besides 
controlling cell survival and apoptosis also plays a role in the regulation of AMP 
production. These three pathways will be discussed later in more detail. In 
addition, the Jak-STAT signaling pathway is known to regulate certain immune-
responsive genes, such as the genes encoding the complement-like protein Tep2 
implicated in opsonization, and Turandots, which have an unknown function but 
are known to be induced as a response to stress and septic injury (Ekengren and 
Hultmark 2001, Agaisse et al. 2003). However, Jak-STAT signaling is not 
essential to AMP release, since Jak-STAT deficient flies are shown to be as 
resistant to bacteria and fungi as wild-type flies. Instead, the mutants are more 
sensitive to the Drosophila C virus (Dostert et al. 2005). Understanding the 
function and importance of Jak-STAT signaling for the fly immune response 
requires further studies. 
2.6.1 Antimicrobial peptides 
Of all the various effector molecules produced upon infection, antimicrobial 
peptides (AMPs) are the best characterized. They are a heterogeneous group of 
peptides that share some common features: a relatively small size, positive 
charge, and antimicrobial properties against a variety of bacteria and even fungi. 
The Drosophila genome encodes 4 Attacins, 4 Cecropins, 7 Drosomycins, 2 
Diptericins, and one Drosocin, Defensin, and Metchnikowin (Imler and Bulet 
2005). These peptides have traditionally been classified into three families 
according to their microbe specificities, but since most of them are produced in 
response to both Gram-negative and Gram-positive bacteria, this kind of division 
can be confusing. In addition, Drosophila has several lysozymes that also play a 
role as digestive enzymes, and a male-specific AMP called Andropin, which is 
likely to locally protect the seminal fluid and reproductive tract from microbial 
infections (Samakovlis et al. 1991). Furthermore, Attacin C has been shown to 
be further processed into another antimicrobial peptide called maturated pro-
domain of Attacin C (MPAC). Cecropin and Drosomycin were the first AMPs to 
be associated with Toll pathway activation (Rosetto et al. 1995, Lemaitre et al. 
1996), but later it has been shown that their production can also be triggered by 
Imd signaling. Diptericin seems to be the only Imd pathway-specific 
antimicrobial peptide, and has therefore been widely used as a read-out in 
various assays monitoring Imd pathway activation. 
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The molecular mechanisms of how AMPs contribute to microbial killing are 
not yet understood. It has been proposed that cationic AMPs bind to the 
negatively charged microbial surfaces and break down the bacterial integrity by 
creating holes through which the bacterial contents leak out (Yang et al. 2000), 
by depolarizing the bacterial membrane (Westerhoff et al. 1989), or by inducing 
hydrolases that degrade the bacterial cell wall (Bierbaum et al. 1985). Since 
AMPs are structurally diverse, it seems plausible to think that more than one 
mechanism for bacterial killing exists. A model that could explain the function of 
most AMPs is referred to as the Shai-Matzuaki-Huang model (Matzuzaki et al. 
1999, Shai et al. 1999, Yang et al. 2000). According to this model the AMPs 
interact with the bacterial membrane, which leads to the displacement of lipids in 
the membrane, alteration of the membrane structure and in some cases 
penetration of the AMPs into the bacterial cell. Cholesterol in the host cell 
membranes is thought to stabilize the lipid bilayer thereby reducing the AMP 
activity that would otherwise harm the host as well. Whatever the mechanism 
behind the activity of AMPs, they are highly efficient and kill microbes at 
micromolar concentrations (Zasloff 2002, Imler and Bulet 2005). 
2.6.2 The Toll pathway 
Since the early 1980s the developmental function of the Toll pathway has been 
known crucial for the establishment of dorso-ventral patterning (Nüsslein-
Volhard at al. 1980). However, it wasn’t until the mid-1990s when the first 
indications of the importance of Toll signaling to the fly immune system were 
obtained. The first pieces of evidence came from Rosetto et al. (1995) who found 
that CecA1 could be induced by overexpressing the constitutively active form of 
Toll, Toll10B in Drosophila hemocyte-like mbn-2 cells. In addition, they showed 
that this induction was dependent on a κB binding site in the CecA1 promoter 
region. These findings were soon accompanied by a report from Lemaitre et al. 
(1996), where they demonstrated that the Toll pathway mutants were susceptible 
to certain fungi but had normal resistance to bacteria, such as the Gram-negative 
Escherichia coli. Shortly after, Medzhitov et al. (1997) identified the human 
homolog of Toll, and reported that the constitutively active form of human Toll 
(i.e. TLR) could induce NF-κB activation and expression of NF-κB target genes, 
such as the inflammatory cytokines. After these pioneering experiments, the Toll 
pathway has been even more extensively studied, and this has yielded a better 
but still incomplete understanding of the signal regulation. 
The intracellular components involved in development and immune signaling 
are nearly the same. Toll, which in Drosophila is not a PRR but a 
transmembrane receptor binding an extracellular protein Spätzle (Weber et al. 
2003), becomes dimerized after ligand binding, and this leads to the interaction 
of the adaptor protein MyD88 and Toll via their TIR domains. MyD88 also 
contains a death domain (DD), which sequentially recruits other DD-containing 
proteins, such as Tube and the kinase Pelle (Shelton and Wasserman 1993), to 
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the signaling complex (Sun et al. 2002). Tube apparently has separate binding 
sites for both MyD88 and Pelle, and can form heterodimeric or heterotrimeric 
complexes with these two proteins. In contrast, no interaction between the DDs 
of MyD88 and Pelle was detected, which implies that their interaction is 
mediated by Tube (Moncrieffe et al. 2008). An additional adaptor protein 
Weckle is required for embryonic development (Chen et al. 2006). It has been 
suggested that Pelle undergoes autophosphorylation (Shen and Manley 1998) 
and phosphorylates Toll and Tube before being released from the signaling 
complex (Sun et al. 2004). Then either activated Pelle or a yet unidentified 
additional kinase phosphorylates Cactus, which is the Drosophila IκB protein 
suppressing the Toll pathway activity. Phosphorylation of Cactus releases the 
NF-κB proteins Dorsal and Dif, which in turn translocate into the nucleus and 
initiate the transcription of their target genes. There are indications that 
additional phosphorylation steps are needed to further activate Dorsal (Edwards 
et al. 1997, Drier et al. 1999, Isoda and Nüsslein-Volhard 1994). Dorsal is 
thought to be more important for the transcription of genes involved in the 
formation of the dorsal-ventral axis, while Dif is thought to be activated in 
response to an immune challenge and to be involved in the transcription of 
immune-responsive genes, such as the AMPs Drosomycin and Metchnikowin 
(Meng et al. 1999, Rutschmann et al. 2000a). 
What then separates the dorso-ventral patterning from immune signaling, and 
contributes to the detection of both fungi (Lemaitre et al. 1996) and Gram-
positive bacteria (Michel et al. 2001)? The answer is the PRRs that in 
Drosophila Toll signaling are not membrane-bound but secreted proteins. A Lys-
type peptidoglycan, which is typical for Gram-positive bacteria, is recognized by 
PGRP-SA, PGRP-SD, and GNBP1 (This abbreviation stands for Gram-negative 
binding protein 1 due to a historical misnomery. Nowadays it is sometimes 
referred to as Glucan-binding protein 1). Two of these proteins, PGRP-SA and 
GNBP1, have been implied to associate with each other in the hemolymph 
(Gobert et al. 2003, Pili-Floury et al. 2004). It is not yet clear if these proteins 
have redundant functions or different specificities for various Gram-positive 
bacteria. The present evidence supports the hypothesis of partial redundancy 
(Bischoff et al. 2004). 
The response to fungi is based on the recognition of β-glucan that is a 
structural component of the fungal cell wall. A member of the GNBP family, 
GNBP3, structurally resembles the lepidopteran β-glucan recognition proteins. 
GNBP3 mutant flies are sensitive to fungal infections and fail to induce Toll 
signaling, which implies that GNBP3 is indeed required for the pathway’s 
activity (Gottar et al. 2006). In addition, the fungal virulence factors, such as 
proteases and chitinases that the entomopathogenic fungi secrete to cross the 
chitinous epitelia, trigger the Toll pathway via a serine protease called 
Persephone (Psh) (Ligoxygakis et al. 2002). Persephone is known to be 
negatively regulated by the serpin Necrotic (Levashina et al. 1999). 
Irrespective of whether the initial stimulus originates from bacteria or fungi, 
the recognition triggers proteolytic cascades that were previously thought to 
converge at Spätzle processing enzyme, SPE (Jang et al. 2006, Kambris et al. 
2006). SPE cleaves Spätzle, whereafter the activated Spätzle can bind Toll. SPE 
shares remarkable similarity with Easter, which is the Spätzle processing 
enzyme, which is active in the embryo (Chasan and Anderson 1989). Recently, 
El Chamy et al. (2008) demonstrated that a serine protease upstream of SPE, 
Grass, is involved in the recognition of both fungi and Gram-positive bacteria.  
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Figure 4. The Toll pathway. 
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Grass then activates another serine protease Spirit, which in sequence activates 
SPE. Based on this and the earlier data, the serine protease cascades leading to 
the activation of the Toll pathway have been proposed to divide into a PRR-
dependent pathway responding to bacterial or fungal cell wall components, and a 
so-called danger pathway responding to proteases and an abnormal proteolysis 
activating Psh (El Chamy et al. 2008, Ashok 2009). The current model for Toll 
pathway signaling is illustrated in Figure 4. 
Curiously, there are eight other Toll-resembling proteins in Drosophila. It has 
been speculated whether these would also play a role in immune signaling, but 
so far there is no evidence supporting this hypothesis. Toll signaling in general 
has been vigorously studied during the last couple of years, but many aspects of 
the signal regulation remain elusive. For example, the kinase that phosphorylates 
Cactus has not yet been identified. Furthermore, the negative regulation of the 
Toll pathway is poorly documented. The only negative regulator reported besides 
the IκB protein Cactus is WntD, which represses Toll signaling through a 
negative feedback loop. WntD is associated with embryonic development, but 
also reported to possess an immunity-related function (Ganguly et al. 2005, 
Gordon et al. 2005). Gordon et al. (2005) reported that WntD mutant flies 
showed elevated transcript levels of certain AMPs. Surprisingly, in wntD mutant 
flies the transcription of Dpt was most severely affected, while the transcript 
levels of Drs did not differ from controls. Although the transcription of AMPs 
can be activated by multiple pathways Dpt is considered Imd pathway-specific. 
In addition, wntD mutant flies were apparently more susceptible to Listeria 
monocytogenes infections than to wild-type flies (Gordon et al. 2005). The PGN 
of L. monocytogenes is a DAP-type PGN that is known to activate the Imd 
pathway instead of Toll signaling. Recently, Gordon et al. (2008) reported that 
both the Drosophila TNF homolog eiger, which encodes a known component of 
the JNK signaling pathway (Igaki et al. 2002), and a novel immunity gene edin 
are upregulated in Listeria-infected wntD flies.  
Together, these data suggest that Toll pathway signaling is more complex 
than was previously thought and involves interactions with other immune 
signaling pathways via mechanisms that are largely unknown. Innate immunity 
signaling cascades are meant to act synergistically and to a certain extent 
redundantly to fully protect the host from a variety of microbes. In addition, the 
Toll and Imd pathways have different temporal profiles. The Toll pathway 
response to microbes is observed later but is sustained longer, while the Imd and 
JNK pathways respond within minutes (Lemaitre and Hoffmann 2007). This may 
also reflect the different microbe specificities of these pathways, since the fungi 
recognized by PRRs signaling via Toll grow slowly compared to bacteria 
detected by the Imd pathway receptor (Steiner 2004). The regulation of Imd 
pathway signaling will be described next in more detail. 
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2.6.3 The Imd pathway 
The first indications of the existence of the Imd pathway were initially obtained 
by studying a fly line with a homozygous viable mutation in the second 
chromosome and with a very peculiar phenotype. The larvae of Bc (Black cells) 
flies have melanized black crystal cells in their hemolymph, and they develop 
melanotic tumors at temperatures higher than +21ºC. In addition, the 
transcription of AMPs was severely impaired in adult flies, excluding Drs 
(Lemaitre et al. 1995). This data implied that AMP induction was regulated by 
two separate pathways, one regulating the production of antibacterial and the 
other antifungal AMPs. The defective AMP response was shown to be 
independent of the Bc phenotype but dependent on a nearby mutation. According 
to this previously uncharacterized mutation, the corresponding gene was 
thereafter called imd (immune deficiency) (Lemaitre et al. 1995) and gave its 
name to the pathway. 
The activation of the Imd pathway is triggered by DAP-type PGN, and not 
LPS like was initially believed. The reason why LPS is still commonly used for 
activating the Imd response in experiments is because PGN is a common 
contaminant in commercial LPS preparations (Werner et al. 2003, Kaneko et al. 
2004). PGN, also called murein, is an essential component of the bacterial cell 
wall, whose molecular structure varies greatly from one bacterial species to 
another. The backbone of this large polymer is formed by chains of alternating 
N-acetylmuramic acid and N-acetylglucosamine residues that are cross-linked 
together by short amino acid chains of 4 to 5 residues. If the third residue in this 
chain is L-lysine, the PGN is defined as Lys-type PGN, which is more common 
in Gram-positive bacteria. Instead, if the third residue is meso-diaminopimelic 
acid, the PGN is called DAP-type PGN. DAP-type PGN can be found in Gram-
negative bacteria but also in some species of Gram-positive bacteria, such as 
Bacillus and Listeria. 
DAP-type PGN is recognized by a member of the peptidoglycan recognition 
protein family, PGRP-LC (Choe et al. 2002, Gottar et al. 2002, Rämet et al. 
2002b). PGRP-LC encodes three alternative splice variants, PGRP-LCa, PGRP-
LCx, and PGRP-LCy. The biological function of PGRP-LCy is not known. 
PGRP-LCa and PGRP-LCx encode transmembrane proteins that have identical 
transmembrane and cytoplasmic parts but different PGRP domains (Werner et al. 
2000), corresponding to the different specificities of these two isoforms. Unlike 
PGRP-LCx, PGRP-LCa is not capable of binding polymeric PGN. In contrast, it 
participates in the recognition of monomeric PGN, also called the tracheal 
cytotoxin (TCT). Structural and biochemical studies suggest that PGRP-LCa and 
PGRP-LCx bind TCT as heterodimers (Stenbak et al. 2004, Chang et al. 2005, 
Kaneko et al. 2005, Mellroth et al. 2005, Chang et al. 2006, Lim et al. 2006). 
Furthermore, another PGRP family member, PGRP-LE has been associated with 
PGN recognition (Takehana et al. 2004, Kaneko et al. 2006, Lim et al. 2006). 
PGRP-LE encodes a protein without an obvious transmembrane domain or 
signal sequence, and curiously has been suggested to be both intracellular and 
 
 
 
 
33
secreted. The detection of the PGRP-LE ectodomain in hemolymph supports this 
theory. PGRP-LE has been suggested to act synergistically with PGRP-LC in 
TCT recognition, and to participate in the recognition of intracellular pathogens, 
such as Listeria (Yano et al. 2008). Upon TCT binding, PGRP-LE is known to 
homodimerize (Lim et al. 2006). How this results in Imd pathway activation is 
still elusive, although both PGRP-LC and PGRP-LE are known to co-
immunoprecipitate with Imd (Aggarwal and Silverman 2008). 
After the initial recognition of the bacterial components, the signal is 
propagated from the PGRP-LC cytoplasmic domain to IMD. IMD is a death 
domain-containing protein and homologous to the mammalian RIP1 (Georgel et 
al. 2001). The DD of IMD mediates the recruitment of other DD containing 
proteins, such as the Drosophila homolog of the Fas-associated death domain 
(FADD) often referred to as dFADD or BG4. dFADD in turn recruits a caspase 
called Death-related ced-3/Nedd2-like protein (Dredd) via its caspase 
recruitment domain to the signaling complex. Dredd is homologous to the 
mammalian caspase-8, and has been proposed to play a dual role in Imd pathway 
activation. First, Dredd has been shown to cleave IMD (Paquette et al. 2010), 
which apparently contributes to its activation. Second, Dredd is required for 
cleavage of the transcription factor Relish (Leulier et al. 2000), although it is not 
certain if Relish is actually cleaved by Dredd. A physical interaction of Dredd 
and Relish has been demonstrated in vitro (Leulier et al. 2000, Stöven et al. 
2003). In addition, the caspase cleavage sites of IMD and Relish are identical, 
which further supports the hypothesis that Dredd is the caspase contributing to 
the activation of Relish. 
In addition to the components described above, Imd pathway signaling 
requires the activation of kinases. The Drosophila homolog of the TGF-β 
activated kinase 1 (Tak1) functions downstream of Imd and is required for the 
activation of the Drosophila IKK complex. (Rutschmann et al. 2000b, Lu et al. 
2001, Vidal et al. 2001, Silverman et al. 2003). The Drosophila IKK complex 
consists of two subunits, the kinase called Immune response deficient 5 (Ird5) 
and the regulatory subunit Kenny, which are homologous to mammalian IKKβ 
and IKKγ, respectively (Rutschmann et al. 2000b, Silverman et al. 2000). The 
IKK complex is also required for Relish cleavage (Silverman et al. 2000), 
although the molecular mechanism for this is not perfectly clear yet. 
Relish is the third Drosophila NF-κB protein homologous with the 
mammalian proteins p100 and p105, and the transcription factor essential for the 
expression of the Imd pathway target genes. Unlike the Toll pathway NF-κB 
proteins Dif and Dorsal, Relish consists of both the N-terminal Rel homology 
domain (RHD) and a C-terminal inhibitory IκB part. The IκB part must be 
removed by endoproteolytic cleavage to release the NF- κB part, which 
thereafter translocates to the nucleus and initiates the transcription of its target 
genes, such as the AMPs, while the C-terminal part remains in the cytoplasm 
(Stöven et al. 2000, Stöven et al. 2003). Besides cleavage, Relish activation is 
further promoted by phosphorylation by the IKK complex (Silverman et al. 
2000). Recently, Ertürk-Hasdemir et al. (2009) reported that Ird5, the Drosophila 
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IKKβ, phosphorylates two serine residues in the N-terminal part of Relish, 
serines 528 and 529. They discovered that these phosphorylation sites were not 
required for Relish cleavage, translocation to the nucleus, or binding to the DNA 
target sequence. Instead, phosphorylation of these residues appears essential for 
the Relish transcription factor activity, possibly by promoting the recruitment of 
RNA polymerase II into the promoter region (Ertürk-Hasdemir et al. 2009). 
Besides Relish, the induction of AMPs requires the presence and function of 
the transcription machinery proteins. Recently, Goto et al. (2008) performed an 
RNAi screen in Drosophila S2 cells, and identified a previously unknown Imd 
pathway regulator Akirin. The Drosophila genome contains only one Akirin, 
which encodes a protein with no other recognizable motifs than a nuclear 
localization signal. The nuclear localization was confirmed by 
immunocytochemistry and epistasis analysis, which implied that Akirin would 
act downstream of Relish. Furthermore, RNAi knock-down of Akirin in vivo 
sensitized the flies to Gram-negative bacterial infections. Interestingly, the 
Akirin null mutation is lethal, suggesting that Akirin might play other roles than 
merely assisting the NF-κB function. Mammals have two Akirins, Akirin1 and 
Akirin2. The role of Akirin1 is not known, but Akirin2 seems to be essential for 
development, since homozygous knock-out mice die before embryonic day 9.5. 
The embryonic fibroblasts derived from these animals show defects in their 
ability to express genes dependent on NF-κB signaling (Goto et al. 2008). The 
discovery of Akirin demonstrates the power and value of novel reverse genetic 
approaches, as well as the relevance of invertebrate model organisms in 
deciphering the mechanisms of evolutionarily conserved signaling pathways. 
2.6.4 The JNK pathway 
JNK signaling is usually triggered by environmental stress and often leads to 
apoptosis. It has, however, also been implicated in hemocyte activation (Boutros 
et al. 2002, Silverman et al. 2003, Bidla et al. 2007) and wound healing (Rämet 
et al. 2001). The JNK pathway components upstream of Tak1 are Mishapen and 
the mammalian TNFR-resembling Wengen, which binds the Drosophila 
cytokine Eiger at the plasmamembrane (Igaki et al. 2002, Moreno et al. 2002). 
These proteins have not been associated with the humoral immune response. 
However, overexpressing Eiger and Wengen is known to induce apoptosis in a 
JNK dependent manner (Igaki et al. 2002, Geuking et al. 2005).  
In addition to stress, the JNK pathway can also be activated via the Imd 
pathway. The Imd pathway branches into the JNK signaling pathway at the level 
of Tak1, which is an essential component of both pathways. Tak1 activates the 
Drosophila MKK7/JNKK homolog Hemipterous (Hep) (Glise et al. 1995), 
which in sequence phosphorylates the Drosophila JNK called Basket. Basket 
then activates the Drosophila Jun and Fos homologs Jun-related antigen (Jra) 
and Kayak (Kay), respectively, which initiate transcription and induce target 
genes (Riesgo-Escovar et al. 1996, Sluss et al. 1996) such as the negative 
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regulator puckered, and genes involved in cytoskeleton remodeling and 
hemocyte activation. In addition, the JNK pathway has been implied to be 
involved in the up-regulation of AMPs during the early response to bacteria 
(Kallio et al. 2005, Delaney et al. 2006), although this is somewhat controversial. 
Others have reported that the JNK pathway would in fact down-regulate AMPs 
via the inhibitory action of AP-1 (the heterodimer of Jun and Fos), and STAT 
(Kim et al. 2005, Kim et al. 2007). The interplay of the Imd and JNK pathways 
in the regulation of the humoral response therefore requires clarification. 
Besides Puckered, two negative regulators of the JNK pathway  have been 
identified. A putative E3 ligase Plenty of SH3 (Posh) has been reported to 
regulate the signaling of both the Imd and the JNK pathways (Tsuda et al. 2005), 
possibly by regulating Tak1 stability by targeting it for proteasomal degradation. 
In addition, the Imd pathway negative regulator dUSP36 also suppresses JNK 
signaling (Thevenon et al. 2009) in an Imd-dependent manner. 
2.6.5 Negative regulation of the Imd pathway 
A hyperactivated immune response can have detrimental effects on the fitness 
and survival of the organism in both invertebrates and vertebrates. Immune 
signaling must therefore be carefully regulated. The Imd pathway activation is 
indeed modulated to ensure a properly timed and adjusted immune response. 
This modulation takes place at multiple levels and involves a variety of 
regulatory proteins emphasizing the significance of control over the expression 
of the target genes. 
The Imd pathway is activated by binding of a DAP-type peptidoglycan to the 
receptor PGRP-LC (Leulier et al. 2003, Choe et al. 2005), which leads to 
receptor dimerization (Mellroth et al. 2005) and signal transduction via the 
PGRP-LC intracellular domain to IMD (Choe et al. 2005). The first level of 
regulation is therefore the dampening of the initial stimulus. This can be 
achieved by the enzyme-catalyzed degradation of PGN into smaller subunits, 
which attenuates the pathway activation (Werner et al. 2003, Kaneko et al. 
2004). Members of the PGRP family, namely PGRP-LB, PGRP-SB1, and 
PGRP-SC1 encode active amidases and others, such as PGRP-SB2, and PGRP-
SC2 have predicted amidase activity (Werner et al. 2000, Mellroth et al. 2003). 
These proteins have been suggested to modulate Imd pathway signaling by 
reducing the immunostimulatory capacity of PGN (Mellroth et al. 2003, Bishoff 
et al. 2006, Zaidman-Rémy et al. 2006). Yet another family member, PRGP-LF, 
has been reported to suppress both Imd and JNK signaling (Persson et al. 2007, 
Maillet et al. 2008), but the mechanism of this action is not known. PGRP 
proteins suppressing the Imd pathway response have different specificities for 
PGN. For example, PGRP-LB is capable of binding the DAP-type PGN only, 
whereas PGRP-SC can digest both DAP-type and Lys-type PGNs (Mellroth et 
al. 2005, Zaidman-Rémy et al. 2006). 
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PGRP-LB is expressed in the fat body, from which the protein is secreted into 
the hemolymph (Zaidman-Rémy et al. 2006). In addition, both PGRP-LB and 
PGRP-SC are expressed in the gut epithelium (Bischoff et al. 2006, Zaidman-
Rémy et al. 2006). Since the fly must tolerate the presence of a certain amount of 
commensal bacteria and the PGN fragments that they release, this kind of 
regulation appears to be necessary in order to avoid excess and redundant Imd 
pathway signaling that might trigger the production of AMPs and even provoke 
apoptosis in non-infective conditions. Indeed, the effects of RNAi silencing both 
PGRP-LB and PGRP-SC in vivo were quite dramatic. Depletion of these proteins 
led to prominent expression of AMPs under normal rearing conditions 
(Zaidman-Rémy et al. 2006) and during infection (Bischoff et al. 2006, 
Zaidman-Rémy et al. 2006,). In addition, most of the PGRP-SC-deficient larvae 
succumbed to Erwinia carotovora natural infection, and the minority that 
survived until adulthood showed developmental defects, such as wing notching. 
These defects were shown to be due to increased apoptosis in the wing disc in 
response to bacterial infection (Bischoff et al. 2006), which highlights the 
importance of properly adjusted immune signaling for the host’s survival.  
In mammals, NF-κB signaling is regulated by post-translational 
modifications of the pathway proteins as well as the IκB proteins, and this 
regulation is tissue-specific and delicately controlled. The Drosophila 
transcription factor Relish differs from the other NF-κB proteins. It contains both 
the NF-κB and IκB parts, and is activated when the IκB part is enzymatically 
cleaved. This reaction is not reversible, and therefore it seems reasonable to 
assume that fine-tuning of the Imd pathway activity requires the presence of 
other negative regulators besides the IκB. 
The caspase Dredd is required for the cleavage and activation of both IMD 
and Relish (Ertürk-Hasdemir et al. 2009, Paquette et al. 2010), which makes it a 
good target for negative regulation. Two proteins have so far been proposed to 
modulate Dredd activity: the Defense repressor 1 (Dnr1), and Caspar (Foley and 
O’Farrell 2004, Kim et al. 2006). Dnr1 is a conserved protein, which consists of 
an ezrin/radixin/moesin domain and a C-terminal RING finger domain, 
suggesting that Dnr1 might function as an E3 ligase. It has been shown that 
RNAi silencing of Dnr1 in S2 cells is sufficient to induce the expression of a 
Dpt-lacZ reporter construct in the absence of infection (Foley and O’Farrell 
2004). However, the molecular mechanism of the inhibitory action of Dnr1  is 
not thoroughly understood, neither has it been verified in vivo. The function of 
the other Dredd regulator, Caspar, has been documented better. Caspar is 
homologous to the human Fas associated factor 1 (FAF1), which has been 
reported to associate with signaling components of the NF-κB pathway, such as 
FAS, FADD, caspase-8 and NF- κB (Chu et al. 1995, Ryu et al. 2003, Park et al. 
2004b). Caspar was identified in a screen of Drosophila mutants for 
hyperactivated immune responses, in which caspar mutant flies were found to 
express AMPs constitutively even in the absence of infection. In addition, the 
mutants were more resistant to Gram-negative bacterial infections than the wild-
type flies. Overexpression of Caspar was sufficient to suppress the Imd pathway 
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activity but did not affect Toll pathway activation. Furthermore, Caspar was 
shown to inhibit the Dredd-dependent cleavage of Relish in vivo (Kim et al. 
2006). The inhibitory mechanism of Caspar has not been revealed yet. However, 
the association of the human homolog FAF1 in ubiquitin-proteasome signaling 
suggests that Caspar might have similar functions in Drosophila (Song et al. 
2005). 
The ubiquitin-proteasome pathway has been implicated in Imd pathway 
regulation also in Drosophila. Khush et al. (2002) performed an EMS 
mutagenesis screen in order to identify negative regulators of the Imd pathway, 
and found two independent mutations of skpA that resulted in the constitutive 
expression of Dpt in larvae and adults. SkpA is homologous to the mammalian 
and yeast Skp1 proteins, which are known components of Skp1/Cullin/F-box 
protein (SCF)-E3 ubiquitin ligases (reviewed in Cardozo and Paganino 2004). 
The SCF complex is involved in the K48-linked ubiquitination of proteins 
targeting them for proteasomal degradation. Khush et al. further demonstrated 
that a deficiency in other components of the SCF complex, such as dCullin or 
Slimb, resulted in the expression of Dpt in a non-infective state. In addition, 
RNAi silencing of skpA or slimb was shown to increase the levels of both full-
length and cleaved Relish suggesting that the SCF complex might regulate the 
stability of Relish and thereby modulate the Imd pathway activity (Khush et al. 
2002). 
Another target for ubiquitin-mediated regulation was recently found to be 
IMD itself. Similar to the mammalian RIP1, IMD is activated by the conjugation 
of K63-linked polyubiquitin chains. In mammalian cells, these ubiquitin chains 
are recognized by TAB2, which thereafter recruits TAK1 into the complex 
(Legler et al. 2003, Ea et al. 2006, Newton et al. 2008). The constitutive and non-
specific activation of IMD was reported to be suppressed by Scrawny (Scny), 
also called dUSP36, which is homologous to mammalian ubiquitin-specific 
proteases (Thevenon et al. 2009). The authors suggest that the removal of K63-
linked ubiquitin chains would sensitize IMD to K48-linked ubiquitination and 
promote its proteasomal degradation. Since dUSP36 acts at the level of IMD, it 
is not surprising that it was found to suppress JNK signaling as well (Thevenon 
et al. 2009). 
In addition to the previously described suppressors, Imd pathway activity is 
dampened by regulating the transcriptional activity of Relish. The transcription 
factors of the JNK and Jak/STAT signaling pathways, AP-1 and STAT, have 
been implicated in this type of regulation together with other proteins. Kim et al. 
(2007) suggested that as a response to continuous immune signaling causing 
increased levels of dAP1 and Stat92E (Drosophila homolog of STAT), these 
proteins would form a repressosome complex with a Drosophila High mobility 
group (HMG) protein called Dorsal switch protein 1 (Dsp1). The complex would 
replace Relish at the promoter and recruit a histone deacetylase to the complex to 
inhibit transcription of the target genes. Mutations in dAP-1, Stat92E or Dsp1 
were shown to induce hyperactivation of Relish target genes. Furthermore, the 
mutant flies were more susceptible to E. coli infections compared to wild-type 
flies. This phenotype could be rescued by reducing the copy number of relish, 
suggesting that the reduced survival of the repressosome complex mutants was in 
fact due to the defective regulation of Relish, and not the inhibited expression of 
dAP-1 or Stat92E target genes (Kim et al. 2007). The positive and negative 
regulators of the Imd pathway are summarized in Figure 5. 
 
Nucleus
PG
RP
-L
Cx
PG
RP
-L
Cx
/a
Dredd
Relish
Rel-68
AMPs
PGRP-LE
Re
l-4
9
Rel-68
Rel-68
TAK1
IMD
PGRP-LE
PGN
Dnr1
Caspar
P
P
P
P
Akirin
Hep
Basket
POSH
Scny
PGRP-SC1/2
PGRP-LB
SCF complex
AP-1
Jra
Kay
PG
R
P-
LF
Cytoplasm
AP-1
stress response
wound repair
Stat92E
AP-1
Dsp1
HDAC1 repressosome
complex
FADD
Key Key
Ird5 Ird5
Puc
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Regulation of the Imd/JNK pathway. 
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2.6.6. Tissue-specific immune response 
The fat body is the main tissue responsible for the synthesis of AMPs and other 
immunomodulatory molecules during a systemic immune response in 
Drosophila. However, to prevent microbes from entering the body, other tissues, 
especially the barrier epithelia, are capable of producing AMPs. The living 
environment and diet of Drosophila mainly consist of fermenting fruits that are 
rich in bacteria, yeast and mold. The local immune response in epithelia and 
especially in the gut is therefore vital for the fly’s survival. 
The first evidence of AMPs produced in epithelia was reported by Ferrandon 
et al. (1998). They used a Drs-GFP reporter fly line to monitor the expression of 
Drosomycin, which at the time was thought to be solely a Toll pathway target 
gene. Expression of Drs was detected in a variety of epithelial tissues that are in 
direct contact with the environment, such as the epithelia of the respiratory, 
digestive and reproductive tracts. Furthermore, this expression was independent 
of the Toll pathway, suggesting another yet unidentified regulatory mechanism 
for the local immune response (Ferrandon et al. 1998). These findings were soon 
confirmed and expanded by Tzou et al. (2000), who studied the tissue-specific 
expression of all Drosophila AMP types. They detected localized AMP 
expression in both unchallenged larvae and adults, but also noticed tissue-
dependent differences in the expression patterns of different AMPs. In larvae, 
Dro and Drs were often observed in tracheal epithelia, while Def and Mtk were 
detected in the oral region and sometimes in the pharynx. The expression of Dpt, 
Def and Att was prominent in the digestive tract. In adults, most of the AMPs 
were expressed in the reproductive tract, suggesting that it too could serve as an 
entry siten for pathogens. In addition, Def and Mtk were detected in the labelar 
glands, Dpt in the gut, and Cec and Mtk in the malpighian tubules. Importantly, 
the tissue-specific expression of AMPs was found to be absent in imd mutant 
flies, suggesting that the local immune response is mediated by the activation of 
the Imd pathway (Tzou et al. 2000). 
AMP production in epithelial tissues appears to be an evolutionarily 
conserved feature that is seen in both invertebrates and vertebrates. Instead, 
secretion of AMPs into the hemolymph during systemic infection seems to be a 
defense response that is typical only to insects. It has therefore been proposed 
that the epithelial immune response would actually be of a more ancient origin, 
and the recruitment of the fat body and specialized cell types in response to AMP 
release has occured later in evolution (Tzou et al. 2000). 
The Drosophila gut harbors a considerable amount of different kinds of 
microbes (Cox et al. 2007, Ryu et al. 2008). Like other microorganisms, the ones 
in the gut continuously generate MAMPs that can potentially evoke a massive 
defense response in the gut epithelial cells. The constitutive expression of AMPs 
in the gut can be detected, but at a surprisingly low level. Maintenance of the 
flies in axenic conditions completely abolishes this expression, which suggests 
that it is after all conditional and triggered by the commensal microbiota (Ryu et 
al. 2008). Imd pathway activation must therefore be dampened in the gut, and 
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this is achieved by the synergistic action of various proteins. PGN degrading 
PGRPs, such as PGRP-LB and PGRP-SC, have been shown to be expressed 
especially in the gut (Bischoff et al. 2006, Zaidman-Rémy et al. 2006). In 
addition, the intestinal homeobox protein Caudal specifically suppresses AMP 
production in the gut, simultaneously allowing the expression of NF-κB-
independent target genes. Uncontrolled AMP production in the gut appears to 
have severe consequences for the host. Caudal knock-down has been reported to 
induce AMP expression, which in turn reduces the levels of Acetobacteriae that 
normally represent the majority of the bacteria colonizing the gut. The freed 
niche is consequently invaded by Gluconoacetobacter, which by an unknown 
mechanism provokes apoptosis of the gut epithelia resulting in the death of the 
host (Ryu et al. 2008). This implies that it is not AMP production itself but its 
deleterious effects on the homeostasis of commensal microbes, which kills the 
fly. It has also been suggested that the battery of AMPs only serves as a back-up 
system to protect the gut from pathogenic bacteria, and that the levels of 
commensals would be mainly regulated by the production of reactive oxygen 
species (ROS). ROS production in flies requires the protein Duox (Ha et al. 
2005a), which contains an NADPH domain and an extracellular peroxidase 
domain (PHD). PHD can convert hydrogen peroxidase into hypochlorous acid 
that is a potent microbicide. Excessive production of ROS is regulated by the 
immune responsive catalase (IRC) (Ha et al. 2005b). Imd pathway mutant flies 
are susceptible to ROS-resistant microbes but can normally tolerate the presence 
of ROS-sensitive ones (Ha et al. 2005, Ryu et al. 2006) underscoring the 
efficiency and importance of ROS for the local immune response in vivo. 
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3. Aims of the study 
Overall, the aim of this study was to gain a genome-wide view of the defense 
strategies and the regulation of the immune system of the fruit fly Drosophila 
melanogaster. Our studies focused on the positive and negative regulation of the 
Imd pathway, which in Drosophila mainly responds to Gram-negative bacterial 
infections. Although the Imd pathway, and insect immunity in general, have 
been under intense investigation during the last decades, all of the components 
had not been thoroughly studied, and especially the negative regulation was 
poorly understood at the time this project was launched. Moreover, the 
intracellular parts of the Imd pathway resemble the mammalian TNFR signaling 
pathway, and hence we were also hoping to acquire some useful data regarding 
the regulation of mammalian immune signaling. 
 
The specific aims of the study were: 
 
1. To identify changes in gene expression during Gram-negative bacterial 
infection of Drosophila melanogaster in vitro by oligonucleotide 
microarrays. 
 
2. To identify previously unknown components of the Imd pathway by 
RNAi screening. 
 
3. To molecularly characterize the selected target genes in vitro and in vivo 
in order to understand their role in the regulation of the Imd pathway 
signaling. 
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4. Materials and methods 
4.1 Cells and cell culture (I-III) 
Schneider-2 (S2) cells are Drosophila hemocyte-like cells, which are derived 
from embryonic cells and are able to phagocytose. The S2 cells used in our 
laboratory were originally brought from R. A. Ezekowitz’s laboratory (Harvard 
Medical School, Boston, MA, USA) in 2002, and are known to phagocytose 
better than the ATCC line of S2 cells. S2 cells were used in most of the in vitro 
experiments, except in the western blot analysis of Relish cleavage in original 
publication III. In that experiment we used another Drosophila hemocyte-like 
cell line, malignant blood neoplasm-2 (mbn-2) cells (Gateff et al, 1978), because 
these cells contain less cleaved Relish under normal conditions, and therefore the 
results were easier to interpret. Mbn-2 cells are derived from circulating larval 
hemocytes and like S2 cells, they have retained the ability to phagocytose and 
express antimicrobial peptide genes. 
S2 cells were cultured in Schneider medium (Sigma) supplemented with 10% 
FBS, 100 U/ml penicillin, and 100 µl/ml streptomycin. For mbn-2 cells, the 
medium was subsequently supplemented with L-glutamine (Sigma) to a 10 mM 
concentration. Both S2 and mbn-2 cells were cultured at +25ºC. 
4.2 dsRNA synthesis (I-III) 
4.2.1 Generation of the dsRNA library 
The dsRNAs used in the RNAi screen (III) were synthesized using an S2 cell-
derived cDNA library cloned into pcDNAI plasmids (Invitrogen) as template 
(Pearson et al. 1995). The library was transformed into competent MC1061/P3 
E. coli, and the bacteria were plated onto ampicillin (20 µg/ml) and tetracycline 
(8 µg/ml) containing LB plates. Subsequently, individual bacterial colonies were 
collected and the plasmids from these randomly picked colonies were isolated. 
The inserted sequence was amplified by PCR using the following primers: 5’-
CAA GCT TGG TAC CGA GCT C-3’ and 5’-CTG CTC CCA TTC ATC AGT 
TC-3’. Then, binding sites for T7 RNA polymerase were introduced by 
performing the second round of PCR with the following nested primers: 5’-TAA 
TAC GAC TCA CTA TAG GGC GGA TCC ACT AGT AAC GG-3’ and 5’-
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TAA TAC GAC TCA CTA TAG GGA GGT GAC ACT ATA GAA TAG G-3’. 
The resulting PCR product was used as a template in an in vitro transcription 
reaction performed using the T7 MegaScript RNA polymerase kit (Ambion) 
according to the manufacturer’s instructions. 
4.2.2 Generation of targeted dsRNAs 
Targeted dsRNAs were generated using gene specific primers (see original 
communication III, Supplementary Table IV). S2 cell-derived cDNA was used 
as template. dsRNA against green fluorescent protein (GFP) was used as a 
negative control, and it was generated using pMT/BiP/V5-His/GFP plasmid 
(Invitrogen) as template. PCR and the synthesis of dsRNAs were performed as in 
the generation of the dsRNAs library. 
4.3 Oligonucleotide microarrays (I, II) 
S2 cells were seeded onto 24-well plates (500,000 cells per well) and 4 µg of 
experimental or control dsRNA was applied to the cell culture medium. After 48 
h heat-killed BL21 E. coli were added and the cells were incubated for 0.5, 1, 4, 
24 or 32 h. Uninduced cells were used as the 0 h time point. At given time points 
the cells were harvested and total RNAs extracted (from ~2x106 cells per 
sample) using the RNeasy Mini Kit (Qiagen CA, USA). The RNA samples were 
sent to the University of Oulu, where the expression analysis was performed 
using the Affymetrix (Santa Clara) Drosophila Genechips according to the 
Affymetrix GeneChip Expression Analysis Technical Manual. 
4.4. Sequencing (III) 
Sequencing of constructs and genomic DNA samples was performed as follows: 
0.3 µg of DNA was applied to a PCR reaction mix containing 1 µl of either 
upstream or downstream primer (final conc. 0.2 µM), 1µl of BigDye v. 3.1 
Reaction mix, 2 µl of 5xDilution buffer and nuclease free H2O up to 10 µl. The 
PCR was performed according to the manufacturer’s instructions. The 
synthesized DNA fragments were precipitated with 90 µl of 70% EtOH (Final 
EtOH conc. ~63%) for 15-20 min in RT. The precipitate was harvested by 
centrifugation (3,000 x g, 60 min. at 20ºC), and the supernatant was discarded. 
The precipitate was washed with excess 70% EtOH, centrifuged at 2000 x g for 
15 min, and the EtOH was discarded. The left-over EtOH was removed by 
centrifuging the tubes up-side-down on a pile of filter papers for 1 min at 700 x 
g. The precipitate was then dissolved into 15 µl of HiDi Formamide (Applied 
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Biosystems), denatured at 95ºC for 2 min. and cooled on ice before inserting the 
tubes into the sequencer (ABI Prism 3130x Genetic Analyzer). The sequencing 
was performed using POP7 polymer with a 36 cm capillary according to the 
instrument user manual. 
4.5 Western blotting (II, III) 
Protein samples were electrophoresed using NuPAGE 10% Bis-Tris gels and 
running buffer supplemented with NuPAGE antioxidant (Invitrogen Life 
Technologies) and blotted onto a nitrocellulose membrane. The membrane was 
thereafter incubated for 2h in blocking buffer (5% milk powder in PBST) before 
adding the 1:5000 diluted primary antibody to the blocking buffer. The primary 
antibodies used were mouse anti-V5 (Invitrogen Life Technologies) (II) and 
mouse anti-C-Relish antibody (a gift from Dr. Svenja Stöven from the Umeå 
University) (III). The primary antibody was incubated on a rocking platform for 
1.5 h, then rinsed twice and washed 3 x in PBST for 5 min. The secondary 
antibody, also diluted 1:5000 in blocking buffer, was added to the membrane and 
incubated for 1 h before rinsing twice and washing 5 x 5 min in PBST. The 
secondary antibodies used were the goat anti-mouse Ab HRP (Molecular Probes) 
(II) and anti-rabbit Ab HRP conjugates (Bio-Rad). The bound antibodies were 
detected with the ECL Plus Western blotting detection system (GE Healthcare). 
 
4.6 Epistasis analysis 
The epistasis analyses were carried out in vitro. S2 cells were transfected with 
experimental or control (GFP) dsRNA together with constructs encoding known 
components of the Imd pathway, such as full-length IMD, Relish or a truncated 
constitutively active form of Relish, Rel ΔS29-S45. The effect of the dsRNA 
treatment to the Imd pathway activity was assessed by luciferase assay, and 
therefore the S2 cells were also transfected with the Attacin-luciferase reporter 
together with the Actin 5C-β-galactosidase reporter, which was used for 
monitoring cell viability. 
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4.7 Assays for measuring Imd pathway activation 
4.7.1 Reporter assays (I-III) 
Luciferase reporter-based assays were used for measuring the Imd, Toll, and Jak-
STAT pathway activities in vitro. Actin 5C-β-galactosidase (Act5C- β-gal) was 
used in all experiments to control cell viability. The reporter constructs were 
kindly provided by Prof J-L. Imler. 
To study the Imd pathway, Attacin A-luciferase (AttA-luc) (Tauszig et al, 
2000) or Cecropin A1-luciferase reporters were used. The S2 cells were 
transfected with luciferase and β-galactosidase reporters together with control or 
experimental dsRNA using the Fugene transfection reagent (Roche). GFP 
dsRNA was used as the negative and Relish dsRNA as the positive control. After 
48 h, 20-hydroxyecdysone (Sigma) was added to a 1 µM concentration to 
promote immune competence (Dimarcq et al. 1997), and 60 h after the 
transfection the Imd pathway was activated by adding heat-killed BL21 E. coli to 
the cells. 90 h post-transfection the S2 cells were harvested by centrifugation and 
lysed in Passive Lysis Buffer (PLB) (Promega). 
For the analysis of Toll pathway activity S2 cells were transfected with 
Drosomycin-luciferase (Drs-luc) reporter and, to activate the pathway, with the 
constitutively active form of Toll, Toll10B (Rosetto et al, 1995). GFP and 
Myd88 dsRNAs were used as negative and positive control dsRNAs, 
respectively. The S2 cells were harvested by centrifugation 72 h after 
transfection and lysed in PLB. 
Jak-STAT pathway activation was assessed by transfecting the S2 cells with 
the TurandotM-luciferase (TotM-luc) reporter together with constitutively active 
hopscotch, which activates the pathway. GFP and STAT dsRNAs were used as 
negative and positive control dsRNAs, respectively. The S2 cells were harvested 
72 h post-transfection and lysed in PLB. 
The cell lysates were centrifuged to remove the cell debris, and luciferase and 
β-galactosidase activities were measured from the cleared lysates. 
4.7.2 Semi-quantitative RT-PCR (I) and quantitative RT-PCR (qRT-
PCR) (II) 
Semi-quantitative PCR was performed using SuperScriptTM II One-Step RT-PCR 
with Platinum Taq kit (Invitrogen) according to the manufacturer’s instructions. 
qRT-PCR was performed using the QuantiTect SYBR Green RT-PCR kit 
(Qiagen) with a LightCycler (Roche) or an ABI7000 (Applied Biosystems) 
instrument. The results were analyzed with the LightCycler version 3.5 software 
or the ABI 7000 System SDS software version 1.2.3., respectively. Total RNA 
extracted either from S2 cells or flies with TRIzol® Reagent (Invitrogen) was 
used as a template in both semi-quantitative and qRT-PCR. 
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4.7.3 Immunocytochemistry (III) 
S2 cells were cultured on a 24-well plate with glass slides on the bottom of the 
wells. 4 µg of control or experimental dsRNA was introduced to the cells by 
soaking, and the cleavage of Relish was induced after 72 h by adding heat-
activated LPS (10 µg/µl) to the cells. 10 min. after the induction the cells were 
spun down onto the glass slides, fixed and labeled with an anti-RHD antibody 
(Stöven et al. 2000). 
4.8 In vivo experiments 
4.8.1 Drosophila stocks (I-III) 
Canton S, RelishE20, and w1118 flies were obtained from Prof. Dan Hultmark from 
the Umeå University. Iap2 null mutant flies were a gift from Dr. Francois Leulier 
(Centre de Génétique Moléculaire, Centre National de la Recherche Scientifique, 
Gif-Sur-Yvette, France). 
RNAi fly lines 15678-R1 and 15678-R2 for pirk, as well as Iap2-IR and 
dFADD-IR were obtained from Prof. Ryu Ueda (National Institute of Genetics, 
Mishima, Shizuoka, Japan). The genetic background of these flies is w1118. 
C564-GAL4 driver flies were obtained from Prof. B. Lemaitre (Centre de 
Génétique Moléculaire, Centre National de la Recherche Scientifique, Gif-Sur-
Yvette, France, and Global Health Institute, EPFL, Lausanne, Switzerland). 
Pirk overexpression flies were generated by microinjecting a UAS-pirk-V5 
construct into w1118 embryos in the Umeå Fly and Worm Transgene Facility, 
Umeå, Sweden. The independent Pirk-overexpressing fly lines UAS-pirk221, 
UAS-pirk351, UAS-pirk432, and UAS-pirk721 harbor the constructs in their 3rd, X, 
3rd and 2nd chromosomes, respectively. 
P-element lines 4440, 14838, and 15039 were ordered from the Bloomington 
Drosophila Stock Center at Indiana University. Δ2-3 transposase carrying stocks 
were received from Prof. Dan Hultmark. Rescue82 and rescue461 flies were 
generated by mobilizing the EY00723 P element in 15039 flies and screening for 
white-eyed offspring after standard crossings. 
4.8.2 RNA extraction from flies (II) 
Equal amounts of male and female flies were anesthetized with CO2, collected 
into microtubes and snap-frozen by immersing the tubes in dry ice. The frozen 
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flies were then homogenized in TRIzol® Reagent (Invitrogen), and the extraction 
of total RNA was carried out according to the manufacturer’s instructions. 
4.8.3 DNA extraction from flies (II) 
Genomic DNA was extracted from 25 snap-frozen flies. At first, the flies were 
homogenized on ice in a buffer containing 0.1M Tris-HCl (pH 9.0), 0.1M 
EDTA, and 1% SDS. The homogenate was then incubated at 70ºC for 30 min, 
KAc was added, and again the homogenate was incubated on ice for 30 min prior 
to centrifugation at 16,000 x g for 15 min. The supernatant was then transferred 
to another tube and the DNA extracted by adding 1 volume of 25:24:1 phenol-
chlorophorm-isoamyl alcohol, and centrifuged at 16,000 x g for 5 min. The 
supernatant containing the DNA was transferred to a clean tube, and the DNA 
was precipitated by adding 0.6 x volume of isopropanol. The DNA pellet was 
harvested by centrifugation (5 min at 16,000 x g), and washed with an excess (1 
ml) of 70% EtOH prior to drying and resuspending in TE buffer or water. 
4.8.4 Protein extraction from flies (II) 
Total protein was extracted from flies by homogenizing 10 snap-frozen flies in 
80 µl of lysis buffer containing 10 mM Tris (pH 8.0), 140 mM NaCl, 1% Triton 
X-100, and the Complete Mini protease inhibitor cocktail (Roche Applied 
Science). The homogenate was incubated on ice for 45 min and centrifuged at 
16,000 x g for 15 min to remove solid particles. The supernatant was pipetted 
into a new tube, and the protein concentration of the supernatant was measured 
by using the BCA protein assay kit (Pierce). 
4.8.5 Infection assays (I-III) 
One-week-old healthy flies were infected by pricking them with a thin 
tungsten needle dipped into a fresh, concentrated bacterial culture. For survival 
assays, the flies were kept at 25ºC and monitored regularly for 72 h. E. coli and 
Enterobacter cloacae were used as representatives for Gram-negative bacteria, 
and Micrococcus luteus as Gram-positive bacteria. Equal amounts of males and 
females were used in all experiments 
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5. Results 
5.1 Gram-negative bacteria-induced changes in the gene 
expression profiles in S2 cells (I) 
Organisms, single and multicellular, have developed ways of responding to 
environmental changes and combatting intruders. The response involves multiple 
changes in gene expression, and varies naturally depending on the stimulus. In 
addition, transcriptional changes are often specific to a certain tissue and cell 
type. To get an overview of the signaling events and genes involved in the 
defense mechanisms of Drosophila against Gram-negative bacteria, we chose S2 
cells as our model system. S2 cells are derived from embryonic cells and share 
many features with hemocytes, like for instance the ability to phagocytose. 
Microbial attack was mimicked by adding heat-killed Gram-negative bacteria, 
namely E. coli, to the cell culture medium. The cells were collected at different 
time points, total RNA was extracted, and gene expression levels were analyzed 
by oligonucleotide microarrays.  
In total, the expression levels of 47 transcripts were greater than two-fold at 
the 4h time point compared to naïve cells (I Table 1). The Imd pathway 
transcription factor relish was among these genes, which suggests a positive 
feedback loop in Imd signaling. In S2 cells, where Relish was removed by 
RNAi, only 14 of these transcripts were induced more than two-fold. Based on 
this, the 46 upregulated transcripts were further divided into 32 Relish-dependent 
and 14 Relish-independent genes. The group of Relish-dependent genes includes 
many well known immune responsive genes, such as the antimicrobial peptides 
Attacin B, Diptericin B, Attacin D, Metchnikowin, Cecropin B, Drosomycin, and 
Drosocin, and the PGRP-proteins PGRP-LB, PGRP-SB1, PGRP-SD, and PGRP-
LF. The group of Relish-independent genes includes the matrix 
metalloproteinase Mmp1, wunen 2, sulphated, and Annexin IX, which are 
predicted to be involved in multiple cellular functions. The rest of the identified 
genes have unknown functions. 
The general trend among the Relish-independent genes was that their 
transcript levels reached their maximum before the 24 h time point. In contrast, 
the transcript levels of the Relish-dependent genes were either still increasing or 
sustained at high levels after 24 h. Therefore the Relish-independent and Relish-
dependent genes are also referred to as the early response genes, and the 
sustained response genes, respectively (I Table 1). The only exception to the rule 
was the gene CG15678, which we call pirk (poor Imd response upon knock-in). 
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Expression of pirk peaked already at 1 h and decreased before 24 h. Previously, 
we have demonstrated that removing Pirk from cells by RNAi leads to increased 
Imd, but not Toll signaling (Kallio et al. 2005). This led us to speculate if pirk 
played a role in the negative regulation of the Imd signaling pathway.  
5.2 Identification of CG15678/Pirk as a negative 
regulator of the Imd pathway (I, II) 
Drosophila has a highly sophisticated and efficient immune response. Immunity, 
however, can not be achieved without costs. For example, Ye et al. (2009) 
reported that flies, which had been selected for an improved defense against the 
bacterium Pseudomonas aeruginosa, showed reduced longevity and larval 
viability compared to control flies. The improved immunity was also rapidly lost 
in the absence of selection. In addition, Valtonen at al. (2010) demonstrated that 
RelishE20 flies, which fail to produce Imd pathway-mediated antimicrobial 
peptides, lived longer under starvation compared to the wild-type flies. Thus, 
maintaining an adequate level of disease resistance and concurrently avoiding 
unwanted and prolonged responses that would harm the host requires delicate 
regulation of the immune signaling. 
Mammalian TNFR signaling, which shares many similarities with 
Drosophila Imd signaling, is regulated temporarily by a negative feedback loop. 
The TNFR signaling pathway transcription factor induces the transcription of the 
inhibitory protein IκB, which sequentially binds to NF-κB and displaces it from 
the DNA binding sites. In Drosophila, the Imd pathway transcription factor 
Relish contains both the NF-κB and inhibitory domains, and is activated by 
cleavage of the inhibitory part of the protein. We therefore hypothesized that the 
putative negative feedback loop in the Imd pathway might act at a different level 
than in the mammalian system and involve still unknown regulators.  
Previously, we showed that pirk expression was highly induced in 
Drosophila S2 cells in response to Gram-negative bacteria (Kallio et al. 2005), 
and that the induction was Relish-dependent (II Fig. 1). To confirm this in vivo, 
we infected wild-type (Canton S) and mutant flies lacking the functional 
transcription factor Relish (RelishE20) with Gram-negative bacteria, and 
compared the levels of the pirk transcript at different time points (II Fig. 1C) by 
qRT-PCR. In Canton S flies, the expression of pirk was greatly induced, the 
relative induction being 23-fold at the 4 h time point. In contrast, pirk expression 
in RelishE20 mutant flies was below the level of detection. 
To study if Pirk was important to the Imd signal regulation, we first analyzed 
the effects of knocking down pirk in S2 cells in luciferase-based reporter assays 
(Fig. 6, II Fig. 2A). In the luciferase reporter constructs the luciferase coding 
sequence is under the control of a promoter region of an Imd pathway dependent 
antimicrobial peptide gene, such as Attacin A or Cecropin A1. The promoter 
activity can thus be quantitated by measuring luciferase activity from the lyzed 
cells by a luminometer. We transfected S2 cells with either control (GFP as 
negative and relish as positive control), or pirk dsRNAs together with the 
reporter construct. Imd pathway activation was triggered by adding heat-killed E.  
coli to the cells. As Figure 6 shows, in cells treated with pirk dsRNA, CecA1 
promoter activity was significantly higher than in GFP dsRNA-treated cells. The 
results were similar when we used the AttA promoter (II Fig. 2A), which 
suggests that the higher activity is not limited to CecA1. 
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Figure 6. Pirk is a negative regulator of the Drosophila Imd pathway in vitro. pirk RNAi 
increases Imd pathway-mediated CecA1 response at 1, 4, 8 and 24 h compared to GFP controls. 
S2 cells were transfected with a CecA1-luc reporter plasmid and treated with dsRNAs. Activation 
of the Imd pathway was induced 48 h later by adding heat-killed E. coli in the cell culture 
medium. GFP and Relish dsRNAs were used as negative and positive controls, respectively.  
 
 
Next, we studied whether the effect of pirk RNAi was specific to the Imd 
pathway. We transfected S2 cells with reporter constructs specific to the Toll and 
Jak/STAT pathways together with control and pirk dsRNAs. pirk RNAi had no 
effect on the Toll pathway. In contrast, Jak/STAT signaling was significantly 
reduced by more than 30%. This implies that Pirk is not a general inhibitor of 
signaling in S2 cells (II Fig. 2F-G). 
To eliminate the possibility that these results were merely a reporter 
construct-related artifact, we monitored the levels of AMP gene expression also 
by qRT-PCR. S2 cells were transfected with either pirk or control (GFP) 
dsRNA, and the Imd pathway was activated by adding heat-killed E. coli to the 
cell culture medium. The cells were collected at 0, 1 h, 4 h, and 24 h after 
induction, and total RNA was extracted and used as template in one-step qRT-
PCR. In GFP dsRNA-treated cells, the expression profile of pirk was as 
expected: strongly induced already at 1 h, reaching its maximum at 4 h, and then 
decreasing. Some pirk expression was detected also in pirk dsRNA-treated cells, 
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yet it was significantly suppressed at all time points. The expression levels of the 
Imd pathway-dependent AMP genes Attacin B (AttB) and Diptericin B (DptB), 
were significantly higher in CG15678 knock-down cells compared to the control 
at the 4 h and 24 h time points (II Fig. 2B-D). Furthermore, this effect was also 
seen with Metchnikowin (Mtk) expression at 24 h (data not shown). This 
indicates that the RNAi-induced reduction in the pirk transcription is sufficient to 
decrease the protein levels, which leads to increased Imd pathway signaling.  
To study whether overexpression of pirk suppressed the Imd pathway 
signaling, we transfected S2 cells with a metal-inducible pMT-pirk construct 
together with the AttA-luciferase reporter construct. An empty pMT vector was 
used as control, and Actin5C-β-galactosidase reporter construct was used to 
assess cell viability. pirk expression was induced by adding CuSO4 to a 300 µM 
concentration and the Imd pathway was activated by heat-killed E. coli. 
Overexpression of pirk reduced the Imd pathway activity more than 70% (II Fig. 
2E). Altogether these results indicate that Pirk suppresses Imd pathway signaling 
in vitro. 
5.2.1 Pirk suppresses Imd pathway activation in vivo (II) 
To examine if Pirk suppressed the Imd pathway signaling also in vivo, we 
analyzed the Imd pathway response of Pirk mutant flies. Fly line 15039 from the 
Bloomington Stock Center carries a P element at the 5’ untranslated region 
(UTR) of the pirk gene. We hypothesized that this might affect the transcription 
of pirk and sequentially alter the fly’s defense responses to Gram-negative 
bacteria. Therefore we infected 15039 and wild-type (Canton S) flies by pricking 
them with a needle dipped into a concentrated culture of E. cloacae, extracted 
the total RNAs at 0, 1h, 4 h, and 8 h post-infection, and measured the transcript 
levels of pirk and AMPs by qRT-PCR. In Canton S flies, the level of the pirk 
transcript increased upon infection, reaching its maximum at 4 h. In contrast, no 
induction was detected in 15039 flies (Fig. 7A). Furthermore, in 15039 flies the 
transcript levels of AttA, Dpt, Mtk, and Dro did not differ from Canton S, but the 
levels of AttB, AttC, AttD, CecB, and DptB were elevated (Fig. 7). 
P elements are transposable elements, which naturally occur around the fly 
genome and can jump and integrate into different loci. The structure and 
integration mechanisms of naturally occurring P elements have been used in 
creating transgenic flies but also in designing artificial P elements that then have 
been introduced into the fly genome in order to disrupt the function of a gene. 
Fly line 15039 had been generated for the latter purpose. To ensure that the 
increase in the AMP expression that we detected was in fact due to low 
expression of pirk and not the genetic background of the flies or an unknown 
environmental factor, we aimed at mobilizing this P element. In this case, P 
element mobilization could result in precise excisions that would rescue pirk 
transcription. However, sometimes the mobilized P element removes part of the 
neighbouring sequence and creates a deletion mutant. We therefore hoped that 
we would simultaneously rescue the P element phenotype and obtain a pirk 
knock-out fly. Curiously, we obtained five precise excisions, but no knock-out 
line. Two of the precise excision lines, rescue82 and rescue461 were studied 
further. Removal of the P element from the 5’ UTR restored pirk expression 
levels in both rescue lines (Fig. 8A). Surprisingly, we did not detect significant 
differences in the transcript levels of AttB or DptB when comparing 15039 flies 
to the rescue flies with restored pirk activity (Fig. 8B and C). 
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Figure 7. Relative expression levels of pirk and AMPs in pirk hypomorphic 15039 flies and wild-
type flies (Canton S). The flies were infected with E. cloacae by pricking and the total RNAs 
were extracted at 0, 1, 4, and 8 h post-infection. mRNA levels of pirk (A), AttA (B), AttB (C), 
AttC (D), AttD (E), CecB (F), Dpt (G), DptB (H), Dro (I), and Mtk (J) were measured by qRT-
PCR and normalized to the levels of Act5C mRNA. 
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Figure 8. Transcript levels of pirk (A) in 15039 flies do not correlate with transcript levels of 
Imd pathway-regulated AMPs AttB (B) and DptB (C). 15039 flies harbor the P element EY00273 
at the 5’ UTR of pirk, which disrupts the gene function. Rescue82 and rescue461 are individual fly 
lines from which the P element EY00723 was removed. The flies were infected by pricking them 
with a needle dipped in a concentrated culture of E. cloacae, and the expression levels of pirk, 
AttB, and DptB were analyzed by qRT-PCR 0 and 4 h post-infection. 
 
 
The strength of the immune response is known to vary from one fly line to 
another due to the influence of the genetic background on the phenotype. To 
overcome the possible background effect, we analyzed the impact of pirk RNAi 
on the AMP gene expression in Drosophila in vivo. We received two parallel 
RNAi mutant fly lines from Prof. Ryu Ueda in Kyoto. These transgenic flies 
have in their genome an incorporated UAS construct that encodes a pirk hairpin 
structure. The expression of this hairpin can be targeted to a given tissue using 
the UAS-GAL4 approach (Brand and Perrimon 1993), where it acts in a way 
comparable to that of dsRNA in the cell-based system. In Drosophila the main 
immunological organs or tissues involved in AMP release are the fat body and 
hemocytes. To target the expression of the pirk RNAi construct to these 
biologically relevant sites, we crossed the flies with a constitutively active C564-
GAL4 driver (Harrison et al. 1995). Control flies were crossed with w1118. The 
week-old healthy offspring were subjected to septic injury by pricking them with 
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a needle dipped into a concentrated culture of E. cloacae, and the flies were 
collected at different time points for total RNA extraction and qRT-PCR. In 
agreement with the in vitro results, pirk RNAi significantly increased the relative 
transcript levels of AttB, Cecropin B (CecB), and DptB at the 4 h and 8 h time 
points compared to the control (II Fig. 3). 
To analyze whether Pirk could suppress Imd pathway activity in vivo, we 
generated Pirk overexpressing flies using the UAS-GAL4 expression system. 
pirk was cloned into the pUAST vector, which was subsequently microinjected 
into w1118 embryos at the Umeå Fly and Worm Transgene Facility. To confirm 
that the expression of this construct led to protein production, and to facilitate its 
detection, pirk was tagged with a V5 epitope. We obtained several parallel UAS-
pirk-V5 fly lines, of which we used four (referred to with the superscript 
numbers 221, 351, 432, and 721) in the following experiments. The induction of 
the transgene was driven by crossing the flies with C564-GAL4 flies. Flies 
crossed with w1118 were used as uninduced controls. The offspring of both 
crosses seemed healthy. The flies were snap-frozen and homogenized in lysis 
buffer, and the production of Pirk was detected by Western blotting using the 
anti-V5 antibody. In uninduced flies, a faint band of Pirk could be seen. This was 
not surprising, since the UAS-GAL4 system is known to be somewhat leaky at 
+25ºC. C564-GAL4–induced flies, however, produced much more Pirk 
compared to the uninduced controls (II Fig. 4A). 
Next, we studied the expression of AMP genes in C564-GAL4-induced and 
uninduced flies by qRT-PCR. The Imd pathway was activated by pricking the 
flies with a needle contaminated with E. cloacae, and the flies were collected and 
total RNA extracted 4 h after infection. Transcript levels of the tested AMP 
genes, AttB, CecB, and DptB, were all significantly decreased compared to  
uninduced controls (II Fig. 4B-D); hence the gene name pirk (poor Imd response 
upon knock-in).  
To examine if these changes in the AMP gene expression were sufficient to 
impair the Drosophila host defense against Gram-negative bacteria, we infected 
pirk-overexpressing flies with E. cloacae and monitored their survival. Three 
parallel UAS-pirk fly lines were crossed with C564-GAL4 driver (induced) or 
w1118 (uninduced) flies. C564-GAL4 flies crossed with w1118 were considered 
wild-type in this experiment. Relish null-mutant flies (RelishE20) do not express 
Imd pathway-dependent AMPs, and are thus very sensitive to Gram-negative 
bacterial infections. They were therefore used as a control to assess the 
efficiency of the septic injury. As expected, only few uninduced or wild-type 
flies died during the 48 h period of surveillance monitoring, while RelishE20 flies 
all succumbed at 20 h post-infection. Moreover, the survival of the C564-GAL4-
induced flies was decreased (II Fig. 8). Although the decrease in survival rate 
was less dramatic than that of the RelishE20 mutant, it was statistically significant. 
This implies that overexpression of Pirk is sufficient to weaken the fly’s immune 
response to Gram-negative bacteria. 
Taken together, these results indicate that Pirk specifically suppresses the 
Drosophila Imd pathway-mediated immune response in vivo. 
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5.2.2 Characterization of Pirk’s mechanism of action (II) 
We found Pirk to be both a structurally and functionally poorly characterized 
protein. According to predictions, it consists of 197 amino acids with no 
recognizable domain structure that would suggest a mechanism of action. Nor 
does it have an N-terminal signal sequence, which implies that Pirk is a 
cytoplasmic protein. We were able to verify this by expressing a GFP-Pirk fusion 
protein in S2 cells, and detecting its cellular localization by confocal microscopy.  
To gain mechanistic insight into Pirk’s role in the Imd signaling cascade, we 
performed a luciferase assay-based epistasis analysis in vitro. S2 cells were 
transfected with either the empty pMT vector or full-length Pirk together with a 
construct encoding the active form of Relish to activate the Imd pathway. 
Overexpression of Pirk did not affect Imd pathway signaling, which implies that 
Pirk acts upstream of Relish. Since the Drosophila Imd pathway branches at the 
level of Tak1 to the JNK pathway, we next examined whether pirk RNAi could 
also affect JNK signaling. Therefore we assessed the transcript levels of a JNK 
pathway target gene puckered (puc) upon induction with heat-killed E. coli in S2 
cells by qRT-PCR. In pirk dsRNA-treated cells, transcript levels of puc were 
significantly higher at 1 h and 2 h after adding the E. coli (II Fig. 6C). This 
suggests that Pirk also suppresses the JNK pathway mediated early response of 
host defense. Hence, Pirk is likely to act at the level of or upstream of Tak1. 
To examine the mechanism of Pirk-mediated Imd pathway down-regulation, 
we concentrated on the Imd pathway components that, according to current 
knowledge, act at the level of or upstream of Tak1. We performed protein 
interaction studies by coimmunoprecipitating full-length V5-tagged Pirk with 
Myc-tagged Tak1, IMD, and the cytoplasmic part of PGRP-LC in S2 cells. Pirk 
coimmunoprecipitated with IMD and the cytoplasmic part of PGRP-LC but not 
with Tak1 (II Fig. 6C). To further characterize the interactions between Pirk, 
PGRP-LC and IMD, we aimed to take a closer look at the structure of Pirk. 
No Pirk homologs had been previously described. Fortunately, the 
Drosophila 12 genomes consortium provided us with the genome sequences of 
the close relatives of Drosophila melanogaster (Drosophila 12 genomes 
consortium, 2007). Combining these with the other assembled genomic 
sequences on Flybase (http://flybase.org), we identified putative orthologous 
proteins from altogether 18 insect species by a tblastn search. However, no 
mammalian or Anopheles orthologs were found. The 18 identified orthologs had 
different N- and C-terminal regions, but the central part of the protein was 
conserved (II Fig. 5). Although this conserved region or domain was previously 
unknown, we used the information as a starting point and designed three Pirk 
deletion constructs coding for N-terminal, central, and C-terminal parts of Pirk. 
Coimmunoprecipitation studies with these constructs revealed that Pirk 
interacted with IMD via its central part, and with the cytoplasmic part of PGRP-
LC via its C-terminal part. In addition, overexpression of either one of these 
domains in S2 cells was sufficient to suppress the Imd pathway (II Fig. 7). 
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5.3 Identification of novel Imd pathway components by 
RNAi screening in S2 cells (III) 
During the last decade, a number of completed genome sequencing projects have 
yielded a vast amount of available DNA sequence data. However, to understand 
the bigger picture, this sequence data needs to be annotated and the genes within 
the sequence to be identified and characterized to elucidate the functions and 
interactions of the proteins that they encode. By RNAi, individual genes can be 
easily knocked down in cell culture systems or in whole organisms, which 
enables searching the genomes to identify the genes related to the loss-of-
function phenotypes of interest. We therefore aimed at identifying the Imd 
pathway components by performing a large-scale RNAi screen in Drosophila S2 
cells. 
5.3.1 RNAi-based screening and validation of the screen in S2 cells 
(III) 
Before initiating the RNAi screen, we assessed the specificity and efficiency of 
gene silencing in our system. CG5210, which encodes a chitinase-like protein, 
was silenced by adding CG5210 dsRNA to the cell culture medium of S2 cells. 
Total RNAs were extracted from both dsRNA-treated and untreated S2 cells, and 
the expression levels of more than 13,500 transcripts were measured by 
oligonucleotide microarrays. The expression level of CG5210 was greatly 
decreased, while the expression levels of the other transcripts remained 
unaffected (III Fig. 1A). From this we concluded that the RNAi in S2 cells was 
both efficient and specific.  
Next, we assayed the reliability and reproducibility of our method of 
screening. We performed targeted RNAi against the Imd pathway transcription 
factor Relish by transfecting S2 cells with increasing amounts of Relish dsRNA 
together with luciferase assay reporter constructs. The Imd pathway was 
activated by adding heat-killed E. coli to the culture medium 24 h before 
harvesting the cells. We found that Relish RNAi suppressed the Imd pathway 
activity in a dose-dependent manner, and that small concentrations (0.1 ng/ul) of 
dsRNA were enough to almost completely block signaling (III Fig. 1C). 
To generate the dsRNAs for the screening, we used a non-commercial S2 
cell-derived cDNA library as a source of templates (Pearson et al. 1995). From 
this library, we synthesized and analyzed altogether 6,713 dsRNAs for their 
effect on Imd signaling by a AttA-luciferase reporter-based assay. Cell viability 
was assessed by a Act5C-β-galactosidase reporter assay to exclude the gene 
products that affected S2 cell homeostasis, or the experiments where  
transfection efficiency was not high enough. As expected, most of the tested 
dsRNAs had little or no effect on AttA-luc or Act5C-β-gal activities. However, 
RNAi against seven genes decreased AttA-luc activity by more than 80% without 
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clearly affecting the Act5C-β-gal activity indicating that none of these dsRNA 
treatments significantly affected cell viability or proliferation (III Table I). Three 
of these genes encoded the known components of the Imd pathway: PGRP-LC, 
imd, and relish. Relish was identified altogether three times, which reflects the 
reproducibility of our screen. The other four genes were kayak, longitudinals 
lacking (lola), inhibitor of apoptosis 2 (Iap2), and CG7417. kayak encodes a 
homolog of the mammalian Fos, and is thus a known component of the JNK 
pathway. Moreover, lola was reported to be required for Drosophila neural 
development (Madden et al. 1999) and normal phagocytosis of bacteria in S2 
cells (Rämet et al. 2002b). We therefore focused on Iap2 and CG7417, whose 
RNAi knock-down decreased the AttA-luc activity by 98%, almost as 
dramatically as the RNAi for relish.  
5.4 CG7417/Tab2 as a component of the Imd pathway 
(III, I) 
According to predictions, CG7417 encodes a protein of 831 aa with two 
recognizable domains: a CUE domain (CUE) at the N-terminus, and a zinc finger 
domain (ZnF) at the C-terminus. These domains are characteristic for 
mammalian TAK1-binding proteins (TABs). The CUE domain has been 
implicated in binding to ubiquitin-conjugated enzymes. ZnF includes a coiled-
coil region, which may mediate protein-protein interactions. Although these 
domains are homologous with the CUE and ZnF domains of mammalian TABs, 
there is very little sequence similarity outside these domains. Since CG7417 is 
the only Drosophila protein containing both CUE and ZnF domains, and the 
protein product CG7417 has been reported to bind TAK1 in a yeast two-hybrid 
interaction study (Giot et al. 2003), CG7417 is referred to as Tab2. 
To confirm our screening results, we first performed semi-quantitative RT-
PCR to rule out that this result was merely a reporter artifact. In agreement with 
the luciferase-assay results, the induction of the Imd pathway-regulated AMP 
genes, CecA1, Dpt, and AttD, was decreased in Tab2 dsRNA-treated S2 cells 
compared to GFP dsRNA-treated controls (III Fig. 2B). An epistasis analysis 
was then performed by overexpressing either imd, full-length relish, or the 
constitutively active RelΔS29-S45 together with the luciferase assay reporters in 
S2 cells. Tab2 RNAi in Rel or RelΔS29-S45 overexpressing cells had no effect 
on AttA-luc activity. However, in imd overexpressing cells, Tab2 RNAi 
completely abolished the AttA-luc activity, indicating that Tab2 was acting 
upstream of Relish but downstream of IMD (III Fig. 3A). This was in line with 
the interaction study by Giot et al. (2003), where Tab2 was reported to interact 
with TAK1. 
To study if Tab2 was essential for the Imd pathway mediated immune 
response in vivo, we aimed at generating a Tab2 null mutant fly line by 
transposase-mediated imprecise excision. For this, we ordered two P element 
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carrying fly lines, 4440 and 14838, from the Bloomington stock center, and 
mobilized the P elements by crossing the flies with a Δ2-3 transposase element 
carrier line. Homozygous offspring of the flies that had lost their P element were 
screened for the absence of Tab2 by RT-PCR. Curiously, we were not able to 
obtain a homozygous viable Tab2 null mutant.   
Unlike other NF-κB proteins, the Imd pathway transcription factor Relish 
contains both the transcription factor part and the inhibitory IκB part, the latter of 
which must be cleaved before the activated transcription factor can translocate to 
the nucleus. This cleavage could be induced by a bacterial peptidoglycan, and 
was thought to be mediated by the caspase Dredd. To better understand the role 
of Tab2 in the Imd pathway signaling, we next investigated if Tab2 was required 
for Relish cleavage. Drosophila hemocyte-like mbn-2 and S2 cells were treated 
with dsRNAs, and the Imd pathway was activated by adding commercial E. coli 
LPS, known to contain contaminating peptidoglycan, to the cell culture medium. 
Relish cleavage was thereafter detected by Western blotting with an α-C Relish 
antibody (Stöven et al. 2000). In GFP dsRNA-treated cells, Relish was cleaved 
rapidly after the LPS stimulus. However, RNAi of Dredd and kenny (key), which 
encodes a component of the Relish-activating IKK complex, blocked the 
cleavage of Relish. RNAi of Tab2 did not affect Relish cleavage (III Fig. 4A-B). 
We next examined if Tab2 was involved in the nuclear translocation of 
Relish. We treated S2 cells with control and Tab2 dsRNAs, stimulated the cells 
with LPS, and assessed the nuclear localization by immunostaining Relish with 
α-RHD antibody (Stöven et al. 2000). Unlike in GFP dsRNA-treated cells, no 
Relish signal could be detected in the nuclei of Dredd or key dsRNA-treated cells 
after LPS stimulation. Tab2 RNAi also affected Relish translocation to the 
nucleus (III Fig. 4C). This was surprising, since Relish was detected in the nuclei 
of Tak1 dsRNA-treated cells. The requirement of Tab2 but not Tak1 in the 
nuclear localization of Relish implies that the regulation of Relish activation is 
more complex and involves more components than was previously thought. 
Besides being a component of the Imd pathway, Tak1 also plays a role in the 
sequential activation of the c-Jun N-terminal kinase (JNK). In addition to 
embryonic development, JNK signaling is required for various processes, such as 
apoptosis, wound healing, and the immune response in Drosophila. In S2 cells, 
the JNK pathway is activated prior to the Relish-dependent Imd pathway in 
response to a Gram-negative bacterial infection (Boutros et al. 2002, Park et al. 
2004a). JNK signaling is terminated approximately 4 h later (Park et al. 2004a), 
after which the Imd pathway is fully activated. Since Tak1 and Tab2 appeared 
necessary for the activation of both pathways (Vidal et al. 2001, Boutros et al. 
2002, Park et al. 2004a, Zhuang et al. 2006), we aimed to investigate, whether 
the roles of Tak1 and Tab2 in Imd pathway activation were mediated via the 
JNK pathway. 
To elucidate this, we used a AttA-luciferase reporter assay and AttD semi-
quantitative RT-PCR to study the roles of the JNK pathway downstream 
components Hemipterous (hep), Basket (bsk), and Kayak (kay) in the expression 
of AMP genes in comparison to Tak1 and Tab2 by (I Fig. 1). In the reporter 
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assay, hep, bsk, and kay RNAi slightly decreased the luciferase activity 
compared to the GFP control RNAi, especially after the 4 h time point. A similar 
trend could be seen with AttD semi-qRT-PCR. In contrast, Tab2 and Tak1 
dsRNA treatments completely abolished the AttA-luc activity and AttD 
expression. This indicates that the JNK pathway is involved in the regulation of 
AMP gene expression as reported previously (Kallio et al. 2005), but Tab2 and 
Tak1 are more important than the downstream components. Moreover, the 
functions of Tak1 and Tab2 are not restricted to the JNK pathway regulation. 
This was further supported by oligonucleotide microarray analysis of Tab2 and 
Tak1 dsRNA-treated S2 cells, which revealed that Tab2 and Tak1 RNAi 
eliminate the induction of Relish-dependent sustained response genes similarly 
to Relish and imd RNAi 4 h post-infection. Tab2 and Tak1 are thus required for 
the induction of all of the Imd pathway target genes (I Fig. 2). The exact 
mechanism for promoting this induction, however, remains elusive. 
5.5 Iap2 as a regulator of the Imd pathway activation (III, 
I, II) 
Another novel component identified in our RNAi screen was Iap2, an 
evolutionarily conserved protein consisting of 498 amino acids. It had previously 
been implicated as an inhibitor of Reaper and FADD-induced apoptosis in insect 
cells (Vucic et al. 1997). Characteristically for other IAPs, Iap2 contains three N-
terminal baculovirus IAP repeat (BIR) domains and a C-terminal really 
interesting new gene (RING) domain. However, the caspase recruitment 
(CARD) domain, which is present in the mammalian homolog, was absent in the 
Drosophila Iap2. Various RING domains have been associated with E3 
ubiquitin-protein ligase activity, and binding activity towards E2 ubiquitin-
conjugating enzymes. The N-terminal BIR domains in human c-Iap2 have been 
suggested to be involved in protein interactions especially with TRAF proteins 
(Rothe et al. 1995). In our screen, however, RNAi targeting of TRAF1 or TRAF2 
(nowadays referred to as Traf4 and Traf6, respectively) did not alter the activity 
of the Imd pathway. We therefore aimed to further characterize the role of Iap2 
in the signal propagation in the Imd pathway. 
We started by performing an in vitro epistasis analysis by overexpressing 
either imd, full-length Relish, or the constitutively active RelΔS29-S45 together 
with the luciferase assay reporters in S2 cells. In Rel or RelΔS29-S45 
overexpressing cells, Iap2 RNAi did not affect the AttA-luc activity. Yet, Iap2 
RNAi in imd overexpressing cells blocked the AttA-luc activity (III Fig. 3). This 
implied that Iap2 was acting upstream of Relish but downstream of IMD. 
Similarly to Tab2, we also asked if Iap2 was required for Relish cleavage or 
nuclear translocation. RNAi of Iap2 did not affect Relish cleavage, but like in 
Tab2 dsRNA-treated cells, the nuclear translocation of Relish was altered. This 
suggested a new approach for Imd pathway regulation. 
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Curiously, when we confirmed our reporter assay results by semi-quantitative 
RT-PCR, we noticed that unlike in the Tab2 dsRNA-treated cells, CecA1 
expression was not completely abolished 6 h post-infection in Iap2 dsRNA-
treated S2 cells (III Fig. 2B). We first speculated if this was due to an incomplete 
inhibitory action of the RNAi, but this was not the case. Our luciferase assays 
with AttA-luc and CecA1-luc reporters had been performed 24 h after inducing 
the Imd signaling by E. coli, and Iap2 RNAi had repeatedly blocked the Imd 
pathway signaling entirely. Hence we hypothesized that the difference might be 
due to the different time points used in these experiments. To study this, we 
assessed the expression kinetics of AttD upon E. coli-induction in Iap2 dsRNA-
treated S2 cells compared to Tab2 and Tak1 dsRNA-treated cells, and GFP 
dsRNA-treated controls by semi-quantitative RT-PCR. While Tak1 and Tab2 
RNAi totally abolished AttD expression, the effect of Iap2 RNAi was once again 
a more moderate. In fact, AttD expression in Iap2 dsRNA-treated cells was as 
strong as in the GFP control at the 4 h time point, and decreased gradually over 
time (I Fig. 1). This was further confirmed by oligonucleotide microarray 
analysis of Iap2 dsRNA-treated S2 cells, which demonstrated that Iap2 RNAi 
had no effect on the induction of Relish-dependent sustained response genes 4 h 
post-infection. After 24 h, Iap2 RNAi moderately decreased the relative 
expression levels of Relish-dependent immune response genes (I Fig. 2). Iap2 
RNAi had merely a minor effect on the expression levels of the Relish-
independent immune response genes,. This implied that Iap2 was necessary for 
the sustained AMP response rather than for the early response in S2 cells. 
To examine if this phenomenon was restricted to S2 cells only, we analyzed 
the expression levels of AttA, AttD, and CecA1 in Iap2 null mutant flies (Leulier 
et al. 2006a) at 0, 1h, 4h, and 8h after E. cloacae infection by semi-quantitative 
RT-PCR (I Fig. 3). Compared to Canton S flies, AttD and CecA1 expression was 
almost abolished in RelishE20 flies, while some AttA expression could still be 
detected. In Iap2 null mutants AttA expression was completely abolished, while 
AttD and CecA1 were clearly expressed (I Fig. 3). Due to the semi-quantitative 
nature of this assay, we can not provide exact measurements for the expression 
levels of AttD or CecA1. However, they are clearly detectable both in Canton S 
and in Iap2 null flies, suggesting that Iap2 is required for a sustained response 
rather than an early response also in vivo. Transcription of AttA seems to be 
independent of these regulatory mechanisms. 
5.5.1 Iap2 is required for resistance towards Gram-negative bacteria 
in vivo (I, III) 
To examine the importance of Iap2 for the Drosophila immune response in vivo, 
we studied Imd pathway activation in Iap2 mutant flies. In collaboration with 
Prof. Lemaitre’s and Prof. Ueda’s laboratories, we acquired flies carrying a UAS-
Iap2-IR construct, which encoded two inverted repeats of the Iap2 gene 
separated by a spacer sequence to form a hairpin-shaped RNA, which in vivo 
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functions as a dsRNA in S2 cells. These UAS-RNAi flies were then crossed with 
flies carrying various GAL4 drivers to activate the expression of the hairpin 
construct. Interestingly, overexpression of UAS-Iap2-IR by the ubiquitous 
daughterless-GAL4 driver resulted in lethality at the pupal stage. The expression 
of UAS-Iap2-IR was therefore driven by the C564-GAL4 driver, which targets 
the expression of the construct into the adult fat body and hemocytes. These flies 
appeared healthy despite the Iap2 RNAi, and were therefore used when assessing 
Imd pathway activity. Iap2 knock-down flies were infected with E. carotovora, 
and the relative Dpt mRNA levels of the flies were monitored 6 h post-infection 
by qRT-PCR. Dpt expression in Iap2 knock-down flies was significantly reduced 
compared to wild-type flies, and almost as low as in the dFADD RNAi flies that 
were used as a positive control (III Fig. 2C). This indicates that Iap2 is required 
for Imd pathway-mediated AMP gene expression also in vivo. 
Next, we aimed to investigate if Iap2 RNAi-induced reduction in AMP gene 
expression was sufficient to affect the fly’s resistance to bacterial pathogens. We 
infected healthy week-old Iap2 RNAi flies by pricking them with a needle 
contaminated with E. cloacae, and compared their survival to similarly treated 
wild-type (Canton S), RelishE20, and dFADD RNAi flies. RelishE20 flies 
succumbed to the Gram-negative bacterial infection within 20 h, while the wild-
type flies were totally resistant to E. cloacae. The survival rates of both dFADD 
RNAi flies and Iap2 RNAi flies were greatly reduced, only 35% of the Iap2 
RNAi flies still being alive at 44 h post-infection (I Fig. 4). This indicates that 
Iap2 is required for normal resistance towards Gram-negative bacteria in vivo. 
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6. Discussion 
6.1 Methodological aspects 
6.1.1 Drosophila as a model in studying innate immunity 
Drosophila has a long history as a model organism in genetic and developmental 
studies, and from the 1980s it has been used increasingly also in immunology. In 
addition to generally having many advantages as model organisms, flies have 
qualities that make them good models also for immunological research. First, the 
pathways of innate immunity are evolutionarily well conserved. Although the 
signaling mechanisms and signal regulation between species may be somewhat 
different, the identification of important signaling components in Drosophila has 
fueled and accelerated the discovery of the components of mammalian signal 
transduction pathways. The most famous example is probably the discovery of 
the mammalian TLRs (Medzhitov et al. 1997) soon after Toll was reported to be 
involved in fly immunity (Rosetto et al. 1995) and to be essential to the fly’s 
resistance to fungal pathogens (Lemaitre et al. 1996). Second, flies have no 
adaptive immunity that would compensate or hide the effects of knocking out an 
important immunity-related gene. Their total dependence on innate immunity 
and reduced genetic redundancy facilitates the interpretation of results. Third, a 
vast variety of tools is available for studying the different aspects of Drosophila 
immunity from the genomic level to complex regulatory networks of proteins 
both in vitro and in vivo. However, one should remember that no model is 
perfect for describing everything. The methods and tools we use should therefore 
be chosen carefully based on their validity for answering the simple questions 
that we ask, bearing in mind the possible drawbacks that the use of the particular 
model involves. Although we are often looking for similarities between the 
human and Drosophila systems, humans can not be seen as scaled-up flies, or 
flies as scaled-down humans. Flies have the right to be considered important and 
interesting simply for what they are: not merely lower organisms or simple and 
ethically trouble-free laboratory animals. 
Both cell-based and in vivo-assays were performed in this thesis study,. Of 
the available tools we used RNAi screening and oligonucleotide microarrays, as 
well as the UAS-GAL4 expression system for the generation of both RNAi 
knock-down and overexpression flies. The possible advantages and 
disadvantages are discussed below. 
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6.1.2 Drosophila cell lines 
The cell-based assays described in this thesis were performed using two 
continuous cell lines, S2 and mbn-2, which are both derived from embryonic 
cells (Schneider 1972, Gateff 1978). They resemble hemocytes in their ability to 
phagocytose, produce various AMPs and express receptors typical for immune 
responsive cells (Samakovlis et al. 1990, Dimarcq et al. 1997, Rämet et al. 2001, 
Rämet et al. 2002b). Although both lines have their limitations, they provide an 
unlimited and more standardized source of cells for different assays compared to 
hemocytes bled from Drosophila larvae. Moreover, efficient gene silencing can 
be induced in these cells simply by adding dsRNAs into the culture medium 
(Clemens et al. 2000). S2 cells are known to be capable of binding and 
internalizing dsRNA via their cell surface receptors (Ulvila et al. 2006), and have 
an efficient RNAi machinery to dice the dsRNA into shorter functional siRNAs. 
Although the use of cell-lines that originate from embryonic blood cells limits 
the possible phenotypes to be mapped, the ease of triggering RNAi and culturing 
these cells explains their wide-spread use in RNAi screening (Rämet et al. 
2002b, Lum et al. 2003, Boutros et al. 2004, Foley and O’Farrell 2004, 
DasGupta et al. 2005, Müller et al. 2005). 
6.1.3 Microarrays 
Genome-wide transcription analysis became a reality in 1997 when the first 
eukaryotic genome-wide microarray was published (Lashkari et al. 1997). 
Microarrays covering a few thousand Drosophila genes had been custom-made 
even before the genome project was completed (White et al. 1999). But as soon 
as the sequence of the Drosophila genome was published in 2000 (Adams et al. 
2000), and commercial oligonucleotide microarrays became available, 
microarrays made their final break-through as a tool that is at hand in every 
laboratory. However, microarray technology is still relatively novel and 
microarray chips have evolved and improved over time. The genomic sequence 
data has been updated and the gene annotation edited, which adds more 
complexity to the interpretation of results when reviewing old and more recent 
microarray data. Still, the most important variables are the source and quality of 
the mRNA to be analyzed. Hence the initial experimental settings before and 
during the RNA extraction should be carefully controlled. 
We used oligonucleotide microarrays to assess, which genes are expressed in 
S2 cells in response to an E. coli-infection. This was performed at different time 
points and after the RNAi silencing of relish. Similar experiment could have 
been performed in vivo comparing E. coli-infected relish mutant and wild-type 
flies. Then, however, the model would have already included many more 
variables, such as the genetic background of the flies, whether we infected the 
flies by septic injury or feeding, whether we extracted the RNA from entire flies 
or just certain tissues, whether we chose male or female flies, and so on. To 
 
 
 
 
64 
acquire a rough overview of transcriptional modifications occurring upon Gram-
negative bacterial infection, we therefore simplified our system and studied a 
genetically homogeneous population of cells that had been subjected to excess 
amounts of heat-killed E. coli in the cell culture medium. It is likely that we 
would have detected a slightly different set of induced genes had we used mbn-2 
cells instead of S2 cells, other bacterial species, live E. coli, different amounts of 
bacteria, or only fragments of the components of the bacterial cell wall. 
Mainly for reasons described above, microarray studies deciphering the genes 
involved in the regulation of the immune system produced lists with some but 
not complete overlap. In accordance with our microarray data, the most induced 
genes (AMPs, PGRPs, and puc) were also detected by others (De Gregorio et al. 
2001, Irving et al. 2001, Rämet et al. 2002b, Agaisse et al. 2003, Johansson et al. 
2005, Vodovar et al. 2005). In addition, Mmp1 was reported to be upregulated in 
two of the studies (Agaisse et al. 2003, Johansson et al. 2005). Curiously, 
Johansson and colleagues reported that challenging mbn-2 cells with E. coli 
resulted in the down-regulation of certain AMPs, such as AttA, AttC, Dpt, Drs, 
and Dro, while they showed increased expression after treatment with crude 
LPS. Similar profiles could be detected also with some of the short PGRPs. Why 
the expression patterns of these genes differ depending on the initial stimulus 
remains unfortunately unclear. In conclusion, one can, from the published 
microarray data, deduce some guide lines for which pathways are involved in the 
signaling, but the expression levels of individual genes vary greatly from one 
experiment to the other. 
6.1.4 In vitro RNAi screening 
Before the discovery of RNAi, Drosophila was favored as a model organism due 
to its potential for carrying out forward genetics, such as mutagenesis screening. 
RNAi has simply broadened the use of Drosophila by enabling the study of 
genes that could not be knocked out by traditional methods due to lethality. 
RNAi in Drosophila works exceptionally well in cells as well as in the whole 
organism from larvae to adults. This is probably due to many reasons. First of 
all, it has been shown that fly S2 cells can bind and internalize dsRNA by 
scavenger-receptor mediated endocytosis (Ulvila et al. 2006). This means that 
dsRNAs can either simply be added to the cell culture medium, or transfected 
into the cells. Second, Drosophila cells have an intact RNAi machinery, which 
makes them capable of dicing 200-700 bp long dsRNAs into 21-23 bp fragments. 
This way, the concentration of each small fragment is relatively small compared 
to the situation where two or three siRNAs would be transfected into the cells. 
The lower concentration might limit the amount of off-target effects. It is also 
plausible to assume that off-target effects are less likely in Drosophila due to a 
lower redundancy of the genome. The use of long dsRNAs has another 
advantage over using siRNAs: dsRNAs are easy to synthesize, which enabled the 
creation of dsRNA libraries very soon after RNAi was discovered. Because 
RNAi is both efficient and relatively straight-forward, it has been used ever since 
to perform large-scale screens aiming to identify components involved in various 
biological processes (Perrimon and Mathey-Prevot, 2007). However, like all 
experimental settings, RNAi screening requires careful planning and 
optimization steps before reasonably reliable data can be acquired (for a review, 
see Boutros and Ahringer 2008). 
In this thesis study, we carried out a large-scale RNAi screen in S2 cells 
using dsRNAs synthesized from an S2 cell-derived cDNA library (Pearson et al. 
1995). The work-flow and optimization steps for designing an RNAi screen are 
illustrated in Figure 9. At the time when we started planning the screen, there 
were no commercial dsRNA libraries available. We therefore chose to proceed 
by synthesizing a collection of our own. The colonies containing the plasmids 
used as template were picked up randomly. The advantage of this approach was 
that we did not have any presumptions about what the results should be like, 
since the genes we were targeting were not known until the plasmids from the 
library were sequenced. 
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Figure 9. Work-flow of designing an RNAi screen. 
 
 
Using cDNA from a continuous cell line as the template for dsRNA synthesis 
has both disadvantages and advantages. On the one hand no cDNA represents the 
whole fly genome. On the other hand, cDNA derived from immune-competent 
hemocytes will only represent the genes transcribed in those cells. This means 
that we were likely to pick up the genes that had relevance for the immune 
response in hemocytes. However, we might have lost some genes that are 
 
 
 
 
65
 
 
 
 
66 
important for the immune response in the fat body, or those that are needed for 
signal transduction between different immune responsive cell types or tissues. In 
addition, the most abundant transcripts are likely to be tested repeatedly, and less 
frequent ones maybe not be picked up at all. Since our cDNA was derived from 
naїve S2 cells instead of ones challenged with PGN or bacteria, our collection of 
dsRNAs lacked genes that are transcribed only in response to microbes, such as 
pirk. 
To examine the activity of the Imd pathway, we decided to use an AttA-
luciferase reporter-based assay. Other AMP-luc reporters, such as Dpt-luc that is 
generally thought to be more specific for the Imd pathway, were tested. In our 
hands the AttA-luc reporter gave the strongest induction, and was therefore 
chosen as our read-out. To exclude dsRNA treatments that would affect cell 
viability, we assayed the level of actin biosynthesis by an Act5C-β-galactosidase 
reporter. S2 cells were cultured on 24-well plates to maximize the amount of 
cells and minimize the standard deviation between samples, and reporter 
constructs were transfected into the cells together with dsRNAs to exclude the 
possibility that the dsRNA treatments might affect the internalization of 
dsRNAs. Imd pathway activation was triggered by adding heat-killed E. coli to 
the cell culture medium to gain a robust and intense response. Before harvesting 
the cells for lysis and measuring the luciferase activity, cells were viewed under 
a microscope to further confirm that the dsRNA treatments did not affect cell 
viability. The luciferase and β-galactosidase activities were measured from 
cleared cell lysates in a 96-well format. The dsRNAs that gave a positive result 
in our screen were further validated by using other reporter constructs and 
targeted RNAi. We were diligent in excluding experimental artifacts, and 
therefore ended up with such a short list of hit genes. 
Others too have screened Imd pathway regulators by RNAi, but chosen 
different experimental settings. Foley and O’Farrell published their genome-wide 
screen as early as in 2004 (Foley and O’Farrell 2004). They created a stable cell 
line expressing a Dipt-LacZ reporter, induced Imd pathway activation by PGN-
contaminated LPS, and detected the β-galactosidase activity by microscopy in  
cells seeded on 96-well plates. Their dsRNA library consisted of 7,216 dsRNAs 
that represented most of the phylogenetically conserved genes of Drosophila. 
However, they did not assay for cytotoxicity of their dsRNA treatments in their 
screen. Foley and O’Farrell identified 121 of the genes involved in the Imd 
pathway, and they further divided them into three categories: positive regulators 
(49 genes), and two types of negative regulators. The first group of negative 
regulators included 26 genes that constitutively activated the reporter in the 
absence of LPS, and the second group of 46 genes that increased the 
responsiveness to the PGN induction. They identified some of the known 
components in their screen, namely PGRP-LC, Dredd, and Relish. Interestingly, 
they did not identify Tab2 or Iap2. Since both of these proteins have a conserved 
domain structure and mammalian orthologs, it would be surprising if dsRNAs 
targeting these genes  had been absent from their dsRNA library. It is therefore 
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reasonable to assume that due to different experimental settings our screening 
results have very little overlap.  
Another screen was published by Gesellchen and colleagues in 2005 
(Gesellchen et al. 2005). They used a Mtk-luc reporter as a read out in their 
preliminary screen, and confirmed their candidate gene list using a AttA-luc 
reporter. In addition, they normalized their results with a constitutive Renilla 
reporter. Their list of candidate Imd pathway regulators is relatively short, but 
has still only partial overlap with the results of our screen. However, Gesellchen 
and colleagues identified both Iap2 and Tab2 as positive regulators of the Imd 
pathway. Once again, the differences in the results may be due to the different 
experimental settings. These examples of published studies emphasize the need 
of careful planning, optimization and validation steps in RNAi screening. 
6.1.5 Drosophila in vivo assays 
Many decades of extensive research carried out in Drosophila have yielded a 
variety of available research tools. We have greatly benefited from the publicly 
available stock collections, but also from the generosity of the Drosophila 
research community, that is famous for kindly sharing fly lines and assay 
methodology when requested. In this thesis study, we used the available P-
element lines, GAL4-driver lines, RNAi lines, and generated some 
overexpression lines of our own. Acquiring fly lines from different sources 
always has one problem: the genetic background of the flies. Immune response is 
one of those features that varies greatly from one stock to another and even 
between individuals. The reasons for this are probably both the genetic 
background and environmental factors, such as the presence of the 
endosymbiotic bacterium Wolbachia pipientis. It is therefore essential to try to 
reduce the effect of the genetic background by back-crossing, which 
unfortunately takes several generations. In the case of Wolbachia, it has been 
reported that around 30% of the stocks at the Bloomington Stock Center are 
Wolbachia-infected (Clark et al. 2005). Wolbachia can infect a wide range of 
different arthropods and nematodes, and both manipulate the host’s reproduction 
and alter its phenotype, such as longevity and viral response (Toivonen et al. 
2009, Hedges et al. 2008), in multiple ways that are still largely unknown. So far 
the stock collections do not provide information about the presence of Wolbachia 
in individual stocks. If one can not feed all the flies with antibiotics to get rid of 
Wolbachia, one should at least bear in mind the possibility of the alterations that 
it might induce. We do not know whether the stocks that we used in our 
experiments contained Wolbachia. Since we did not rely solely on in vivo 
phenotypical analysis when sorting out the regulators of the Imd pathway, it 
seems reasonable to assume that the possible Wolbachia-induced phenotypic 
changes did not significantly affect our results. 
The infection assays that we used to assess the strength of the Imd pathway 
response were conducted by pricking the flies with a needle contaminated with a 
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concentrated bacterial culture. This model of septic injury is commonly used 
when studying the innate immune response in Drosophila, but one can argue if it 
has little or any relevance outside the laboratory. The bacteria that we and others 
widely use in the laboratory are usually of human origin, and are less likely to be 
found in the natural environment of Drosophila. The advantages of using E. 
cloacae and E. coli are that they are easy to access and culture, and more 
standardized and tractable as bacterial species than the ones found in fermenting 
cactus fruits in Latin America. In addition, the survival assays are convenient to 
perform using E. cloacae, since the results can be obtained within a few days. 
The Imd pathway mutants succumb relatively quickly to the infection. Using this 
method, however, may leave the milder phenotypes undetected. As an alternative 
to the septic injury model, the Imd response can be studied by orally infecting 
Drosophila with Erwinia carotovora carotovora (Ecc15), which is an 
entomopathogenic Gram-negative bacterium. Ecc15 has been used for pricking 
flies as well, and it also probably serves as a more relevant model for that 
purpose. Ideally, it would be good if the infection assays were performed using 
different bacteria as well as both oral infection and septic injury, depending on 
the type of response under study. 
In vivo RNAi in Drosophila was first performed by Kennerdell and Carthew 
in 1998. They induced gene silencing by injecting dsRNAs straight into the 
embryos (Kennerdell and Carthew 1998). This technique could be applied to 
smaller screens and for the silencing of individual genes, but was labor-intensive 
and technically rather difficult. RNAi became more feasible when the dsRNA 
was expressed in vivo in a UAS-driven hairpin construct containing a long 
inverted repeat of the target sequence (Kennerdell and Carthew 2000). The 
expression of this kind of a construct could be targeted to any tissue or cell type 
for which a GAL4 driver line was available (for details of UAS-GAL4 
expression system, see Brand and Perrimon 1993). In addition, the expression of 
the RNAi construct could be triggered at the developmental stage of interest. 
This enabled the creation of knock-down animals also for those genes whose 
knock-down in the embryo would otherwise result in lethality. 
Gene silencing by in vivo RNAi has the same limitations as in vitro RNAi 
when it comes to off-target effects, efficiency and specificity. In addition, the 
developmental stage of the fly, the type of tissue targeted, and the gene to be 
silenced may all affect the efficiency of RNAi. For example, genes that are 
regulated through efficient feedback mechanisms might react to the depletion of 
mRNA levels with an increased rate of transcription. Furthermore, the 
integration site of the transgene may influence the knock-down efficiency. 
Techniques for site-specific integration might at least partially solve this 
problem, and are currently being developed (Bischof et al. 2007, Ni et al. 2008). 
Currently, two publicly available collections of transgenic RNAi fly lines 
exist: the National Institutes of Genetics Fly Stocks (NIG-FLY), and the Vienna 
Drosophila RNAi Center (VDRC) (Dietzl et al. 2007). The first genome-wide in 
vivo RNAi screen was performed using the latter collection (Cronin et al. 2009). 
The flies that were used in our experiments were from Prof. Ryu Ueda and 
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essentially the same as the NIG-FLY stocks, since the VDRC collection had not 
yet been opened for common use at that time. The transgene insertion sites of 
these flies are less well documented. In addition, some stocks suffer from 
balancing problems probably caused by multiple insertions of the transgene. 
Nevertheless, we have been able to rule out that these problems would have 
biased our results. Our in vivo experiments regarding Iap2 were confirmed by a 
study performed using a null mutant (Leulier et al. 2006a, Huh et al. 2007), and 
the Pirk results corresponded well with the phenotype of the P element-induced 
hypomorph studied by others (Aggarwal et al. 2008, Lhocine et al. 2008). 
In original article III we reported that crossing Iap2 RNAi with a ubiquitous 
da-GAL4 driver resulted in pupal lethality. The reasons for this are unknown but 
probably due to the ubiquitous driver. Iap2 null mutant flies are viable (Leulier 
et al. 2006a, Huh et al. 2007), unlike Iap1 null mutants. Although these proteins 
share homology at the protein level, their DNA sequence contains only 8 
identical nucleotides. Since dsRNA or the hairpin construct in Drosophila cells 
is cleaved into 21-23 nt siRNA-duplexes that target the complementary mRNAs, 
it is unlikely that 8 nucleotides would be enough to efficiently silence the gene 
encoding Iap1, thread, and cause lethality. Curiously, Iap1 has recently been 
associated with the cellular immune response. Matova and Anderson reported 
thread to be the primary transcriptional target gene of the NF-κB transcription 
factors Dorsal and Dif, and Iap1 to be essential for blood-cell survival. Dorsal 
and Dif double-mutant flies have fewer hemocytes, and the existing hemocytes 
have abnormal morphology and reduced phagocytic ability (Matova and 
Anderson 2006). The constitutive expression of thread in hemocytes was 
sufficient to rescue all these phenotypes (Matova and Anderson 2010). However, 
it remains unclear if the defects in cellular response and phagocytosis result in 
the lethality of thread mutant. 
In conclusion, UAS-driven RNAi is a valid method for creating knock-down 
alleles, silencing multiple genes, and even individual isoforms of genes, but like 
in any other RNAi experiment, adequate controls must be used to exclude driver 
or insertion site-related artifacts. However, the phenotype of a knock-down allele 
is sometimes not dramatic enough, and a null allele, if available, is then the only 
option. 
6.2 Pirk as an Imd pathway negative regulator 
At the time this thesis work began, hardly anything was known about the 
negative regulation of Imd pathway signaling, but it has been intensively studied 
since. Recent evidence shows that the intensity, duration, and localization of the 
Imd pathway-mediated responses are under tight regulation, and that the down-
modulation takes place on multiple levels by different types of regulatory 
proteins (for a review, see Aggarwal and Silverman 2008). In this thesis study 
we show that Pirk is a negative regulator of the Imd pathway and that it interacts 
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either directly or indirectly with PGRP-LC and Imd. These results were soon 
confirmed by two other groups (Aggarwal et al. 2008, Lhocine et al. 2008). 
Lhocine and colleagues reported that Pirk, which they refer to as PGRP-LC-
interacting inhibitor of Imd signaling (PIMS), is an essential modifier of the Imd 
pathway response to commensal bacteria particularly in the gut, but also during 
systemic infection. They initially identified pirk as a strongly induced, Imd-
dependently expressed gene in a large-scale microarray analysis (De Gregorio et 
al. 2001). This is in line with our findings (Kallio et al. 2005, original 
communication I). Lhocine et al. (2008) showed that pirk expression is Relish-
dependent, and that there are four putative NF-κB binding sites in the predicted 
regulatory region of pirk, one of which perfectly matches the DNA-binding 
motif of Relish. In addition to RelishE20 mutant flies, pirk expression was 
significantly reduced in flies reared in axenic conditions, in pirk RNAi flies, and 
in pimsEY00723 flies, which have the corresponding P element insertion as the 
Bloomington stock 15039 that we also briefly used in our studies. Lhocine et al. 
reported clear differences between pimsEY00723 and wild type flies, and 
demonstrated that this P element insertion is haploinsufficient at certain time 
points during infection, since pimsEY00723/+ flies displayed elevated levels of Dpt 
8 h after septic injury with Ecc15 or E. coli. Furthermore, they showed that Pirk 
co-immunoprecipitated with PGRP-LC. However, they detected a much weaker 
signal from the immunoprecipitation experiments with IMD than we did. Hence 
they suggest that the Pirk interaction with IMD could be indirect, and possibly 
mediated by PGRP-LC. They also observed that coexpression of Pirk and PGRP-
LC altered the subcellular localization of PGRP-LC. They therefore hypothesize 
that Pirk suppresses Imd pathway activity by promoting the internalization of 
PGRP-LC from the plasmamembrane, or by preventing PGRP-LC from reaching 
it. Pirk would primarily act as a negative regulator protecting the gut and to a 
lesser extent the fat body in order to maintain normal bacterial homeostasis 
(Lhocine et al. 2008). 
The study by Aggarwal et al. (2008) also identified Pirk, which they refer to 
as Rudra, as a negative regulator of the Imd pathway. Instead of using 
microarray data as a starting point, they performed a yeast two-hybrid screen to 
identify proteins interacting with the cytoplasmic domain of PGRP-LC. They 
further confirmed the yeast two-hybrid screening results by performing co-
immunoprecipitation experiments, which demonstrated that Pirk binds both 
PGRP-LC and PGRP-LE, and that this interaction is at least to some extent 
mediated by the RHIM domain, although the interaction with PGRP-LC requires 
also the IMD interaction domain. In addition, they found that Pirk also co-
immunoprecipitated with IMD. Similar to Lhocine et al., Aggarwal and 
colleagues showed that rudraEY00723 flies are strong hypomorphs with a 
hyperactivated immune response after infecting them with E. coli. When infected 
by Ecc15, rudraEY00723 flies were more resistant to the infection than the wild-
type flies. For the mechanism of Pirk action, Aggarwal et al. suggest that Pirk 
disrupts the signaling complex formed by PGRP-LC and IMD, which in turn 
leads to the downregulation of the signaling. 
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In their in vivo experiments both Aggarwal et al. and Lhocine et al. used flies 
that carry the P-element insertion EY00723 at the pirk 5’ UTR. The same 
insertion is in the Bloomington stock 15039 that we used in our experiments. 
Both groups report a significant decrease in Pirk expression, and a significant 
increase in AMP gene expression in infected EY00723-carrying flies. Lhocine et 
al. further suggest that EY00723-carrying flies are Pirk null mutants. In our 
15039 flies, pirk expression was markedly lower than in wild-type flies, and 
removing the P element restored expression levels to normal (rescue82 and 
rescue461 flies). However, when we compared the AMP expression of P element 
harboring and rescue flies, we could not detect significant differences (Fig. 8). 
This was probably due to the different genetic backgrounds of the flies. The 
strength of the immune defense and the expression levels of immune responsive 
genes are known to vary more than many other traits between individual flies 
and fly lines, which makes controlling the genetic background absolutely 
necessary. By completing a more thorough back-crossing scheme we might have 
detected the differences between P-element harboring and rescue flies, but since 
we were worried about the initial results being a mere artifact related to the use 
of a cell line and reporter assays, we chose to proceed to use RNAi fly lines to 
verify our results in vivo. Otherwise, the results that we acquired using pirk 
RNAi flies are in line with the data obtained by Aggarwal et al. and Lhocine et 
al. using the pirk hypomorph. Pirk knock-out flies of which pirk had been 
removed by precise excision, have not been published yet. 
Besides being an Imd pathway inhibitor, Pirk has also been implicated in 
JNK pathway signal regulation (II, Bond and Foley 2009). This is not surprising 
since the Imd pathway bifurcates at the level of Tak1 (i.e. down-stream of Pirk). 
However, according to data from our lab and Aggarwal et al., Pirk is not 
involved in Toll signaling. Lhocine et al. further demonstrated that Pirk does not 
bind Wengen, a Drosophila member of TNFR superfamily, and is therefore not 
likely to act as a general suppressor of immune regulatory pathways in 
Drosophila. Surprisingly, we detected a decrease in Jak/STAT signaling after 
pirk RNAi in S2 cells. Although this decrease was quite modest, it was still 
significant. This may be due to the interplay of the Imd and Jak/STAT pathways, 
or a mere reporter artifact. 
Based on the data published so far, one can conclude that Pirk negatively 
regulates Imd pathway activity by binding PGRP-LC and IMD either by 
disrupting the signaling complex or triggering PGRP-LC internalization from the 
membrane (Fig. 10). However, how the activity of Pirk is regulated at the post-
transcriptional level, is not known. Relish is required for pirk transcription, but 
the mechanisms that fine-tune the Imd pathway response are elusive. The 
question that still remains to be answered is how the fly maintains the 
homeostasis of normal flora, being simultaneously ready to trigger the full 
battery of AMPs as a response to systemic infection. Unveiling the detailed 
mechanism for this requires further studies. 
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Figure 10. The current hypothesis for Pirk function. Pirk interacts with PGRP-LC, PGRP-LE, 
and IMD, and suppresses Imd signaling by disrupting the signaling complex or by eliciting 
internalization of PGRP-LC from the plasma membrane. 
6.3 Iap2 and Tab2 as novel components of the Imd 
pathway 
Before the publication of original communication III, Drosophila Iap2 was 
regarded as a caspase regulator and apoptosis antagonist rather than an essential 
component of the innate immune signaling machinery. Indeed, Iap2 plays a 
partially redundant role with Iap1 in controlling the cell death machinery 
(Leulier et al. 2006b), although Iap1 seems to be more important for caspase 
regulation. However, the association of Iap2 with the immune response was soon 
verified by other groups both in vitro (Gesellchen et al. 2005) and in vivo 
(Leulier et al. 2006a, Huh et al. 2007). The exact mechanism of Iap2 function is 
still not completely understood. Based on the predicted domain structure, Iap2 
could act as an E3 ubiquitin ligase. This is supported by the observation that the 
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RING domain of Iap2 is indispensable for its function in immune response (Huh 
et al. 2007). 
Ubiquitination has been reported to be involved in the activation of the Imd 
pathway (Zhou et al. 2005), and it has also been implicated in mammalian NF-
κB signaling. Like Iap2, mammalian TRAF proteins contain the N-terminal 
RING domain, typical for ubiquitin E3 ligases. It has been shown in vitro that 
the Tak1/TAB2 complex is activated by TRAF6, which in turn is activated via 
K63-linked ubiquitination (Wang et al. 2001). This requires the E2 proteins 
Ubc13 and UEV1a (Deng et al. 2000), the orthologs of which have been reported 
to participate in the activation of Tak1 and the IKK complex in Drosophila 
(Zhou et al. 2005). In addition, the mammalian homolog of IMD, RIP1, has been 
shown to be K63 polyubiquitinated as well (Lee et al. 2004). However, the E3 
ligase involving these ubiquitination steps still remains unknown. 
Due to the complexity of mammalian TNFR signaling, the effector molecules 
involved in the ubiquitination-mediated regulation of the pathway activity in 
mammals have not been thoroughly mapped. Instead, Thevenon et al. (2009) 
recently reported a Drosophila deubiquitinating enzyme dUSP36 (or Scrawny) to 
be important for the negative regulation of the Imd pathway in vivo. They 
demonstrated that IMD was K63-polyubiquitinated in response to pathway 
activation, and that dUSP36 reduced the amount of K63-ubiquitinated IMD. This 
in turn led to increased proteasomal degradation of IMD (Thevenon et al. 2009). 
Based on this they proposed a model, where IMD is activated by K63-linked 
polyubiquitination, and these ubiquitins are then removed by dUSP36, which 
deactivates Imd, targets it to degradation and suppresses the activation of the Imd 
pathway. The E3 ligase activating IMD is missing from this model, but the 
authors proposed that Iap2 could be a potential candidate. 
Recently, Paquette et al. (2010) demonstrated that Iap2 is an active E3 ligase 
interacting with IMD. They reported that upon PGN stimulation, IMD is 
enzymatically cleaved by the caspase Dredd. This cleavage reveals an interaction 
site for Iap2, which binds to IMD via its BIR2 domain, and to a lesser extent via 
its BIR3 domain. E2 ligases Bendless (Bend), Uev1a, and Effete (Eff) participate 
in the K63-linked polyubiquitination mediated by the Iap2 RING domain. The 
authors speculate that K63-linked polyubiquitin chains could recruit both 
Tab2/Tak1 and IKK complexes, which sequentially leads to kinase activation 
and signal transduction. Ubiquitination of cleaved IMD was shown to be rapid 
and to occur within minutes after a PGN or bacterial stimulus, reaching its 
maximum in 10 minutes. Thereafter the levels of polyubiquitinated IMD started 
decreasing until the ubiquitination was almost undetectable at 30 min (Paquette 
et al. 2010). 
When studying the kinetics of the Imd pathway response by microarray and 
PCR-based methods, we found that knocking down Iap2 in S2 cells could not 
block signaling within the first hours of infection (I Fig. 2, III Fig. 2B). This was 
also seen in vivo in Iap2 null mutant flies (I Fig. 3), which confirms that this was 
not an RNAi-related artifact. In contrast, knocking down other Imd pathway 
components, such as Tab2, completely abolished the transcription of AMPs. This 
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implies that Iap2 is not required for the early response. It could therefore be 
hypothesized that Iap2-induced K63-polyubiquitination of IMD could be the 
trigger for switching from the JNK pathway-mediated early response to a 
sustained response. Ubiquitination of IMD would therefore be unnecessary for 
activation and signaling via the JNK branch, but instead essential for maintaining 
Imd pathway activity high after a few hours. Prolonged signaling may ensure 
host survival during a systemic infection, but as a response to commensal 
bacteria in the gut this could severely harm the host. Therefore suppressing the 
constitutive activation of IMD by dUSP36 as suggested by Thevenon et al. 
(2009) would be required for the temporal control of the immune response. To 
test this, one should first determine if IMD cleavage alone is sufficient to initiate 
Imd signaling at all, or if the K63-linked polyubiquitination of IMD is crucial for 
signal transduction. In addition, the signaling steps required for Dredd 
recruitment and activation in response to bacterial recognition, and how this 
activation is regulated, require further research. Dnr1 and Caspar have been 
implicated as negative regulators of the Imd pathway  possibly targeting Dredd 
(Foley and O’Farrell 2004, Kim et al. 2006), but the mechanisms for this are not 
fully understood. Furthermore, the putative E3 ligase POSH has been reported to 
regulate Tak1 stability and to be required for the accurately timed termination of 
JNK activation (Tsuda et al. 2005). How all these factors work in concert to 
carefully adjust the Drosophila Imd and JNK-mediated responses, requires the 
study of  the complex signaling network as a whole, as well as the understanding 
of the function of the individual proteins. The current model for signal regulation 
at the level of IMD is illustrated in Fig. 11. 
In mammals, the activation of NF-κB and IKK requires a complex formed by 
Tak1 together with the adaptor proteins TABs. It has been reported that 
mammalian TAB2 and TAB3 proteins bind K63-polyubiquitin via the ZnF 
domain. Mutations in the ZnF domain can abolish this binding ability, resulting 
in the deactivation of Tak1 and IKK. Furthermore, TAB2 has been shown to 
bind RIP1 after TNFα stimulation (Kanayama et al. 2004). TABs also contain a 
CUE domain, which has been suggested to be involved in binding ubiquitin 
conjugating enzymes. It is therefore tempting to speculate if Tab2 in Drosophila 
acts as a mediator between IMD and the proteins involved in the ubiquitinylation 
machinery, such as the E2 ligases Bendless (Drosophila Ubc13) and Uev1A. 
Nevertheless, this is a further indication of the  significance of ubiquitinylation in 
the regulation of immune signaling also in Drosophila. 
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Figure 11. The current hypothesis for the ubiquitin-dependent regulation of IMD. Dredd-
dependent cleavage of IMD reveals a binding site for the E3 ligase Iap2, which together with the 
E2 ligases Uev1a, Bendless (Bend) and Effete (Eff) link K63 polyubiquitin chains to IMD. Tab2 
contains a domain that can bind K63 polyubiquitin chains, and this interaction is likely to 
mediate the recruitment of Tak1 to the signaling complex leading to the activation of both Imd 
and JNK signaling. IMD activation can be suppressed by the ubiquitin protease dUSP36, which 
removes the K63 polyubiquitin chains promoting K48-linked polyubiquitination and proteasomal 
degradation of IMD. 
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7. Conclusions and future perspectives 
During the past decades studies conducted using Drosophila melanogaster as a 
model have been essential in expanding our knowledge and understanding of 
various biological processes. A compact genome combined with relatively low 
redundancy, evolutionarily conserved cell signaling pathways, the broad variety 
of tools available for genetic studies, and the fact that flies lack the adaptive 
immune system, have fueled the use of Drosophila in studying innate immunity. 
After the implication of Toll involvement in immune signaling led to the 
discovery of mammalian TLRs, the fly has become even more popular. 
Traditionally the use of Drosophila was more limited to forward genetic 
screening, but since RNAi was found to work exceptionally well in Drosophila 
in vitro and in vivo, both reverse and forward genetics have been used. This has 
enabled scientists to uncover new connections between cellular and 
environmental factors that otherwise would have been difficult to examine.  
In this study, we used the reverse genetic approach by performing a large-
scale RNAi screen in Drosophila S2 cells to identify novel Imd pathway 
components. Thereafter we used the more traditional tools of molecular biology 
and genetics to verify our findings in vitro and in vivo. We found that Tab2 and 
Iap2 are essential for Imd pathway signaling. Both of these proteins have 
mammalian homologs, and mammalian TABs have been implicated in the 
regulation of NF-κB signaling. Tab2 is required for both the early and sustained 
response to Gram-negative bacteria, while Iap2 is required for the sustained 
response only. Furthermore, flies that lack Iap2 succumb to Gram-negative 
bacterial infections. Recently, others have demonstrated that Iap2 is a functional 
E3 ligase activating IMD by K63-linked ubiquitination. The interaction between 
Iap2 and IMD requires the cleavage of IMD by the caspase Dredd (Paquette et 
al. 2010). Dredd has a dual role in Imd pathway activation, since it is required 
for the cleavage of both IMD and Relish. Recruitment of Dredd to the PGRP-
LC-IMD signaling complex is possibly mediated by the death domain-containing 
adaptor protein dFADD, but the exact mechanism of Dredd activation remains 
elusive. Nor is it known which proteins are responsible for the temporal control 
of the early and sustained responses, and how this process is regulated. 
In addition to the two positive regulators, we identified an Imd pathway 
negative regulator, Pirk. Pirk suppresses Imd pathway activity in vitro and in 
vivo, and the overexpression of Pirk sensitizes the flies to Gram-negative 
bacterial infections. Pirk is likely to interact with PGRP-LC and IMD directly, 
but there might be other proteins involved that further facilitate the silencing of 
the pathway. The exact mechanism for how Pirk suppresses the Imd pathway is 
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not thoroughly understood. Nor is it known how the activity of Pirk is regulated 
under normal conditions or during infection. 
Overall, the present study further verifies that Drosophila is a relevant model 
for studying innate immune signaling pathways, and demonstrates that Imd 
signaling is strictly regulated and more complex than was previously thought. 
The identification of both positive and negative Imd pathway regulators 
hopefully opens up novel insights also into the regulation of mammalian NF-κB 
signaling. 
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Abstract
Fruit ﬂies have effective immune response against Gram-negative bacteria. Upon infection, early JNK-signaling
pathway mediated response is followed by the action of the Immune deﬁciency (Imd) signaling cascade, a Drosophila
equivalent of mammalian TNF-receptor pathway, leading to the release of antimicrobial peptides. Recently, Tak1-binding
protein 2 (Tab2) and Inhibitor of apoptosis 2 (Iap2) were identiﬁed as components of the Imd pathway. In this study, we
carried out a genome-wide kinetic analysis of the role of Tab2 and Iap2 for immune response in Drosophila S2 cells using
oligonucleotide microarrays. Tab2 RNAi abolished the induction of all immune response genes in S2 cells indicating its
requirement for signaling both via the Imd and the JNK pathway. The role of Iap2 was more speciﬁc. Kinetic analysis
indicated that Iap2 is required to sustain antimicrobial peptide gene expression in S2 cells. Furthermore, inactivation of
Iap2 by RNAi resulted in impaired microbial resistance in Drosophila in vivo.
r 2007 Elsevier Ltd. All rights reserved.
Keywords: NF-kB pathway; Signal transduction; Innate immunity; Drosophila; Inhibitor of apoptosis2
1. Introduction
Drosophila melanogaster has emerged as a pro-
ductive model to study conserved signaling cascades
regulating immune response. There are two major
pathways for microbe recognition in ﬂies leading to
production of antimicrobial peptides (AMPs): the
Toll pathway which mainly responds to Gram-
positive bacteria and fungi, and the Immune
deﬁciency (Imd) pathway, which responds to
Gram-negative bacteria (reviewed in [1–3]). Imd
pathway is evolutionarily conserved and it
corresponds closely to mammalian TNF receptor
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signaling pathway. The Imd pathway signaling is
mediated through PGRP-LC [4–6] to a death-
domain containing protein Imd [7]. The exact
signaling events occurring downstream of Imd are
currently unclear, but it is known that at least the
IkB kinase (IKK) complex, dFADD, Dredd and
Tak1 (TGFb-activated kinase1) are required for
Relish activation. Of these, Tak1 has been implied
in the sequential activation of the c-Jun N-terminal
kinase (JNK) and the Imd pathways [8–11]. How-
ever, recently it was shown that although needed for
AMP production, Tak1 is not required for Relish
nuclear translocation in S2 cells [12] or in vivo [13],
proposing a more complex regulation of Relish
activity than previously suggested.
Recently, a Drosophila homologue of TAK1-
binding proteins 2 and 3 (Tab2) was identiﬁed and
shown to be required for AMP gene expression
[12,14] and JNK phosphorylation [14]. In mammals,
it has been proposed that TAB2 and TAB3 act as
adaptor proteins in TRAF6, TRAF2 and TAK1
interaction [15], which leads to phosphorylation and
subsequent activation of TAK1 [16]. In addition, it
has been suggested that ubiquitination is needed for
the activation of Tak1 and the IKK complex [17]. In
mammals, TRAF proteins are known to act as K63-
ubiquitin E3 ligases in NF-kB signaling, but in
Drosophila Imd signaling, the E3 ligase required has
not been identiﬁed. Some conﬂicting data have been
published about the role of Trafs in Drosophila
immunity [18] (reviewed in [3]). However, current
reports about knockdown of all Drosophila Trafs in
S2 cells [19] as well as the resistance of Traf2 mutant
ﬂies to Erwinia carotovora septic injury [20] suggest
that Trafs do not participate in Imd signaling.
Instead, a putative E3 ligase Iap2, a member of the
Inhibitor of apoptosis protein family, was recently
identiﬁed as a new component of the Imd pathway
in Drosophila [12,21]. In Drosophila, there are two
IAP-proteins: DIAP1 and Iap2. Both of them
contain BIR (baculovirus IAP repeat) domains
and a RING (really interesting new gene) domain,
which is a signature for an E3 ligase. DIAP1
regulates the cell death machinery by inhibiting
caspases and is hence essential for survival [22]. In
mammals, there are several IAPs (reviewed in [23]),
out of which the best characterized are cellular
proteins cIAP1 and cIAP2 [24] and X-chromosome-
linked IAP (XIAP) [25]. Although the best known
function of IAPs is caspase inhibition and therefore
anti-apoptotic action, they are also able to bind
other molecules and change their activity by
ubiquitination [23]. The exact mechanism how
Iap2 and Tab2 affect the Imd pathway signaling
in Drosophila is unknown. In this study, we have
further characterized the role of Iap2 and Tab2 in
the Imd pathway signaling. In particular, we have
analyzed the kinetics of the AMP gene expression in
S2 cells and in vivo, and evaluated the role of Iap2
for normal resistance in vivo.
2. Materials and methods
2.1. Cell culture
S2 cells were cultured in Schneider medium
(Sigma)+10% FBS, 100U/ml penicillin and
100 mg/ml streptomycin at 25 1C.
2.2. Synthesis of dsRNAs
dsRNAs were produced using targeted primers
(see Supplemental Table S1) and cDNA from S2
cells as a template. First the selected region of the
gene was ampliﬁed using the outer primers. The
obtained PCR product was used as a template for
nested PCR with primers containing binding sites
for T7 RNA polymerase. pMT/BiP/V5-His/GFP
plasmid (Invitrogen) was used as a template for the
production of the negative control GFP dsRNA.
dsRNA synthesis was performed by in vitro
transcription using T7 MegaScript RNA polymer-
ase (Ambion) and the PCR products containing T7
sites as templates.
2.3. Luciferase reporter assay
Attacin A (AttA)-luciferase [26] reporter construct
was kindly provided by Prof. Jean-Luc Imler and
Prof. Jean-Marc Reichhart. Luciferase reporter
assay for Imd pathway was performed essentially
as described earlier [12,27,28]. Brieﬂy, S2 cells were
transfected with AttA-luciferase or Drs-luciferase
reporter together with dsRNAs, using Fugenes
transfection reagent (Roche) according to manufac-
turer’s instructions. Heat-killed Escherichia coli was
added to the cells 48 h after transfection to induce
the Imd pathway. The cells were harvested in
Passive lysis buffer (Promega) at 0 (uninduced),
1, 4, 8, or 24 h after induction with heat-killed
E. coli and stored at 20 1C until analyzed.
Luciferase values were measured using standard
procedures.
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2.4. Genome-wide analysis of mRNA levels using
oligonucleotide microarrays
0.5 106 S2 cells were seeded on 24-well plates
and treated with 4 mg of control (GFP) or experi-
mental dsRNAs. 48 h later heat-killed E. coli was
added and cells incubated with the bacteria for 0
(uninduced), 0.5, 1, 4, 24 or 32 h. Cells (2 106
cells/well) were harvested and total RNA extracted
using RNeasy Mini Kit (Qiagen CA, USA). Gene
expression analysis was performed using the Affy-
metrix (Santa Clara) Drosophila Genechips accord-
ing to the Affymetrix GeneChip Expression
Analysis Technical Manual.
2.5. Semi-quantitative RT– PCR from S2 cells
5 105 S2 cells were seeded onto 24-well plates
and treated with 3 mg of experimental or control
dsRNA. 48 h later, antimicrobial peptide expression
was induced by heat-killed E. coli treatment. At
selected time points after induction, ranging be-
tween 0 and 72 h, cells were harvested in TRIzols
Reagent (Invitrogen) and stored at –80 1C until total
RNA extraction according to manufacturer’s in-
structions. cDNA syntheses and PCR reactions for
Attacin D (AttD) were carried out using Super-
ScriptTM II One-Step RT-PCR with Platinums Taq
(Invitrogen) kit. Primers and sizes of PCR products
are listed in Supplemental Table S1.
2.6. Fly stocks
Canton S and RelishE20 ﬂies were obtained from
Prof. Dan Hultmark from the Umea˚ University.
GAL4 driver C564-GAL4, UAS-RNAi transgenic ﬂy
stocks Iap2-IR and dFADD-IR as well as recently
described Iap2 null mutant ﬂies [20] were kindly
provided by Prof. Bruno Lemaitre, Prof. Ryu Ueda
and Dr. Franc-ois Leulier. The generation of the
RNAi transgenic ﬂy stocks is described elsewhere
[12,29]. The C564-GAL4 driver expresses GAL4 in
adult fat body and hemocytes. C564-GAL4 ﬂies were
crossed with UAS-RNAi ﬂies and the adult ﬂies
carrying one copy of the GAL4 driver and one copy
of the UAS-RNAi construct were used in infections.
2.7. RNA extraction from flies and semi-quantitative
RT-PCR
Canton S, RelishE20, and Iap2 ﬂies were infected 0,
1, 4 or 8 h prior to RNA extraction by pricking
them with a needle dipped into concentrated culture
of Enterobacterium cloacae (E. cloacae). 20 ﬂies (10
males and 10 females) were collected at each time
point and snap-frozen in dry ice. The ﬂies were
homogenized in TRIzols Reagent (Invitrogen) and
the total RNAs were extracted according to
manufacturer’s instructions. Semi-quantitative RT-
PCR was performed using SuperScriptTMII One-
Step RT-PCR with PlatinumsTaq (Invitrogen) kit.
Primers and PCR product sizes are listed in
Supplemental Table S1.
2.8. Survival assay
Bacterial infections were performed by pricking
adult ﬂies with a thin tungsten needle dipped into a
fresh, concentrated culture of bacteria. The survival
of the ﬂies was monitored for 72 h. The Gram-
positive and Gram-negative bacteria applied were
Micrococcus luteus (M. luteus) and E. cloacae,
respectively.
3. Results
3.1. Iap2 activity determines the duration of AttD
expression in S2 cells
Iap2 was recently identiﬁed as an essential
component of the Drosophila Imd pathway [12,21].
In our earlier study, Iap2 RNAi robustly reduced
the AttA-luciferase reporter activity (9871% de-
crease) in response to heat-killed E. coli, whereas the
effect was clearly more moderate on endogenous
CecA1 gene expression as shown by semi-quantita-
tive RT-PCR [12]. We hypothesized that this
difference might be due to different AMPs studied
and/or different time points used in these experi-
ments: in the luciferase reporter assays we had used
a 24 h E. coli-treatment to induce the Imd pathway,
whereas a 6 h time point was used in RT-PCR
reactions.
To study our hypothesis, we performed experi-
ments where the Imd pathway was induced with
heat-killed E. coli, and the expression of selected
AMP genes was measured at various time points
after induction, using both a luciferase reporter
assay and a semi-quantitative RT-PCR assay. As
shown in Fig. 1a, dsRNA-treatments targeting Rel,
Tab2, Iap2, Dredd or key completely abolished the
E. coli-induced AttA-luciferase activity at all time
points measured. Similar results were obtained
with CecA1-luciferase and Drs-luciferase reporters
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(Supplemental Fig. 1). In addition, Tab2 and Tak1
dsRNA-treatments almost entirely blocked the
E. coli-induced endogenous AttD induction as
measured by semi-quantitative RT-PCR (Fig. 1b).
Intriguingly, endogenous AttD mRNA was induced
comparably in Iap2 dsRNA-treated S2 cells com-
pared to GFP dsRNA-treated controls at 4 h (Fig.
1b). In later time points however, AttD mRNA
levels were markedly reduced in Iap2 dsRNA-
treated cells compared to GFP dsRNA-treated
controls (Fig. 1b). Incidentally, the expression of
AttA in S2 cells was not sufﬁcient to perform RT-
PCR experiments. In conclusion, Iap2 appears
necessary for sustained AMP response, but it is
not needed for early response in S2 cells.
Drosophila JNK pathway is required for a
number of processes, including wound healing
[30], development, apoptosis and immunity
(reviewed in [31]). During immune challenge with
Gram-negative bacteria, the JNK pathway is
activated prior to the IKK/Relish dependent Imd
pathway in S2 cells [9,10]. In S2 cells, the early
response of JNK pathway signaling is terminated
approximately after 4 h [10], after which the Imd
pathway and consequently a different set of target
genes are activated. Tak1 and Tab2 are necessary
for both the Imd and the JNK pathway activity in
Drosophila [8–10,14]. As neither Tak1 nor Tab2 are
required for Relish cleavage [12,13], it is plausible
that the role of these proteins in the regulation of
ARTICLE IN PRESS
Fig. 1. Iap2 is required for sustained AMP gene expression in S2 cells. (a) and (c), S2 cells were transfected with AttA-luciferase reporter
plasmid together with shown dsRNAs. Imd pathway was induced with heat-killed E. coli, and luciferase values measured from cells
collected at given time points after induction. Luciferase values were normalized to uninduced GFP controls. Data is shown as mean7SD,
N ¼ 2. (b) and (d), S2 cells were treated with indicated dsRNAs and 48h later the Imd pathway was induced as above. Cells were collected
at given time points after induction, total RNA extracted with TRIzols and Attacin D and Actin 5C expression levels measured by RT-
PCR.
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the Imd pathway activity is mediated via the JNK
pathway.
To test this, we investigated the role of the JNK
pathway downstream components (Hemipterous
(JNKK), Basket (JNK) and Kayak (homologue of
human Fos; part of the AP1-complex)) to AMP
gene expression using both AttA-luciferase reporter
assay and AttD semi-quantitative RT-PCR. As
shown in Fig. 1c, hep, bsk and kay RNAi
moderately reduced the E. coli-induced AttA-
luciferase activity compared to GFP dsRNA-treated
controls in S2 cells. Similar results were obtained
using semi-quantitative RT-PCR estimation of the
endogenous AttD mRNA levels. These results are in
line with our earlier results indicating that the JNK
pathway has a role in regulating AMP expression in
S2 cells [12,28]. However, Tak1 and Tab2 are clearly
much more important for the AMP response than
the downstream JNK pathway components. This
indicates that the function of Tak1 and Tab2 is not
restricted to regulation of the JNK pathway activity
in S2 cells.
3.2. Iap2 is required for maintaining the expression
of sustained immune response genes at genome level in
S2 cells
To obtain a genome-wide view to the role of Tab2
and Iap2 in regulation of the immune response
genes in S2 cells, we used oligonucleotide micro-
arrays. S2 cells were exposed to heat-killed E. coli
for 0, 0.5, 1, 4, 24, and 32 h and thereafter the
mRNA levels of 18,500 transcripts were measured
using Affymetrix Drosophila Genechips. The genes
whose induction with heat-killed E. coli is greater
than two-fold in 4 h can be grouped into two groups
based on the Relish RNAi result at the 4 h time
point: Relish-dependent or sustained (n ¼ 32), and
Relish-independent or early (n ¼ 14) response gene
groups (Table 1). Others have also shown this time-
dependent clustering of immune response genes
[9,10]. As shown in Fig. 2a, at 4 h after E. coli
induction, Relish RNAi completely eliminates the
induction of sustained immune response genes.
Likewise, imd, Tak1 and Tab2 RNAi block this
induction, whereas Iap2 RNAi has no effect (Fig.
2a). This indicates that Imd, Tak1, Tab2 and Relish
are required for induction of all the Imd pathway
target genes in S2 cells, whereas Iap2 is not required
at the 4 h time point. The inhibitory action of all the
dsRNA treatments was analyzed and was found to
be effective (Supplemental Fig. 2).
The early immune response is mediated via the
JNK pathway and it does not require Relish activity
(Fig. 2b) [9,10]. Relish RNAi at the 4 h time point
actually increased and/or prolonged the induction
of the early group genes by nearly three-fold
compared to GFP dsRNA-treated samples
(Fig. 2b). This demonstrates that Relish induction
is required for termination of the early response as
shown earlier by Park and coworkers [10]. In
contrast, the induction of early response genes is
almost completely blocked by Tak1 and Tab2 RNAi
(Fig. 2b) indicating that Imd/Relish and Imd/JNK
pathways branch at the level of Tak1 and Tab2 as
shown earlier [9,10]. The effect of Iap2 RNAi to the
induction of the early response group genes
(Fig. 2b) was modest (29734% decrease). There-
fore it appears that Iap2 has minor role in the JNK
pathway signaling which is in line with recent results
by Huh et al. [32].
Next, we monitored the E. coli-mediated induc-
tion of gene expression in the sustained response
gene group as a function of time. The fold induction
of Attacin B (AttB; the most strongly induced gene
at 4 h) in S2 cells treated with indicated dsRNAs is
shown in Fig. 2c. In Tak1 and Tab2 dsRNA-treated
cells, a marginal induction of AttB can be seen at 4 h
but this induction is quickly returned to baseline
levels. In contrast, in Iap2 dsRNA-treated cells, the
induction at 4 h is greater than in the GFP dsRNA-
treated controls, but by 32 h this induction is
reduced to less than half of the controls. The same
was observed when the induction levels of all the
sustained response group genes (n ¼ 32) were
analyzed together (Fig. 2d). These results conﬁrm
at the genome level that Iap2 is required to maintain
the expression of the sustained immune response
genes in S2 cells.
Of note, the expression levels of AttA, Attacin C
and Diptericin, genes whose expression has been
shown to be induced in vivo in response to E. coli
infection [33,34], were not markedly induced with E.
coli in S2 cells. This indicates that activated Relish
alone is not sufﬁcient to induce these genes in S2
cells but another, yet unidentiﬁed factor, is required.
3.3. Impaired expression of AMPs in Iap2 knockout
flies
To rule out the possibility, that in S2 cells the
time-dependent effect of Iap2 RNAi on AMP
expression was caused by leftover Iap2 protein, we
monitored the expression levels of AttA, AttD and
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CecA1 in Iap2 mutant ﬂies that fail to express Iap2
[20]. In Fig. 3, the expression patterns of these
AMPs at different time points after septic injury
with E. cloacae are shown in wild-type (Canton S),
Relish mutant (RelishE20) and Iap2(-/-) ﬂies. In Iap2
null ﬂies, the level of AttA expression is extremely
ARTICLE IN PRESS
Table 1
Genes induced by E. coli in S2 cells at 4 h
CG# Name 0h 0.5 h 1 h 4 h 24 h 32 h 4 h Rel RNAi
Sustained response i.e. Relish-dependent genes
CG18372 Attacin B 170.1 1.5 6.0 60.6715.1 87.272.0 108.8 0.170.0
CG10794 Diptericin B 170.0 2.3 3.6 52.474.3 78.171.8 95.9 0.270.1
CG7629 Attacin D 170.0 1.1 2.6 47.676.3 92.572.1 112.9 0.170.1
CG8175 Metchnikowin 170.0 1.7 6.5 41.3715.7 52.272.0 52.7 0.470.1
CG32185 170.1 0.9 3.5 29.876.4 48.571.1 61.3 0.070.0
CG15678 170.2 2.0 15.5 15.170.6 5.470.0 6.4 0.470.1
CG14704 PGRP-LB 170.0 1.2 2.0 8.572.0 20.770.3 19.9 0.770.2
CG1878 Cecropin B 170.0 1.2 3.2 7.470.9 4.070.3 3.6 0.670.0
CG8180 170.3 1.1 1.7 5.571.1 8.572.2 9.1 1.170.7
CG13458 170.7 0.7 3.1 5.270.0 7.370.7 9.2 1.170.7
CG10145 M-spondin 170.0 0.9 0.8 5.071.0 12.070.9 13.3 0.670.4
CG13335 170.1 1.1 1.2 4.970.0 12.970.7 13.5 0.470.4
CG7142 170.1 1.2 4.5 4.571.4 4.570.8 5.2 0.970.4
CG9312 170.3 2.3 1.3 4.070.1 5.170.2 7.0 0.970.2
CG10810 Drosomycin 170.1 1.3 1.7 3.671.5 15.970.4 17.9 0.170.1
CG10816 Drosocin 170.2 1.5 1.3 3.570.1 3.670.0 2.7 0.270.0
CG9681 PGRP-SB1 170.6 1.3 1.3 3.470.2 3.470.1 2.6 0.970.1
CG32145 omega 170.2 1.2 1.1 3.470.1 4.070.0 3.6 0.570.1
CG2217 170.1 1.3 1.0 3.370.7 3.870.2 3.0 0.470.1
CG13077 170.1 1.3 1.3 3.371.5 7.070.2 6.3 0.870.4
CG13482 170.1 1.3 2.1 3.170.3 2.070.1 2.7 1.670.2
CG14489 olf186-M 170.0 1.1 0.9 3.170.3 1.970.1 1.8 0.870.1
CG7496 PGRP-SD 170.1 1.2 1.4 2.970.7 5.170.0 5.4 0.070.0
CG32170 170.1 1.0 1.6 2.971.0 2.770.1 3.1 0.670.1
CG32040 170.2 0.6 1.4 2.770.6 2.170.1 1.9 1.270.1
CG30377 170.0 1.2 1.4 2.670.4 3.170.3 2.8 0.570.2
CG8008 170.0 1.1 1.3 2.670.2 1.370.0 1.2 1.170.1
HDC07235 170.3 0.5 1.5 2.470.1 4.170.1 4.1 0.870.2
CG8046 170.0 1.1 1.3 2.370.0 1.470.1 1.6 1.270.2
CG4437 PGRP-LF 170.0 1.0 1.2 2.270.1 2.070.3 1.9 0.870.1
CG1225 RhoGEF3 170.0 1.0 1.0 2.170.5 1.270.1 1.1 0.970.4
CG33468 170.1 1.1 1.2 2.070.5 3.870.5 3.3 0.170.0
Early response i.e. Relish-independent genes
CG7778 170.2 1.1 2.8 6.870.7 4.170.0 4.4 6.572.1
CG4859-RA Mmp1 170.1 1.3 1.3 4.770.4 1.370.1 1.1 14.675.2
CG4859-RB Mmp1 170.1 1.2 1.2 3.770.1 0.970.1 0.4 7.372.2
CG4859-RB Mmp1 170.0 1.4 1.9 3.470.9 1.470.1 1.2 13.571.8
CG8805 wunen 2 170.1 1.3 2.1 2.670.1 0.870.1 0.6 11.571.0
CG8177 170.1 1.2 1.1 2.470.5 1.270.1 1.1 2.170.6
CG6765 170.1 0.8 1.8 2.370.3 1.770.6 0.9 3.771.2
CG6725 sulfated 170.1 1.0 0.9 2.270.4 1.870.0 1.6 2.170.7
CG32030 170.0 1.0 1.9 2.170.4 1.270.0 1.6 4.370.5
CG17124 170.1 1.0 1.1 2.170.0 1.370.1 0.9 3.970.0
CG5730 Annexin IX 170.1 1.1 1.1 2.170.4 1.370.1 1.2 3.271.1
CG7702 170.3 0.7 0.9 2.170.6 0.770.1 0.4 4.170.6
CG7554 comm2 170.1 1.2 3.0 2.070.3 0.670.2 0.6 3.270.5
CG4196 170.1 0.4 0.8 2.070.0 0.970.2 1.2 4.970.2
Relish
CG11992 Relish 170.0 1.1 2.3 2.870.3 1.870.0 1.9 0.370.0
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low at all time points, whereas AttD and CecA1 are
clearly produced especially during the ﬁrst hours
after infection as measured by semi-quantitative
RT-PCR (Fig. 3). This is in line with our results in
S2 cells (Fig. 1b) and indicates that at least certain
AMP genes can be expressed independently of Iap2
in the early phases of infection. Unexpectedly,
moderate levels of AttA expression are present in
RelishE20 ﬂies suggesting the existence of a Relish-
independent means to induce AttA expression.
Corresponding levels of AttA expression were also
observed in RelishE20 larvae naturally infected
with Erwinia carotovora by Leulier and coworkers
[20 Fig. 5C].
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Fig. 2. Microarray data analysis of mRNA levels in S2 cells. S2 cells were treated with GFP, Iap2, Tab2, Tak1, imd and Relish dsRNAs,
Imd pathway was induced with heat-killed E. coli and cells collected at given time points after induction. The expression levels of
approximately 18,500 Drosophila genes were measured using Affymetrix Drosophila Genome 2.0 arrays. Genes, whose E. coli-mediated
induction was more than two-fold in 4 h were divided into sustained immune response or Relish-dependent (n ¼ 32) an early immune
response or Relish-independent (n ¼ 14) groups (see also Table 1). (a) Relish RNAi completely eliminates the induction of sustained
immune response genes at 4 h after E. coli induction. imd, Tak1 and Tab2 RNAi also block this induction, whereas Iap2 RNAi has no
effect at 4 h. (b) The induction of early immune response genes at 4 h is enhanced with Relish RNAi compared to GFP dsRNA-treated
cells, whereas imd, Tak1, and Tab2 RNAi block this induction. (c) The fold induction of Attacin B as a function of time in S2 cells treated
with given dsRNAs. (d) The fold induction of all sustained response group genes as a function of time in S2 cells treated with given
dsRNAs.
S. Valanne et al. / Developmental and Comparative Immunology 31 (2007) 991–1001 997
Author's personal copy
3.4. Iap2-IR flies are susceptible to Gram-negative
bacteria
To examine the importance of Iap2 to Drosophila
immunity, we tested whether Iap2 in vivo RNAi
mutant (Iap2-IR) ﬂies were susceptible to Gram-
negative or Gram-positive bacteria. Canton S,
RelishE20, dFADD-IR and Iap2-IR ﬂies were in-
fected with either M. luteus or E. cloacae (represent-
ing Gram-positive or Gram-negative bacteria,
respectively). None of the tested ﬂy strains was
susceptible to M. luteus (Fig. 4a). Likewise, Canton
S wild-type ﬂies were resistant to E. cloacae. As
expected, in vivo RNAi knockdown of dFADD—a
known component of the Imd signaling pathway—
lead to signiﬁcantly reduced resistance. Iap2-IR ﬂies
behaved comparably to the dFADD-IR ﬂies
(Fig. 4b). 44 h after E. cloacae infection, only 35%
of Iap2-IR ﬂies were alive. RelishE20 ﬂies were, as
expected, very sensitive to E. cloacae. These results
indicate that Iap2 is required for normal immune
response in Drosophila.
4. Discussion
Both the Imd and the JNK pathways regulate the
immune response against Gram-negative bacteria in
Drosophila. During immune challenge, the JNK
pathway is activated prior to the activation of the
Imd pathway [9,10]. It has been proposed that the
AP1 complex, the main target of JNK pathway
activation, inhibits the activation of the Relish
dependent genes [35]. This could explain the
relatively slow kinetics of AMP gene expression
after rapid cleavage and nuclear localization of
Relish. On the other hand, Relish and IKK
activities are required for terminating the expression
of the JNK pathway target genes (Fig. 2b) [10]. The
exact mode of regulation of these pathways is
unclear. It has been shown that Tak1 and Tab2 are
required for the JNK pathway activation
[9,10,13,14]. The role of the JNK pathway in the
expression of the AMP genes is more controversial
[9–13,28,34]. It was recently reported by Delaney
and coworkers [13] that the role of Tak1 in AMP
release is mediated via the JNK pathway in
Drosophila in vivo. In their study, Tak1 mutant
immune response phenotype was rescued by over-
expression of a downstream JNKK, proposing that
JNK pathway activation is sufﬁcient to induce
AMP gene expression in vivo.
In our current study, we have tested the effect of
RNAi knockdown of Tak1 and Tab2 and of the
JNK pathway downstream components on AMP
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Fig. 3. Impaired antimicrobial peptide gene expression Iap2(-/-)
ﬂies. AMP expression in ﬂies was induced by E. cloacae septic
injury. AttA, AttD and CecA1 expression levels were measured
from RNA isolated from ﬂies at given time points after infection
by semi-quantitative RT-PCR. The experiment was repeated
three times with an identical result; a representative picture is
shown.
Fig. 4. Iap2-IR ﬂies are susceptible to E. cloacae infection. Wild-
type (Canton S), RelishE20, dFADD-IR, and Iap2-IR ﬂies were
pricked with a needle dipped in concentrated culture of either M.
luteus or E. cloacae. The respective survival rates are presented in
panels (a) and (b). Number of ﬂies was as follows: Canton S (20
and 27), RelishE20 (20 and 30), dFADD-IR (52 and 67), and Iap2-
IR (43 and 67).
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gene expression in S2 cells. We observed a much
more moderate effect with hep, bsk and kay
dsRNA-treatments compared to those of Tak1
and Tab2. Therefore, the JNK pathway components
appear to have a role in the AMP gene expression in
S2 cells, but Tak1 and Tab2 are much more
important to the AMP gene response than the
downstream JNK pathway components. We con-
clude that the function of Tak1 and Tab2 is not
restricted to JNK pathway regulation in S2 cells.
We hypothesize that Relish activity is regulated
both by cleavage and phosphorylation and that
these two may be separate events. Tak1/Tab2
complex has no role in Relish cleavage [12,13], but
it is possible that the complex functions as an IKK
kinase—as the human TAK1 kinase complex [36]—
regulating the IKK activity and thus phosphoryla-
tion of Relish.
The controversial reports about the involvement
of the JNK pathway in AMP gene expression may
be in part due to diverse times of induction used in
different studies. It seems that the JNK pathway
requirement for AMP gene expression is time-
dependent: as shown in Fig. 1d, the expression of
AMP genes appears normal within the ﬁrst few
hours after immune challenge in S2 cells treated
with dsRNAs targeting JNK pathway (Fig. 1d).
However, dsRNA treatments targeting JNK path-
way components clearly decrease the AMP gene
expression from 24 h onwards (Fig. 1d) [12,28].
Iap2 is required for sustained AMP gene response
and therefore appears as a unique molecular switch
determining the duration of the AMP gene expres-
sion in S2 cells. Correspondingly, Iap2 null mutant
ﬂies were able to express AttD and CecA1 during
the ﬁrst hours after infection. This indicates that at
least certain AMP genes can be expressed indepen-
dently of Iap2 in the early phases of infection.
Curiously, we were unable to detect any AttA
expression in Iap2 mutant ﬂies. This suggests that
the role of Iap2 to the induction of different AMP
genes in vivo varies.
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Fig. 5. Schematic representation of the JNK and Imd pathways in Drosophila immune response. (a) Early response, (b) Sustained
response. Dashed line illustrates translation; asterisk (*) represents Relish putative phosphorylation. CG15678 is a potential negative
regulator of the JNK and Imd pathways [28]. Question mark (?) indicates that the exact mechanism of action remains to be characterized.
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How Drosophila Iap2 functions is yet unclear, but
it can be hypothesized that the mechanism involves
changing the activity of a component of the Imd
pathway by ubiquitination perhaps in a similar
fashion as TRAF2 and TRAF6 function in mam-
mals. It has been suggested that an E3 ligase
analogous to human TRAF2 or TRAF6 is needed
in Drosophila to function with Bendless (Ubc13) and
dUEV1a (UEV1a) in the activation of Tak1 and the
IKK complex [17]. However, when we knocked
down bendless, dUEV1a, Traf1 or Traf2 in S2 cells
by RNAi, we observed no marked effect on AMP
response as measured by AttA-luciferase reporter
assay, AttD RT-PCR and AttD qRT-PCR. So in
contrast to mammalian NF-kB signaling, we are
unable to demonstrate any role for Ubc13, UEV1a
or Trafs in the Imd pathway signaling in S2 cells
using dsRNA-treatment either alone or in combina-
tion (Supplemental Fig. 3). Others have also
demonstrated that knocking down all Drosophila
Trafs by RNAi has no effect on Imd signaling in S2
cells [19], and that Traf2 mutant ﬂies are resistant to
Gram-negative bacteria [20]. Therefore other yet
unidentiﬁed factors are most likely involved in the
Imd pathway signaling. Our current model of the
Imd and JNK pathways is presented in Fig. 5.
It has been proposed that JNK pathway inactiva-
tion is caused by the proteasomal degradation of
Tak1 [10], and that the E3 ligase responsible for
Tak1 ubiquitination and subsequent degradation is
Plenty of SH3s (POSH) [37]. As Iap2 is a putative
E3 ligase, we hypothesized that it might play a role
in the degradation of Tak1. However, we could not
demonstrate Tak1 degradation when the Imd path-
way was activated either with heat-killed E. coli or
by Relish overexpression: Tak1-V5 signals from
cells collected at the same time points with or
without E. coli did not differ and no potential
degradation products were seen. Likewise, over-
expression of either wild type Relish or active form
of Relish (RelDS29-S45) did not cause decreased
stability of Tak1-V5 (Supplemental Fig. 4). Further-
more, we did not see a stabilizing effect upon
knockdown of Iap2 by RNAi (data not shown).
In conclusion, the Imd signaling appears more
complex than previously thought. There are many
similarities to mammalian immunity pathways, but
there are some important differences. For example,
the roles of TRAFs, Ubc13 and UEV1a in immune
challenge in Drosophila appear to differ from those
of the mammalian counterparts. The exact mole-
cular mechanisms of Iap2, Tak1 and Tab2 still
remain elusive and are targets for further investiga-
tion.
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Supplemental methods 
Quantitative real-time PCR from S2 cells 
S2 cells were seeded on 24-well plates and treated with 3μg of experimental or 
control dsRNA. 48h later, antimicrobial peptide expression was induced by heat-
killed E. coli treatment. At 0 (uninduced), 1, 2 and 4h after induction, cells were 
harvested in TRIzol® Reagent (Invitrogen) and stored at -80˚C until total RNA 
extraction according to manufacturer’s instructions. cDNA synthesis was carried out 
with the M-MuLV reverse transcriptase enzyme (Fermentas) as previously described 
[12]. Quantitative real-time PCR analysis for AttD expression was performed from the 
cDNA samples using the LightCycler® Fast Start DNA Master SYBR Green I kit 
(Roche Diagnostics) according to manufacturer’s instructions. Results were analyzed 
with the LightCycler version 3.5 software. 
 
Plasmids 
 Cecropin A1 (CecA1)-luciferase and Drosomycin (Drs)-luciferase reporter 
plasmids were kindly provided by Prof. Jean-Luc Imler and Prof. Jean-Marc 
Reichhart.  
For Tak1 overexpression, Tak1 cDNA was cloned into EcoRI and XhoI sites of 
the CuSO4-inducible Drosophila expression vector pMT/V5-HisA. Full-length Relish 
construct FLAG-Relish-RGSH6 (FRH) and a Relish construct harboring a mutation at 
ΔS29-S45 (RelΔS29-S45) were kindly provided by Dr Svenja Stöven, and have been 
described previously [38]. 
 
Protein analysis 
Tak1-V5 construct was transfected into S2 cells and 24h later induced with 
CuSO4 (150 μM) for 12h. Medium containing CuSO4 was replaced with fresh 
medium and in half of the samples the Imd pathway was induced with heat-killed E. 
coli. Cells with or without E. coli were collected by centrifugation at 0, 0.25, 0.5, 1, 2, 
4, 8 or 24h after induction, suspended in lysis buffer (10mM Tris pH 8.0, 140mM 
NaCl, 1% Triton® X-100, complete mini protease inhibitor cocktail (Roche)) and 
kept at -80ºC until protein analysis.  
S2 cells were transfected with a Tak1-V5-construct together with either a full-
length Relish construct (FRH), a construct containing an active form of Relish (ΔS29-
S45) or an empty vector (pPacPL). Tak1-V5 was induced with CuSO4 (150μM) and 
cells collected at 0, 1, 2, 4 or 8h after induction. 
Protein concentrations of the lysates were determined by BCA (Bicinchroninic 
Acid) Protein Assay Kit (Pierce). Proteins (25μg of protein per lane) were separated 
by SDS-PAGE on NuPAGE 10% Bis-Tris Gels (Invitrogen) and blotted on membrane 
(Hybond-C extra, GE Healthcare Life Sciences). The membranes were incubated in 
blocking buffer (PBS, 0.05% Tween-20, 5% milk powder) for 2h after which α-V5-
antibody (Invitrogen) in blocking buffer (1:5,000) was applied for 1.5h. The 
membranes were washed for 4x15min in PBS, 0.05% Tween-20. The secondary 
conjugate (Invitrogen) was applied 1:5,000 in blocking buffer for 1.5h, followed by 
washing as above. Immunocomplexes were visualized with the ECL Plus Western 
Blotting Detection System (GE Healthcare Life Sciences). 
 
Supplemental Table S1: 
 
Table S1. PCR-primers. 
 
Gene 
 
Upstream primer (5’→3’) 
 
Downstream primer (5’→3’) 
cDNA-
product 
(bp) 
 Primers for dsRNA design and synthesis. (I) Outer primers; (II) Nested primers with T7 sites.   
GFP T7 + GCT CGG GAG ATC TCC T7 + CTA GAC TCG AGC GGC 777 
Rel (I) CCA GCA CCA GTG GCT ATA GC GCT CAT CGT TGC CCA TCA CC 916 
Rel (II) T7 + GCA AAC GGA CTT CGC T7 + CTC ACG CTC TGT CTC 635 
Tab2 (I) GAG CAA TGG AGT GGC TAC GC CGT CCG ACG TCA TAT CAG CG 878 
Tab2 (II) T7 + AGA GGG ATC ACC AGC T7 + TCC GTC ACA GTC AGC 580 
Iap2 (I) CGG AGT CCT GCT CTT GTC CC CTG CGC CAA AGC CGA AGC G 401 
Iap2 (II) T7 + CCC AAC ATC ACG CCG T7 + CTC AAT CTG GCG TCC 275 
Dredd (I) CGA GTG CAA TTT ATC GGC CCA GCA GCT GAA CAT CG 642 
 Dredd (II) T7 + CGG CCA TTT CCT AAA G T7 + CCA CTC TGC ACC AAC 461 
key (I) GGA CGA AGA GTC ATT CG CAC CTC CTG CTT CTG G 793 
key (II) T7 + CTTGGGTAGCTCGCC T7 + CGT CTC TAG GTC CC 523 
Tak1 (I) CCA CAG CAT CGC TGG AC CGG TCA TCA GGT CCT CG 738 
Tak1 (II) T7 + GCA CTG CAG GCA GCC T7 + CCG CGA TTG TTG GTC 503 
hep (I) GAA CAT CAA CGG GCG CTC GTA CGG GGA TCG 643 
hep (II) T7 + GCA GTA TCC GAC T7 + CCA CAC ATC TGC 577 
  bsk (I) GCC GAT ATG CTC CTT AGA GTG CAG TCG GCC 537 
  bsk (II) T7 + GCT CTC AAC TAG T7 + TGG CTT TAA GTC 490 
kay (I) CCC TTG GAT CTC AAG CCG G CTC ATC ATG CAT CGT CGG TC 1000 
kay (II) T7 + GAC TCA GGA TCC AGC T7 + CTG TTC GGT ACG AGG 473 
    
 RT-PCR-primers   
Act5C CGA AGA AGT TGC TGC TCT GG AGA ACG ATA CCG GTG GTA CG 453 
AttA GCA TCC TAA TCG TGG CC GCT TCT GGT TGG CAA ACG 609 
AttD GAG TAT TCG CCT CCA CTC C CTC CGC CAA ACT GAT CG 225 
CecA1 CGT CGC TCT CAT TCT GGC GTT GCG GCG ACA TTG GC 153 
 
Supplemental Figures: 
Supplemental Figure 1: 
 
Supplemental Figure 2: 
 
Supplemental Figure 3: 
 
Supplemental Figure 4: 
Supplemental Figure legends 
 
Supplemental Figure 1. Iap2 is required for sustained AMP release in S2 cells. S2 
cells were transfected with (a) CecA1-luciferase reporter plasmid and (b), Drs-
luciferase reporter plasmid together with shown dsRNAs; Imd pathway was induced 
with heat-killed E. coli, and luciferase values measured from cells collected at given 
time points after induction. Luciferase values were normalized to uninduced GFP 
controls. Data is shown as mean±SD, N=2. 
 
Supplemental Figure 2. RNAi effectively decreases the expression of the targeted 
gene in S2 cells. The effectiveness of the RNAi-mediated inhibition of Tab2, Iap2, 
Tak1, Relish and imd expression was analyzed by comparing the gene expression 
levels in cells treated with the targeted dsRNA to GFP dsRNA-treated cells. 
 
Supplemental Figure 3. Bendless, dUEV1a, TRAF1 and TRAF2 are not required, 
either alone or in combination, for Imd pathway activation in Drosophila S2 cells. (a) 
S2 cells were transfected with AttA-luciferase and Act5C-β-galactosidase reporter 
plasmids, Imd pathway induced with heat-killed E. coli, and luciferase and β-
galactosidase values measured using standard procedures as described in [12]. (b and 
c) S2 cells were treated with GFP or bendless+dUEV1a dsRNAs and 48h later the 
Imd pathway was induced with heat-killed E. coli. Cells were collected at 0, 1, 4 or 
24h after induction, total RNA extracted with TRIzol® and Attacin D in comparison 
to Act5C expression levels was measured by RT-PCR (b) and qRT-PCR (c). Each 
sample was done as a duplicate and the average is shown in (c). 
 
Supplemental Figure 4. Induction of the Imd pathway does not affect Tak1 
degradation. (a) E. coli-induction of the Imd pathway does not induce Tak1 
degradation. Tak1-V5 construct was transfected into S2 cells and induced overnight 
with CuSO4 (150 μM). After removal of CuSO4, the Imd pathway was induced with 
E. coli and cells collected at given time points after E. coli induction. Western blots of 
protein extracts (25μg protein/lane) using an anti-V5-antibody. (b) Overexpression of 
Relish does not induce Tak1 degradation. S2 cells were transfected with Tak1-V5 
with either a full-length Relish construct (FRH), a construct containing an active form 
of Relish (ΔS29-S45) or an empty vector (pPacPL). Tak1-V5 was induced with 
CuSO4 and cells collected at given time points after induction. Western blots of 
protein extracts (25μg protein/lane) using an anti-V5-antibody.  
 
[38] Stöven S, Silverman N, Junell A, Hedengren-Olcott M, Erturk D, Engström Y, 
Maniatis T, Hultmark D. Caspase-mediated processing of the Drosophila NF-κB 
factor Relish. Proc Natl Acad Sci USA 2003; 100(10):5991-5996. 
 
Pirk Is a Negative Regulator of the Drosophila Imd Pathway1
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NF-B transcription factors are involved in evolutionarily conserved signaling pathways controlling multiple cellular processes
including apoptosis and immune and inflammatory responses. Immune response of the fruit fly Drosophila melanogaster to
Gram-negative bacteria is primarily mediated via the Imd (immune deficiency) pathway, which closely resembles the mammalian
TNFR signaling pathway. Instead of cytokines, the main outcome of Imd signaling is the production of antimicrobial peptides. The
pathway activity is delicately regulated. Although many of the Imd pathway components are known, the mechanisms of negative
regulation are more elusive. In this study we report that a previously uncharacterized gene, pirk, is highly induced upon Gram-
negative bacterial infection in Drosophila in vitro and in vivo. pirk encodes a cytoplasmic protein that coimmunoprecipitates with
Imd and the cytoplasmic tail of peptidoglycan recognition protein LC (PGRP-LC). RNA interference-mediated down-regulation
of Pirk caused Imd pathway hyperactivation upon infection with Gram-negative bacteria, while overexpression of pirk reduced
the Imd pathway response both in vitro and in vivo. Furthermore, pirk-overexpressing flies were more susceptible to Gram-
negative bacterial infection than wild-type flies. We conclude that Pirk is a negative regulator of the Imd pathway. The Journal
of Immunology, 2008, 180: 5413–5422.
S ignaling mediated by members of the TNF superfamily ofcytokines is involved in many cellular processes in bothnormal and diseased stages. Besides having anticancer po-
tential, TNF is of crucial importance in regulating the innate and
adaptive immune systems and in initiating host responses against
microbial infections. Impaired TNF response is associated with
recurrent bacterial infections. In contrast, excessive and inappro-
priate TNF signaling can lead to many pathological stages such as
septic shock, rheumatoid arthritis, allergy, and asthma (1, 2).
The Drosophila Imd (immune deficiency) signaling pathway
closely resembles the TNF signaling pathway; both share several
homologous components and lead to nuclear localization of an
NF-B family transcription factor (3–5). Drosophila Imd signaling
is triggered by recognition of Gram-negative bacteria by the re-
ceptor peptidoglycan recognition protein (PGRP)3 LC (6–8). The
signal proceeds via Imd, a homologue to mammalian RIP (receptor
interacting protein) (9, 10), the adaptor protein dFADD (FAS-as-
sociated death domain protein) (11), the Drosophila IKK (IB
kinase) complex Kenny/Ird5 (immune response deficient 5), which
phosphorylates the NF-B transcription factor Relish (12), and the
caspase Dredd (death-related Ced-3/Nedd2-like protein), which is
thought to cleave the C-terminal inhibitory domain of Relish (13–
15). In addition, Drosophila Tak1 (TGF--activated kinase) (16),
Tab2 (Tak1 binding protein 2), and Iap2 (inhibitor of apoptosis
protein 2) (17–20) are required for signal transduction via the Imd
pathway. Finally, the activated N-terminal part of Relish translo-
cates to the nucleus where it binds DNA and activates the tran-
scription of several target genes, including antimicrobial peptides,
which effectively target and kill bacteria. Imd signaling is crucial
for the fly’s immune defense, especially against Gram-negative
bacteria.
Several genome-wide screens have identified components and
positive regulators of Imd signaling (17, 18, 21). Overall, the com-
ponents of Imd signaling are relatively well known and the sig-
naling itself appears to be tightly regulated to avoid unwanted and
prolonged responses (22). The duration of mammalian TNF sig-
naling is regulated by a negative feedback loop because the ac-
tivated NF-B induces, among other target genes, the expres-
sion of its inhibitory protein IB, which in turn can bind to
NF-B and displace it from its DNA binding sites (2). To date,
the negative regulators of Imd signaling are less well known.
Secreted PGRPs PGRP-LB, PGRP-SC1, and PGRP-SC2 have
been reported to suppress Imd pathway response possibly by
enzymatic degradation of peptidoglycan, which otherwise
would trigger the pathway activation (23, 24). The membrane-
bound PGRP-LF has also been reported to be immune suppres-
sive, although the mechanism remains elusive (25). Other sug-
gested mechanisms of down-regulation target the transcription
factor Relish by proteasomal degradation (26) or by preventing
its cleavage and nuclear translocation (27) or transcriptional
activity by formation of a repressosome complex (28). In this
study we have identified a previously uncharacterized gene
called pirk (poor Imd response upon knock-in) among genes
induced upon Gram-negative bacterial challenge. Pirk mediates
Imd pathway inhibition at the level of Imd and PGRP-LC.
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Materials and Methods
Genome-wide analysis of mRNA levels in S2 cells by
oligonucleotide microarrays
dsRNA treatments, Imd pathway induction, total RNA extractions, and
oligonucleotide microarrays were performed as previously reported (20).
Cell culture and transfections
S2 cells, which are Drosophila hemocyte-like cells, were maintained in
Schneider’s insect cell culture medium (Sigma-Aldrich) with 10% FBS,
100 U/ml penicillin, and 100 g/ml streptomycin at 25°C. All transfections
were performed with FuGENE transfection reagent (Roche Applied Sci-
ence) according to the manufacturer’s instructions.
dsRNA treatments and luciferase assays
dsRNA treatments and luciferase assays for monitoring Imd and Toll path-
way activities were performed as described earlier (20, 17, 29). To monitor
Jak/STAT pathway activity, the cells were transfected with TotM (Turan-
dotM)-luciferase (-luc) reporter plasmid and constitutively active hop-
scotch, which activates Jak/STAT signaling. Cell viability was assessed
using Actin5C--galactosidase reporter. Transfections were performed on
24-well plates and 1 g of dsRNA was used for each dsRNA treatment.
The pirk overexpression construct was created by cloning CG15678 from
S2 cell cDNA to pMT/V5/His-A vector (Invitrogen Life Technologies).
Deletion mutants Pirk(M1–K51), Pirk(D52–V136), and Pirk(V137–I197) were cre-
ated by cloning nucleotides 1–153, 154–408, and 409–591, respectively,
from pirk cDNA to pMT/V5/His-A vector.
Drosophila stocks
C564-GAL4 driver flies were obtained from Prof. B. Lemaitre (Centre de
Ge´ne´tique Mole´culaire, Centre National de la Recherche Scientifique, Gif-
Sur-Yvette, France) and CG15678 RNAi flies were from Prof. R. Ueda
(National Institute of Genetics, Mishima, Shizuoka, Japan). The pirk
cDNA was ligated with a V5 epitope tag and cloned into a pUAST plasmid
(30). Flies overexpressing pirk were generated by microinjecting pUAST-
pirk-V5 construct to w1118 background in the Umeå Fly and Worm Trans-
gene Facility, Umeå, Sweden. Independent UAS-pirk-V5 transgenic fly
lines used in experiments were referred to as UAS-pirk 221, UAS-pirk 351,
UAS-pirk 432, and UAS-pirk 721, having the insertion in the third, X, third,
and second chromosomes, respectively.
Infection and RNA extraction from flies
Flies were infected by pricking them with a tungsten needle dipped into a
concentrated culture of Enterobacter cloacae 0, 1, 4, or 8 h before RNA
extraction. Triplicates of five flies (three males and two females) were snap
frozen in dry ice and homogenized in TRIzol reagent (Invitrogen Life
Technologies), and the total RNAs were extracted according to the man-
ufacturer’s instructions. For survival assay, 50 flies of each line were in-
fected as described above and their survival was monitored for 48 h at
25°C.
Protein extraction from flies and Western blotting
To extract total proteins, 10 flies of each line were anesthetized, snap
frozen in dry ice and homogenized in 80 l of lysis buffer (10 mM Tris (pH
8.0), 140 mM NaCl, 1% Triton X-100, and Complete mini protease inhib-
itor cocktail (Roche Applied Science)). Fly extracts were incubated on ice
for 45 min, centrifuged at 16,000  g for 15 min, and the protein concen-
tration of the cleared lysates was measured using a BCA protein assay kit
(Pierce). Forty micrograms of each lysate was electrophoresed in NuPAGE
10% Bis-Tris gel (Invitrogen Life Technologies), blotted on a nitrocellu-
lose membrane, and detected by Western blotting using mouse anti-V5
primary Ab (Invitrogen Life Technologies) and goat anti-mouse Ab HRP
conjugates (Molecular Probes) together with ECL Plus Western blotting
detection system (GE Healthcare).
Quantitative real-time PCR
Quantitative RT-PCR (qRT-PCR) was performed by either a LightCycler
(Roche) or an ABI7000 (Applied Biosystems) instrument using the Quan-
tiTect SYBR Green RT-PCR kit (Qiagen) according to the manufacturer’s
instructions. Results were analyzed with the LightCycler version 3.5 soft-
ware or ABI 7000 System SDS software version 1.2.3. Primers contained
the following sequences: Actin5C (Act5C), 5-CGAAGAAGTTGCTGCT
CTGG-3 (forward) and 5-AGAACGATACCGGTGGTACG-3 (re-
verse); AttB, (5-CAGTTCCCACAACAGGACC-3 (forward) and 5-CT
CCTGCTGGAAGACATCC-3 (reverse); CecB, (5-TTGTGGCACTCA
TCCTGG-3 (forward) and 5-TCCGAGGACCTGGATTGA-3 (reverse);
DptB, 5-GACTGGCTTGTGCCTTC-3 and 5-CCTGAAGGTATACACT
CC-3 (reverse); pirk, 5-CGATGACGAGTGCTCCAC-3 (forward) and
5-TGCTGCCCAGGTAGATCC-3 (reverse); and puc, 5-GACGGCGA
CAGCGTGAGTC-3 (forward) and 5-GCCGTTGATGATGACGTCG-3
(reverse).
Confocal microscopy
S2 cells were seeded onto 24-well plates and transfected with 0.1 g of a
modified pMT/GFP/V5/His plasmid (a gift from Dr. I. Kleino) expressing
Pirk as C-terminal GFP fusion protein. Pirk expression was induced 24 h
later by adding CuSO4 to a final concentration of 100 M. Forty-eight
hours after induction the cells were passed 1:3 to 6-well plates with a
coverslip on the bottom of each well. The cells were allowed to attach for
30 min after which the culture medium was removed and the cells were
fixed with 3.7% formaldehyde and 5% sucrose for 20 min. The coverslips
were washed three times with PBS and mounted to objective glasses with
Vectashield mounting medium for fluorescence with 4,6-diamidino-2-
phenylindole (Vector Laboratories).
Coimmunoprecipitation and Western blotting
S2 cells were seeded onto 6-well plates and transfected with 0.5 g of
C-terminally V5-tagged full-length pirk construct or deletion construct in
pMT/V5/HisA vector (Invitrogen Life Technologies) and 0.5 g of myc-
tagged imd, Iap2, and Tak1 or the cytoplasmic tail of PGRP-L(M1-V293) in
the same vector of which the V5 tag was replaced by myc tag. Expression
of the tagged proteins was induced 24 h post-transfection by adding CuSO4
to a final concentration of 250 M. Cells were harvested 48 h later and
lysed in 1% Nonidet P-40 lysis buffer (50 mM Tris-HCl (pH 7.4), 50 mM
FIGURE 1. pirk is strongly and rapidly induced after Gram-negative
bacterial infection in a Relish-dependent manner in vitro and in vivo. A,
Relative gene induction profiles of the genes induced 5-fold upon Gram-
negative bacteria infection, 11 in total. To induce the Imd pathway, Dro-
sophila S2 cells were treated with heat-killed E. coli for 0, 0.5, 1, 4, 24, and
32 h. Thereafter the total RNAs were extracted and the expression level of
18,500 transcripts was measured using oligonucleotide microarrays. One
hundred percent (100%) indicates the maximum induction of each gene. B,
pirk induction is Relish-dependent in vitro. S2 cells were treated with either
control (GFP) or Relish dsRNA 48 h before Imd pathway activation with
heat-killed E. coli. Total RNAs were extracted at the 4-h time point and
used in oligonucleotide microarrays. C, pirk induction is Relish-dependent
in vivo. Wild-type (Canton S) and RelishE20 flies were infected by E. clo-
acae and the expression level of pirk was quantitated by qRT-PCR at 0, 1,
4, and 8 h after infection. Error bars represent the SD; n  3.
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NaCl, 0.5% sodium deoxycholate, 20 mM NaF, 1% Nonidet-P40, 10%
glycerol, 100 g/ml PMSF, and Complete mini protease inhibitor cocktail
(Roche Applied Science)). Lysate volume corresponding to 1 mg of total
protein for each sample (as measured by BCA protein assay kit; Pierce)
was first precleared by adding 25 l of a 1:1 suspension of protein G-
Sepharose (GE Healthcare) in lysis buffer and incubating the mixture for 50
min with rotation at 4°C. The resulting supernatants were transferred to
fresh tubes. Twenty-five microliters of protein G-beads were added to 1 g
of anti-c-Myc rabbit IgG Ab. The samples were incubated overnight with
rotation at 4°C and then washed with PBS containing PMSF and protease
inhibitors for 4  10 min. Immunoprecipitates were separated from the
beads by adding 25 l of 2  SDS loading buffer, vortexing, and incu-
bating at 95°C for 5 min, then electrophoresing in NuPAGE 10% Bis-Tris
gel (Invitrogen Life Technologies), and blotting on nitrocellulose mem-
brane. Proteins were detected by 1/5000 diluted mouse anti-V5 or rabbit
anti-c-Myc primary Ab and by goat anti-mouse or anti-rabbit Ab HRP
conjugates (Invitrogen Life Technologies), respectively, and visualized by
ECL Plus Western blotting detection system (GE Healthcare).
Statistical analysis
Statistical analysis of results was conducted using one-way ANOVA and,
for survival experiments, logrank analysis. p  0.05 was considered
significant.
Results
Pirk is induced upon Gram-negative bacterial infection in vivo
and in vitro in Relish-dependent manner
Antimicrobial response of Drosophila is delicately regulated and
includes a precise temporal control. Drosophila Imd pathway tran-
scription factor Relish contains both NF-B and IB homologous
parts and is activated when the C-terminal IB part is cleaved. We
hypothesized that inhibition of the Imd signaling is mediated by a
negative feedback loop. In theory, a putative negative regulator
FIGURE 2. Pirk is a negative regulator of the
Drosophila Imd pathway in vitro. A, Knocking
down pirk by RNAi increases Imd pathway-me-
diated AttA response at 4, 8 and 24 h compared
with GFP controls. S2 cells were transfected
with AttA-luc reporter plasmid and treated with
dsRNAs, and the Imd pathway was induced 48 h
later by heat-killed E. coli. GFP dsRNA was
used as a negative control and Relish dsRNA as
a positive control. B–D, Imd pathway mediated
induction of antimicrobial peptide genes is in-
creased in pirk RNAi knock-down cells. S2 cells
were treated with pirk dsRNA 48 h before add-
ing heat-killed E. coli, and total RNAs were ex-
tracted at 0, 1, 4, and 24 h after induction. The
levels of pirk (B), AttB (C), and DptB (D) tran-
scripts were analyzed by qRT-PCR and normal-
ized to Actin-5C transcript levels. E, In vitro
overexpression of pirk suppresses Imd pathway
activation in S2 cells. S2 cells were transfected
either with an empty vector or a pirk overex-
pression construct together with AttA-luc re-
porter. Imd pathway was activated by heat-killed
E. coli. F and G, Pirk does not affect Toll path-
way activity but decreases Jak/STAT-mediated
TotM response. S2 cells were transfected with
Drosomycin-luc (F) or TotM-luc (G) reporter
plasmids for Toll and Jak/STAT pathway, re-
spectively, and treated with dsRNAs. Luciferase
activity was measured 72 h posttransfection.
Drosophila MyD88 (dMyD88) dsRNA was used
as a positive control for Toll pathway and STAT
dsRNA for Jak/STAT pathway. hop, hopscotch.
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should be induced upon microbial challenge via the Imd pathway.
Previously, we have identified all genes that are induced upon
Gram-negative bacterial challenge via the Imd pathway in S2 cells
(29). In this study, RNAi targeting a gene of unknown function,
CG15678, enhanced Imd pathway activity in vitro. To further ex-
amine the role and function of this gene, which we call pirk, we
first monitored the expression kinetics of the genes induced upon
heat-killed Escherichia coli treatment. According to microarray
analysis, 11 genes were expressed 5-fold in 4 h in S2 cells (20).
Fig. 1A shows the relative induction profiles of these genes. Most
of them were steadily induced and reached their maximum induc-
tion at 24 after bacterial challenge. Antimicrobial peptide gene
CecB (Cecropin B) was an exception, reaching its maximum at 4 h.
However, only pirk was rapidly induced, reaching its maximum
already at 1 h postinfection and then decreasing.
To examine whether this induction is Relish-dependent, we
treated S2 cells with either control (GFP) or Relish dsRNA 48 h
before inducing the Imd pathway activation by E. coli and ana-
lyzed pirk expression levels at 4 h by oligonucleotide microarrays.
Fig. 1B shows that pirk expression levels were abolished after
Relish RNAi. To confirm this in vivo, we infected wild-type (Can-
ton S) and Relish null mutant (RelishE20) flies by septic infection
with E. cloacae and monitored pirk expression levels by qRT-PCR
at 0, 1, 4, and 8 h after bacterial challenge. pirk was highly induced
in Canton S but not detected in RelishE20 flies (Fig. 1C). These
results indicate that pirk expression is Relish-dependent both in
vitro and in vivo.
FIGURE 3. pirk in vivo RNAi increases Imd pathway activity. Two
independent pirk in vivo RNAi fly lines were crossed to C564-GAL4
driver, and the offspring was infected with E. cloacae. Total RNAs from
triplicate samples were extracted at 0, 1, 4, and 8 h after infection, and
expression levels of three Imd pathway-mediated antimicrobial peptide
genes, AttB (A), CecB (B), and DptB (C), were analyzed by qRT-PCR.
w1118 was used as a wild-type control. Error bars represent SD, n  3.
Asterisks indicate statistical significance: , p  0.05; , p  0.01; ,
p  0.001.
FIGURE 4. Overexpression of pirk suppresses Imd pathway activation
in vivo. A, UAS-pirk-V5 transgenic fly lines express Pirk-V5 protein. Two
independent lines, UAS-pirk 721 and UAS-pirk 351, were crossed over w1118
or C564-GAL4 driver flies, and Pirk-V5 expression of the offspring was
analyzed from whole fly extracts by Western blot. B–D, Two independent
UAS-pirk-V5 fly lines, UAS-pirk 221 and UAS-pirk 432, were crossed to
C564-GAL4 driver (induced) and to w1118 (uninduced). The Imd pathway
was activated with E. cloacae, and RNAs were extracted at 0 and 4 h after
infection. Expression levels of AttB (B), CecB (C), and DptB (D) were
analyzed by qRT-PCR. Error bars represent SD, n  3. Asterisks indicate
statistical significance: , p  0.05; , p  0.01; , p  0.001.
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Pirk specifically suppresses Imd pathway activity in vitro
To study the role of Pirk in Imd pathway regulation, we used an
Attacin A-luc reporter-based assay in S2 cells treated either with
control (GFP dsRNA as negative and Relish dsRNA as positive
control) or pirk dsRNA, together with heat-killed E. coli to activate
the Imd response. Fig. 2A shows AttA-luc activity representing Imd
pathway activation measured at 1, 4, 8, and 24 h after induction
with heat-killed E. coli. AttA-luc activity in pirk dsRNA-treated
cells was increased at all time points studied. The results were
similar with Cecropin A1-luc reporter (data not shown). We also
monitored expression levels of Imd pathway-dependent antimicro-
bial peptide genes in S2 cells treated either with control (GFP) or
pirk dsRNA by quantitative RT-PCR. Again, the Imd pathway was
activated by adding heat-killed E. coli to the cells. As expected,
pirk expression in pirk RNAi knock-down cells was strongly de-
creased, indicating the effectiveness of the dsRNA treatment (Fig.
2B). Fig. 2, C and D show the relative expression levels of AttB
(Attacin B) and DptB (Diptericin B), which were significantly
higher in pirk dsRNA-treated cells compared with the GFP
dsRNA-treated controls. In conclusion, pirk RNAi increases Imd
pathway activation in vitro.
Next, we tested whether in vitro overexpression of pirk affects
Imd pathway activity. S2 cells were transfected with luciferase
reporter construct together with either empty or pirk overexpress-
ing pMT vector, and the Imd pathway was activated by adding
heat-killed E. coli to the cells. Relative AttA-luc reporter activities
are shown in Fig. 2E. pirk overexpression reduced Imd pathway
activation by 70%, indicating that Pirk suppresses Imd signaling
in S2 cells.
To study whether Pirk action is Imd pathway specific, we tested
the effect of pirk RNAi on activation of the Toll (Fig. 2F) and
Jak/STAT (Fig. 2G) pathways. For analyzing the Toll pathway, S2
cells were transfected with Drosomycin-luciferase (Drs-luc) re-
porter and, to activate the pathway, constitutively active Toll10B
together with GFP (negative control), dMyd88 (positive control),
or pirk dsRNA. For Jak/STAT pathway, transfections were con-
ducted with TotM-luc reporter together with GFP (negative con-
trol), STAT (positive control), and pirk dsRNAs, and the pathway
was activated by overexpressing the Janus kinase hopscotch. pirk
RNAi did not affect the activity of the Toll pathway. Similar re-
sults were obtained by activating the Toll pathway with an active
form of the Spa¨tzle ligand (data not shown). However, pirk RNAi
significantly reduced Jak/STAT pathway activity. These results in-
dicate that Pirk is not a general inhibitor of signaling cascades in
S2 cells.
Pirk suppresses Imd pathway activity in vivo
To examine the effect of Pirk on Imd pathway activation in vivo,
we first monitored Imd pathway-mediated, antimicrobial peptide
gene expression levels in pirk in vivo in RNAi flies by qRT-PCR.
Two independent UAS-RNAi lines, CG15678 R1 and -R2 were
crossed to C564-GAL4 driver (31) to target pirk-RNAi construct
expression to hemocytes and fat body, and Imd pathway activation
in a week-old offspring was induced by septic injury with E. clo-
acae. w1118 flies were used as a control. Like in vitro (Fig. 2, C and
D), in vivo RNAi of pirk significantly increased AttB, CecB, and
DptB expression levels (Fig. 3, A–C, respectively) at the 4- and 8-h
time points after Gram-negative bacterial infection.
Subsequently, we wanted to investigate whether overexpression
of pirk in vivo was sufficient to reduce Imd pathway activation
upon E. cloacae infection. Therefore, we generated pirk-V5-over-
expressing flies using the UAS-GAL4 system (30). UAS-pirk-V5
flies from two independent lines were crossed over a C564-GAL4
driver. To ascertain that the transgenic pirk was translated to pro-
tein, we homogenized both uninduced and C564-GAL4-induced
pirk transgenic flies in lysis buffer and analyzed the lysates by
Western blotting using anti-V5 Ab (Fig. 4A). To study the Imd
pathway response, the 1-wk-old offspring were exposed to E. clo-
acae by septic injury. AttB, CecB, and DptB expression levels were
analyzed by qRT-PCR at 0 and 4 h postinfection (Fig. 4B-D, re-
spectively). AttB, CecB, and DptB were highly expressed at 4 h
postinfection in control flies. The expression levels were signifi-
cantly lower in pirk-overexpressing flies compared with uninduced
controls. This indicates that Pirk suppresses the Imd pathway ac-
tivity in vivo.
Pirk is a cytoplasmic protein interacting with Imd and
cytoplasmic part of PGRP-LC
Pirk is a 197-aa protein with no recognizable signal sequence or
previously characterized domain structure. No Pirk homologues
have been described from other species, but a tblastn search of the
assembled genomic sequences on the Flybase web site (flybase.bio.
indiana.edu) identified likely orthologs in 18 sequenced holo-
metabolous insect genomes. They all share a central conserved
domain, but the N-terminal and C-terminal regions differ between
different insect orders. The central domain, which we call the Pirk
domain, shows a weakly conserved repetitive structure with three
copies of an 18-aa repeat and two copies of a possibly related
12-aa repeat, referred to as A1–3 and B1–2, respectively (Fig. 5).
In all cases the open reading frames were uninterrupted by introns.
Additional exons may exist, but cDNA and expressed sequence tag
sequences support the absence of introns in Drosophila melano-
gaster, Aedes aegypti, and Bombyx mori. The four different B. mori
sequences probably include allelic variants of two to three paralo-
gous genes. Curiously, we found no homologue in the Anopheles
genome.
Pirk has no recognizable signal sequence and is thus expected to be
an intracellular protein. To test this, we visualized the cellular local-
ization of an expressed GFP-Pirk fusion protein using confocal mi-
croscopy. GFP-Pirk was detected as green dots in the cytoplasm out-
side the blue 4,6-diamidino-2-phenylindole (DAPI)-stained nucleus,
as shown in Fig. 6A. Treatment of GFP-Pirk-expressing S2 cells
with E. coli did not affect Pirk’s localization (data not shown). Pirk
was also detected in cell extracts but not in the cell culture medium
by Western blotting (data not shown). These results imply that Pirk
is a cytoplasmic protein.
To study the mechanism of Pirk-mediated inhibition of Imd sig-
naling, we conducted epistasis analysis using the active form of
Relish. S2 cells were transfected with Rel S29–45 and CuSO4-
inducible pirk construct together with AttA-luc reporter construct
to see whether overexpression of Pirk affected Relish-induced Imd
pathway activity (AttA-luc expression). No effect was detected,
indicating that Pirk is located upstream of Relish in the Imd sig-
naling cascade (Fig. 6B).
The Drosophila Imd pathway also triggers an immediate re-
sponse via JNK pathway, because the JNK pathway branches from
the Imd signaling cascade at the level of Tak1 (22, 41). To find out
whether Pirk suppresses the Imd pathway activity upstream of
Tak1, we analyzed the effect of pirk RNAi on JNK pathway ac-
tivity. This was performed by measuring the expression levels of
a JNK pathway target gene, puc (Puckered), by qRT-PCR. pirk
RNAi increased puc expression in S2 cells (Fig. 6C), indicating
that Pirk negatively regulates the JNK pathway-mediated response
as well. This suggests that Pirk suppresses the Imd pathway ac-
tivity at the level of or upstream of Tak1.
To determine the mechanism for Pirk-mediated Imd pathway
suppression, we coimmunoprecipitated V5-tagged Pirk with the
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Myc-tagged Imd pathway components Iap2, Tak1, Imd, or the cy-
toplasmic tail of PGRP-LC (LC(M1–V293)) in S2 cells. As shown in
Fig. 6D, Pirk coimmunoprecipitated with Imd and the cytoplasmic
part of PGRP-LC. In addition, a faint band was visible in Iap2
samples, but not in Tak1 samples. These results imply that Pirk is
likely to interact with Imd and the cytoplasmic tail of PGRP-LC
and either directly or indirectly with Iap2, but not with Tak1.
Therefore, it is likely that Pirk suppresses Drosophila Imd signal-
ing by interacting directly with Imd and the cytoplasmic part of
PGRP-LC.
To gain more mechanistic insight to the interactions between
Pirk, Imd, and the cytoplasmic tail of PGRP-LC, we created three
Pirk deletion constructs based on the predicted protein structure
described in Fig. 5A and tested whether they coimmunoprecipi-
tate with Imd and PGRP-LC. At first, the expression of these
deletion mutants was confirmed by Western blotting (data not
shown). The N-terminal part of Pirk, Pirk(M1–K51), coimmuno-
precipitated neither with Imd nor the PGRP-LC cytoplasmic tail
(data not shown). Pirk(D52–V136) encoding the Pirk domain co-
immunoprecipitated with Imd (Fig. 7A), whereas the C-terminal
part, Pirk(V137–I197), coimmunoprecipitated with cytoplasmic part
of PGRP-LC (Fig. 7B). In addition, a weak band was detected
when Pirk(D52–V136) coimmunoprecipitated with the cytoplasmic
part of PGRP-LC and when Pirk(V137–I197) coimmunoprecipitated
with Imd. To test whether these deletion constructs mediated the
inhibitory action of Pirk, we monitored Imd pathway activity in S2
cells overexpressing Pirk or Pirk deletion mutants (Pirk(M1–K51),
Pirk(D52–V136), and Pirk(V137–I197)) by luciferase assay (Fig. 7C).
The N-terminal part of Pirk had no effect on Imd pathway activity.
However, both the Pirk domain and the C-terminal part of Pirk
abolished Imd pathway activation. These results implicate that Pirk
interacts with Imd primarily via the Pirk domain and with the
cytoplasmic tail of PGRP-LC via the C-terminal domain. Each of
these domains is capable of suppressing the Imd pathway
activation.
Pirk-overexpressing flies have lower survival rates upon
Gram-negative bacterial infection
To study whether Pirk mediated Imd pathway suppression was
sufficient to impair the fly’s immune response in vivo, we moni-
tored the survival of pirk-overexpressing flies upon Gram-negative
bacterial infection. Three independent UAS-pirk-V5 fly lines were
crossed over C564-GAL4 driver (induced) or w1118 wild-type flies
(uninduced), and the week-old healthy offspring were infected
with E. cloacae by septic injury. C564-GAL4 crossed over w1118
was used as a negative control, and RelishE20 flies as a positive
control. As Fig. 8 shows, the survival rates of the uninduced UAS-
pirk-V5 flies and negative control flies did not differ. However,
C564-GAL4 induced flies had significantly lower survival rates
compared with the uninduced UAS-pirk-V5 flies. This indicates
that overexpression of Pirk suppresses immune response against E.
cloacae in Drosophila in vivo.
Discussion
A malfunctioning immune system can cause severe damage to the
target tissue. NF-B signaling is of paramount importance in reg-
ulating the immune response and thus must be delicately con-
trolled. In mammals, NF-B activation is regulated by posttrans-
lational modifications of NF-B and other pathway proteins. The
primary NF-B inhibitors, however, are IB proteins, which are
expressed in a tissue-specific manner and have different affinities
to individual NF-B protein complexes. The Drosophila IB ho-
mologue Cactus (42) inhibits Toll pathway by binding the NF-B
proteins Dif (Dorsal-related immunity factor) and Dorsal. How-
ever, the Imd pathway transcription factor Relish is inactive until
it is cleaved. Still, signaling events leading to Relish activation
must be carefully regulated, which implies that there are other
IB-independent regulatory mechanisms.
In Drosophila, Imd pathway activation is triggered by diamin-
opimelic acid (DAP)-type peptidoglycan (43), which binds to the
receptor PGRP-LC (44). Recent studies implicate that one way of
regulating the Imd pathway activity is to dampen the initial stim-
ulus. The extracellular proteins PGRP-LB, PGRP-SC1, and
PGRP-SC2 are amidases, which are thought to degrade pepti-
doglycan and thus act as detoxifying proteins (23, 24). This type of
regulation may be especially important when the fly, during all
developmental stages, has to adapt to the presence of commensal
bacteria in the gut without evoking massive production of antimi-
crobial peptides or activating apoptosis pathways. Besides the ex-
tracellular PGRPs, the membrane-bound PGRP-LF has also been
reported to play an immune-suppressing role (45, 25), but the
mechanism of this action is still unknown. Another suggested reg-
ulatory mechanism of the Imd pathway is proteasomal degradation
of either Relish or proteins involved in Relish activation in an SCF
(Skp, Cullin, F-box) complex-dependent manner (26). Others have
reported that Caspar, the Drosophila FAF1 (Fas associated factor
1) homologue, would suppress Imd pathway activation by prevent-
ing Relish cleavage (27). Furthermore, a recent report implies that
the active form of Relish, REL-68, can be displaced from the pro-
moter region by a repressor complex formed by JNK and the Jak/
STAT pathway transcription factors dAP-1 and Stat92e together
with a high mobility group protein Dsp1 (Dorsal switch protein 1),
consequently leading to termination of transcription (28).
In this study we report a novel negative regulatory protein of the
Imd pathway that acts on a different level than the previously char-
acterized negative regulators. Pirk is rapidly induced upon the ac-
tivation of Imd signaling and is likely to mediate its action via
direct interaction with Imd and the cytoplasmic part of PGRP-LC.
Whereas all the known intracellular components of the Imd path-
way are conserved from flies to man, the Pirk sequence is not that
highly conserved. We were unable to identify any clear homo-
logues outside the holometabolous insects. There is a putative do-
main structure (Fig. 5), referred to as the Pirk domain, at the cen-
tral part of the protein that may be present in other species.
FIGURE 5. Conserved repeats in the Pirk protein sequence. A, Schematic outline of the Pirk sequence with the central conserved domain and the
N-terminal and C-terminal regions that are found in the Drosophila species. B, Partial hidden Markov model logo (32) generated by the alignment of the
conserved domain in Pirk, positions 52–136, to the homologous regions in 17 other species. Similarities between the three copies of an 18-aa repeat and
two copies of a 12-aa repeat are emphasized by aligning the corresponding logos under each other. C, Alignment of Pirk homologues from 18 sequenced
insect genomes. The sequence data are from the following: Dmel, Drosophila melanogaster; Dsec, Drosophila sechellia; Dsim, Drosophila simulans; Dyak,
Drosophila yakuba; Dere. Drosophila erecta; Dana, Drosophila ananassae; Dpse, Drosophila pseudoobscura; Dper, Drosophila persimilis; Dwil, Dro-
sophila willistoni; Dmoj, Drosophila mojavensis; Dvir: Drosophila virilis; Dgri. Drosophila grimshawi; Aaeg, Aedes aegypti; Cpip, Culex pipiens; Bmor,
Bombyx mori; Tcas, Tribolium castaneum; Amel, Apis mellifera; and Nvit, Nasonia vitripennis (Ref; 33–40; unpublished sequences are available on the
Baylor and Broad Institute web sites (www.hgsc.bcm.tmc.edu and www.broad.mit.edu).
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Determining whether any functionally or structurally related pro-
teins exist in mammals may require solving of the three-dimen-
sional structure of Pirk. Of note, the receptors of Imd and TNFR
signaling pathways are not conserved. Therefore, the interaction of
Pirk with PGRP-LC may explain why Pirk is not highly conserved
from insects to mammals.
FIGURE 6. Pirk is a cytoplasmic protein that coimmunoprecipitates
with Imd and the cytoplasmic part of PGRP-LC. A, Pirk is localized in the
cytoplasm. S2 cells were transfected with GFP-Pirk fusion protein and
GFP-Pirk expression was thereafter analyzed using confocal microscopy.
B, Pirk is located upstream of Relish in Imd signaling. Pirk overexpression
has no effect on Relish-induced Imd pathway activity. The Imd pathway
was activated by overexpressing the active form of Relish (Rel29–45),
and pirk was expressed under a CuSO4-responsive promoter. Pathway ac-
tivity was measured using AttA-luc reporter. C, Pirk negatively regulates
JNK pathway. Knocking down pirk increases JNK pathway-mediated ex-
pression of puc. S2 cells were treated with pirk dsRNA, JNK signaling was
activated with heat-killed E. coli, and puc expression levels were measured
by qRT-PCR at the indicated time points. D, Pirk coimmunoprecipitates
with Imd and the cytoplasmic tail of PGRP-LC. S2 cells were transfected
with myc-tagged constructs of imd, Iap2, Tak1, or the cytoplasmic tail of
PGRP-LC (LC(M1–V293)) and V5-tagged pirk. Immunoprecipitation (IP)
was done with anti-Myc ( myc) Ab and immunoblotting (IB) with anti-V5
( V5) Ab. Asterisk at the uppermost panel indicates a nonspecific band.
FIGURE 7. Inhibitory action of Pirk is mediated by the Pirk domain and
the C-terminal region of Pirk. A and B, Pirk domain coimmunoprecipitates
with Imd and C-terminal region of Pirk with cytoplasmic tail of PGRP-LC.
In addition, a faint signal is seen when the Pirk domain is immunoprecipi-
tated with PGRP-LC cytoplasmic tail and the C-terminal region of Pirk is
immunoprecipitated with Imd. S2 cells were transfected either with V5-
tagged Pirk domain encoding Pirk(D52–V136) construct (A) or Pirk C-termi-
nal region encoding Pirk(V137–I197) construct (B), and myc-tagged imd or
myc-tagged cytoplasmic part of PGRP-LC (LC(M1–V293)). Immunoprecipi-
tation (IP) was performed using anti-Myc ( myc) Ab, and immunoblotting
(IB) with anti-V5 ( V5) V5 Ab. C, Pirk domain and the Pirk C-terminal
region strongly inhibit Imd signaling. S2 cells were transfected either with
an empty vector, full-length pirk, or deletion constructs (Pirk(M1–K51),
Pirk(D52–V136), and Pirk(V137–I197)) together with an AttA-luc reporter. Imd
pathway was activated by heat-killed E. coli for 24 h.
FIGURE 8. Pirk-overexpressing flies are susceptible to E. cloacae in-
fection. Three independent UAS-pirk-V5 lines (UAS-pirk 221, UAS-pirk 351,
and UAS-pirk 432) were crossed over C564-GAL4 (induced) or w1118 (un-
induced), and the survival of the offspring was monitored after septic injury
by E. cloacae. C564-GAL4 over w1118 and RelishE20 flies were used as
negative and positive controls, respectively.
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Imd pathway regulation is complex and takes place in many
levels. Our current model of Imd pathway regulation is illustrated
in Fig. 9. We suggest that Pirk interacts with Imd primarily via the
Pirk domain and with the cytoplasmic part of PGRP-LC via the
C-terminal region. Curiously, the domain mediating the interaction
between PGRP-LC and Imd is not required for signaling (10, 46),
which raises a question of whether there still are unidentified com-
ponents or adaptor proteins essential for signal transduction. Fur-
thermore, the domain of Imd, which mediates interaction with the
Pirk domain, is currently not known. Whether a similar regulatory
mechanism is applied in mammalian TNFR signaling remains to
be elucidated.
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